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New	  synapses	  are	  generated	   throughout	   life	   to	  enable	  memory	   formation	  and	  retrieval.	  The	  efficacy	  of	  synaptic	  transmission	  must	  be	  precisely	  regulated	  for	  the	   immense	   neuronal	   network	   of	   the	   nervous	   system	   to	   function	   properly.	  Synaptogenesis	   during	   postnatal	   development	   and	   in	   adult	   organisms	   is	   a	  poorly	   understood	   process.	   Many	   synaptic	   organizers	   and	   synaptogenic	  proteins	  have	  been	  found	  but	  their	  precise	  function	  and	  their	  physiological	  role	  often	  remains	  unknown.	  One	  of	  them	  is	  the	  heparan	  sulfate	  proteoglycan	  agrin.	  Agrin	   is	   necessary	   for	   the	   formation	   and	   maintenance	   as	   well	   as	   the	  regeneration	   of	   the	   neuromuscular	   junction,	   the	   synapse	   between	   a	  motoneuron	   terminal	   and	   its	   target	   muscle	   fiber.	   There	   is	   evidence	   for	   the	  transmembrane	   form	  of	   agrin	   (TM-­‐agrin)	   being	   involved	   in	   synaptogenesis	   in	  the	  CNS.	  For	  instance,	  TM-­‐agrin	  overexpression	  in	  various	  cell	  culture	  systems,	  including	  neurons,	  causes	  the	  cells	  to	  produce	  filopodia,	  which	  are	  hypothesized	  to	   constitute	   the	   precursors	   for	   dendritic	   spine	   synapses.	   Moreover,	   mice	  depleted	   for	   agrin	   in	   the	   CNS	   show	   a	   reduction	   in	   the	   number	   of	   dendritic	  spines	   and	   synapses	   as	   well	   as	   fewer	   dendritic	   branches	   and	   impaired	  excitatory	   synaptic	   transmission.	  This	   can	  be	  explained	  by	  TM-­‐agrin	  playing	  a	  role	  in	  synaptogenesis	  and/or	  in	  synaptic	  plasticity.	  	   The	   aim	   of	   this	   thesis	   was	   to	   investigate	   the	   role	   of	   TM-­‐agrin	   in	   the	  formation	  of	  synapses.	  Specifically	  I	  wanted	  to	  address	  the	  following	  questions:	  1.	  Does	  the	  overexpression	  of	  TM-­‐agrin	  induce	  filopodia-­‐like	  processes	  in	  vivo?	  2.	   Does	   overexpression	   of	   TM-­‐agrin	   in	   glutamatergic	   neurons	   affect	   their	  existing	  synapses	  in	  the	  adult?	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Before	  1888,	  it	  was	  widely	  believed	  that	  the	  nervous	  system	  was	  made	  up	  of	  one	   continuous	   network	   of	   tubular	   structures,	   despite	   mounting	   evidence	  that	  all	  organisms	  and	  tissues	  consist	  of	  cells.	  This	  made	  the	  nervous	  system	  the	  only	  exception	   from	   the	   ‘cell	   theory’,	  which	  was	  originally	  proposed	  by	  Matthias	  Schleiden	  and	  Theodor	  Schwann	  in	  1838	  and	  still	  holds	  true,	  stating	  that	   all	   organisms	   are	   composed	   of	   organs	   and	   that	   cells	   constitute	   the	  smallest	  independent	  units	  of	  organs	  (Schleyden	  &	  Schwann,	  1847).	  	  	   However,	   Santiago	   Ramon	   Y	   Cajal	   discovered	   in	   1888	   that	   individual	  nerve	  cells	  are	  responsible	   for	   the	   transduction	  of	  signals	   through	  what	  we	  call	   the	   nervous	   system	   and	   he	   was	   the	   first	   researcher	   to	   describe	   the	  ‘neuron	  doctrine’	  (reviewed	  in	  translation:	  Lopez-­‐Munoz	  et	  al.,	  2006).	  Today	  we	  know	  that	  the	  neuron	  doctrine	  holds	  true.	  Neurons	  of	  the	  nervous	  system	  are	  the	  smallest	  functional	  units	  and	  they	  communicate	  with	  each	  other	  using	  chemical	   synapses	   rather	   than	   forming	   a	   continuous	   tubular	   network.	   At	  synapses,	   nerve	   impulses	   are	   transmitted	   via	   a	   chemical	   neurotransmitter	  between	  individual	  neurons.	  This	  facilitates	  communication	  between	  a	  wide	  range	   of	   different	   cell	   types	   making	   up	   the	   functional	   units	   of	   the	   entire	  central	  and	  peripheral	  nervous	  system	  (CNS	  and	  PNS).	  	   Throughout	   the	   life	  of	   an	  organism,	   synapses	  are	   formed,	  pruned	  and	  removed.	   This	   so-­‐called	   synaptic	   plasticity	   generates	   and	   modulates	  memories,	   allowing	   adaptation	   to	   changing	   environments.	   The	   efficacy	   of	  synaptic	   communication	   needs	   to	   be	   regulated	   precisely	   for	   this	   immense	  neuronal	  network	  to	  function	  properly	  and	  to	  enable	  memory	  formation	  and	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retrieval.	   The	   cerebral	   cortex	   of	   an	   adult	   human,	   for	   instance,	   harbours	   on	  average	  10	  billion	  neurons,	  which	  communicate	  through	  60	  trillion	  synapses	  (Tang	  et	  al.,	  2001).	  Thus,	  the	  formation	  of	  synapses	  as	  well	  as	  their	  changes	  during	  adult	  plasticity	   is	   a	   central	  question	  of	  developmental	  neuroscience.	  Synaptogenesis,	   the	   formation	   of	   new	   synapses,	   which	   for	   the	   largest	   part	  occurs	   during	   early	   postnatal	   development,	   is	   defined	   as	   the	   process	   of	   a	  presynaptic	  membrane	  of	  one	  neuron	   forming	  a	   chemical	   synapse	  with	   the	  postsynaptic	  membrane	  of	   the	  neuron	  receiving	  the	  chemical	  signal.	  During	  this	  process,	  both	  pre-­‐	  and	  postsynaptic	  specializations	  form	  in	  response	  to	  trans-­‐synaptic	   interactions,	   mainly	   of	   trans-­‐synaptic	   adhesion	   proteins	  across	   the	   emerging	   synaptic	   cleft	   (for	   recent	   review	   see	   de	  Wit	   &	   Ghosh,	  2016).	  As	  a	  result,	  the	  presynaptic	  terminal	  forms	  an	  active	  zone	  where	  the	  vesicles	  carrying	  neurotransmitter	  dock	  and	  release	  the	  transmitter	  into	  the	  synaptic	   cleft.	   In	   addition,	   the	   postsynaptic	   density	   forms,	   incorporating	  scaffolding	  proteins	  such	  as	  PSD95	  and	  neurotransmitter	  receptors,	  such	  as	  NMDA	  and	  AMPA	  receptors	  in	  glutamatergic	  postsynapses.	  	  	   Both	   during	   synaptogenesis	   and	   after	   the	   pre-­‐	   and	   postsynaptic	  specializations	   are	   established,	   synapses	   are	   strengthened	   by	   synaptic	  activity,	   the	   postsynaptic	   density	   grows	   in	   size	   and	   incorporates	   a	   larger	  amount	   of	   neurotransmitter	   receptors	   (Matsuo	   et	   al.,	   2008).	   Molecular	  mechanisms	   that	   guide	   synaptogenesis	   during	   development	   are	   very	   likely	  similar	  to	  those	  mechanisms	  that	  are	  responsible	  for	  synaptic	  plasticity	  in	  the	  adult.	  	   Despite	   a	   vast	   amount	   of	   research	   on	   the	   formation	   and	   function	   of	  synapses	  and	  despite	  the	  identification	  of	  many	  synapse	  organizers,	  we	  so	  far	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have	   no	   comprehensive	  model	   of	   how	   a	   particular	   synapse	   is	   formed	   at	   a	  particular	  time	  point	  and	  at	  a	  particular	  position	  in	  the	  CNS.	  In	  contrast	  to	  the	  complex	   situation	   in	   the	  CNS,	   a	   particular	   synapse	   in	   the	  PNS	   is	   fairly	  well	  understood.	  This	   synapse	   is	   the	  contact	   site	  between	  a	  motoneuron	  and	   its	  target	  muscle	   fiber.	   In	   1987,	   the	   key	   regulator	   of	   the	  NMJ	  was	   discovered,	  that	  is	  essential	  for	  the	  formation	  of	  postsynaptic	  specializations	  at	  the	  motor	  endplate:	   the	  heparan	  sulfate	  proteoglycan	  agrin	   (Nitkin	  et	  al.,	  1987).	  Since	  then,	  many	  independent	  lines	  of	  evidence	  have	  shown	  that	  agrin	  is	  involved	  in	  synaptogenesis	  in	  the	  CNS	  as	  well	  (for	  review	  see:	  Kröger	  &	  Pfister,	  2009).	  However,	   the	   precise	  mechanism	   of	   action	   of	   agrin	   in	   the	   CNS	   and	   how	   it	  affects	  synaptic	  structure	  and	  development	  are	  unknown.	  
1.1.	  Synaptic	  organization	  in	  the	  forebrain	  
In	   order	   to	   understand	   how	   synaptic	   organizers	   might	   function	   it	   is	  important	  to	  consider	  the	  structure	  of	  synapses	  in	  the	  CNS.	  George	  Gray	  first	  described	   cortical	   synapses	   in	  detail	   in	   the	   rat	   visual	   cortex	   in	  1959.	  Using	  electron	  microscopy	  he	  characterized	  two	  different	  types	  of	  synapses	  (Gray,	  1959a	  and	  Gray,	  1959b).	  Type	   I	   synapses	   form	  on	  dendritic	   spines	  and	  are	  asymmetric,	   showing	   a	   thicker	   postsynaptic-­‐	   than	   presynaptic	   density.	   The	  presence	   of	   glutamate-­‐immunoreactivity	   in	   electron	   micrographs	   later	  confirmed	  that	  these	  synapses	  use	  the	  neurotransmitter	  glutamate	  (Clements	  et	  al.,	  1990).	  Type	  II	  synapses	  form	  directly	  on	  the	  soma	  or	  on	  the	  dendritic	  shaft	  and	   the	  pre-­‐	  and	  postsynaptic	  densities	  are	  symmetric	  and	   less	  dense	  than	   the	   ones	   of	   type	   I	   synapses.	   Symmetric	   type	   II	   synapses	   were	   later	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shown	  to	  be	  mainly	   inhibitory,	   the	  presynaptic	   terminal	  often	  releasing	   the	  neurotransmitter	  γ-­‐aminobutyric	  acid	  (GABA,	  Chase	  et	  al.,	  1976).	  	  
	  
Figure	   1:	   Type	   I	   (left)	   and	   type	   II	   (top	   and	   bottom	   right)	   synapses	   in	   electron	  
micrographs	   of	   the	   cortex	   of	   adult	   rats.	   Type	   I	   synapses	   exhibit	   the	   typical	  
postsynaptic	   thickening.	   Reproduced	   from	   Gray,	   1959a	   with	   the	   publisher’s	  
permission.	  a:	  Non-­‐thickened	  membranes;	  t:	  dendrite	  tubules;	  den:	  dendrite;	  pre:	  pre-­‐
synaptic	  process;	  m:	  mitochondria;	  my:	  myelin	  sheath.	  	   Neurotransmitters	  other	  than	  GABA	  and	  glutamate	  also	  use	  asymmetric	  type	   I	   and	   symmetric	   type	   II	   synapses.	   Serotonergic	   synapses	   can	   form	  asymmetric	   type	   I	   synapses	   as	   well	   as	   symmetric	   type	   II	   synapses	   (Van	  Bockstaele	   et	   al.,	   1994),	   while	   noradrenergic	   synapses	   have	   been	   found	   to	  form	   symmetric	   type	   II	   synapses	   in	   the	   cat	   spinal	   dorsal	   horn	   (Doyle	   &	  Maxwell,	  1991).	  Axonal	  projections	  of	  dopaminergic	  neurons	  were	  found	  to	  form	  small	  symmetric	  synapses	  with	  dendritic	  spines	  of	  their	  target	  neurons	  in	  the	  rat	  neostriatum	  (Groves	  et	  al.,	  1994).	  Also	  cholinergic	  synapses	  in	  the	  central	   nervous	   system	  have	   been	   found	   to	   be	  mainly	   symmetric,	   although	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Figure	   2:	   Simplified	   schematic	   representation	   of	   the	   molecular	   organization	   of	   an	  
excitatory	  synapse.	  The	  presynaptic	  active	  zone	  is	  depicted	  with	  proteins	  involved	  in	  
vesicle	  docking,	  release	  and	  recycling.	  Cytoplasmic	  and	  vesicular	  transporters	  fill	  the	  
vesicles	   with	   the	   appropriate	   neurotransmitter,	   scaffolding	   proteins	   and	   vesicle-­‐
bound	   SNAREs	   together	   mediate	   precise	   docking	   and	   release	   of	   primed	   vesicles.	  
Vesicles	   are	   released	   in	   response	   to	   Ca2+-­‐influx,	   which	   is	   triggered	   by	   an	   incoming	  
action	  potential.	  Plasma	  membrane	  is	  recycled	  by	  clathrin-­‐mediated	  endocytosis	  and	  
fusion	  of	  recycled	  vesicles	  with	  the	  early	  endosome.	  Adhesion	  molecules	  connect	  the	  
presynaptic	  terminal	  to	  the	  postsynaptic	  density	  (see	  text	  for	  examples).	  Postsynaptic	  
scaffolding	  proteins	  (for	  example	  PSD95)	  cluster	  and	  lock	  neurotransmitter	  receptors	  
in	   the	   postsynaptic	   plasma	   membrane.	   Neurotransmitter	   receptors	   generate	   an	  
excitatory	   postsynaptic	   potential	   upon	   binding	   the	   neurotransmitter,	   which	   might	  
lead	  (after	  spatial	  and	  temporal	  summation)	  to	  the	  formation	  of	  an	  action	  potential	  at	  














































Presynaptic	   Function	   Synapse	  type	   References	  Neurexins	   Adhesion	  to	  neuroligins	  and	  LRRTMs	   Excitatory	  and	  inhibitory	   Reissner	  et	  al.,	  2008;	  de	  Wit	  et	  al.,	  2009	  Glypican	  	  1,	  2,	  3,	  4,	  5	   Adhesion	  to	  LRRTM4,	  synaptogenic	   Excitatory	   de	  Wit	  et	  al.,	  2013;	  Siddiqui	  et	  al.,	  2013	  	   	   	   	  
Postsynaptic	  Neuroligins	   Adhesion	  to	  neurexins	   1,3:	  excitatory	  2,4:	  inhibitory	   Reissner	  et	  al.,	  2008	  LRRTM4	   Adhesion	  to	  glypican	  1	   Excitatory	   de	  Wit	  et	  al.,	  2013;	  Siddiqui	  et	  al.,	  2013	  LRP4	   Unknown	   Excitatory	   Gomez	  et	  al.,	  2014;	  Tian	  et	  al.,	  2006;	  Karakatsani	  et	  al.,	  2016,	  manuscript	  submitted	  	   	   	   	  
Pre-­‐	  and	  postsynaptic	  Agrin	   Unknown	   Possibly	  excitatory	  and	  inhibitory	   Ksiazek	  et	  al.,	  2007;	  McCroskery	  et	  al.,	  2006	  	  Cadherins	  	   Adhesion,	  stability,	  synaptic	  vesicle	  recruitment	  	  
N-­‐cadherin:	  excitatory	  	  E-­‐cadherin:	  inhibitory	  
Yamagata	  et	  al.,	  1995;	  Benson	  and	  Tanaka,	  1998;	  Fiederling	  et	  al.,	  2011	  	  Integrins	   Synaptic	  strength,	  plasticity	   Excitatory	  and	  inhibitory	   Yamagata	  et	  al.,	  1995;	  Kawaguchi	  and	  Hirano,	  2006	  Syndecan	  2	   Adhesion	  to	  LRRTM4,	  synaptogenic	  Spine	  maturation	  through	  EphB	  
Excitatory	   Siddiqui	  et	  al.,	  2013;	  Ethell	  et	  al.,	  2001;	  Ethell	  and	  Yamaguchi,	  1999	  ephrinB	   Synapse	  formation	  by	  binding	  to	  EphB	  receptor,	  presynaptic	  differentiation	  
Excitatory	   Dalva	  et	  al.,	  2000;	  Klein,	  2009;	  Grunwald	  et	  al.,	  2004	  
EphB	   Synaptogenesis	  and	  plasticity,	   Excitatory	   Dalva	  et	  al.,	  2000;	  Klein,	  2009;	  Grunwald	  et	  al.,	  2004	  	   	   	   	  
Astrocyte-­‐secreted	  Thrombospondins	   Synaptogenic	   Excitatory	   Christopherson	  et	  al.,	  2005	  Hevin	   Synaptogenic	   Excitatory	   Kucukdereli	  et	  al.,	  2011	  Sparc	   Anti-­‐synaptogenic	   Excitatory	   Kucukdereli	  et	  al.,	  2011	  Glypican	  4	  and	  6	   Synaptogenic	   Excitatory	   Allen	  et	  al.,	  2012	  	   	   	   	  
Table	   1:	   Proteins	   involved	   in	   synaptogenesis	   and	   synapse	   stability.	   This	   table	  
summarizes	  some	  of	  the	  known	  synapse	  organizers	  and	  is	  not	  exhausting.	  	  
1.2.	  Dendritic	  spine	  morphology	  and	  maturation	  
Most	   glutamatergic	   synapses	   form	   on	   spines	   decorating	   the	   dendrite.	  Dendritic	   spines	   were	   first	   observed	   as	   small	   protrusions	   on	   dendrites	   of	  cortical	  neurons	  in	  the	  early	  works	  of	  Ramon	  Y	  Cajal	  in	  1888,	  using	  the	  silver	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impregnation	   technique	   introduced	   by	   Camillo	   Golgi	   (for	   translations	   of	  original	  observations	  see	  Ramon	  Y	  Cajal,	  1995	  and	  Golgi,	  1989).	  	  	   Dendritic	  spines	  can	  be	  divided	  into	  three	  different	  main	  types	  based	  on	  their	  morphology:	   Filopodia,	   stubby	   spines	   and	  mushroom	   spines	   (Jones	  &	  Powell,	  1969).	  Additionally,	  synapses	  can	  form	  directly	  on	  the	  dendrite	  shaft	  (shaft	   synapses).	  A	  detailed	  electron	  microscopic	   study	  of	   serial	   sections	  of	  the	  developing	  rat	  hippocampus	  CA1	  region	  revealed	  that	  the	  percentages	  of	  different	   types	  of	  synapses	  change	  dramatically	   in	   the	   first	   two	  weeks	  after	  birth,	  the	  period	  during	  development	  when	  most	  synapses	  are	  being	  formed	  (Fiala	   et	   al.,	   1998).	   Between	   postnatal	   day	   1	   and	   postnatal	   day	   12,	   the	  percentage	  of	   filopodia	  carrying	  synapses	  decreases	   from	  22%	  to	  7%	  while	  synapses	   on	   dendritic	   spines	   increase	   from	   5%	   to	   37%.	   The	   number	   of	  synapses	  on	  the	  dendrite	  shaft	  decreases	  from	  53%	  to	  32%	  during	  this	  time.	  These	   observations	   confirmed	   the	   hypothesis	   that	   synapse	   development	  starts	  with	  filopodia	  which	  mature	  to	  mushroom-­‐like	  dendritic	  spines	  (Papa	  et	   al.,	   1995,	   Dailey	   and	   Smith,	   1996,	   for	   review	   on	   excitatory	   synapse	  structure	  see	  Harris	  and	  Weinberg,	  2012).	  	  	   Dendritic	   spines	  not	   only	   increase	   the	  membrane	   surface	  of	   a	   neuron	  but	  also	  create	  a	  locally	  restricted	  area	  for	  protein	  synthesis	  and	  degradation	  (Bourne	  and	  Harris,	  2008).	  Moreover,	  the	  size	  of	  the	  spine	  neck	  represents	  a	  strong	   barrier	   for	   postsynaptic	   electrical	   currents,	   suggesting	   that	   spine	  morphology	   influences	   the	   efficacy	   of	   synaptic	   transmission.	   Long-­‐term	  potentiation	  (LTP),	  the	  most	  extensively	  studied	  form	  of	  synaptic	  plasticity,	  is	  a	   phenomenon	   observed	   at	   glutamatergic	   synapses.	   It	   describes	   the	   long-­‐lasting	   increase	   in	   synaptic	   efficacy	   (determined	   by	   the	   amplitude	   of	   the	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excitatory	  postsynaptic	  potential)	   in	   response	   to	  high	   frequency	  NMDA	   (N-­‐methyl-­‐D-­‐aspartate)	   receptor	   activation	   (Bliss	   and	   Lomo,	   1973).	   LTP	   is	  widely	   regarded	   as	   the	   cellular	   basis	   for	   memory	   formation,	   since	   it	  describes	   a	   use-­‐dependent	   change	   in	   transmission	   and	   is	   accompanied	   by	  changes	   in	   synaptic	   structure,	   such	   as	   dendritic	   spine	   enlargement	   (for	  review	  see	  Blundon	  and	  Zakharenko,	  2008	  and	  van	  Bommel	  &	  Mikhaylova,	  2016).	   Local	   protein	   synthesis	   has	   been	   linked	   to	   long-­‐lasting	   synaptic	  plasticity	  after	  LTP	  induction	  (Pierce	  et	  al.,	  2000;	  Deller	  et	  al.,	  2003).	  
	  
Figure	  3:	  Model	  of	  different	  synapses	  forming	  on	  filopodia,	  spines	  or	  dendritic	  shaft.	  
Branched	  spines	  can	  contact	  more	  than	  one	  axon.	  Adapted	  from	  Fiala	  et	  al.,	  1998	  and	  
Harris	  et	  al.,	  1992	  and	  extensively	  modified.	  	   	  












1.3.	  Agrin	  at	  the	  neuromuscular	  junction	  




Figure	   4:	   Schematic	   representation	   of	   neuromuscular	   junction	   development.	   The	  
approaching	   motoneuron	   growth	   cone	   secretes	   agrin,	   which	   binds	   to	   LRP4	   in	   the	  
muscle	   fiber	  membrane.	   LRP4	   forms	   a	   complex	  with	  MuSK,	   leading	   to	  MuSK	   kinase	  
activation	  and	  downstream	  signaling	  events.	  These	  result	  in	  AChR	  aggregation	  and	  the	  
formation	   of	   junctional	   folds	   in	   the	   muscle	   fiber	   basement	   membrane.	   Nuclei	  
producing	   synapse-­‐specific	   mRNA	   for	   NMJ	   development	   accumulate	   close	   to	   the	  
synaptic	  specializations.	  MuSK:	  muscle	  specific	  kinase;	  AChR:	  acetylcholine	  receptor;	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aggregates	   on	   cultured	   myotubes	   (Nitkin	   et	   al.,	   1987;	   Wallace,	   1989).	  Moreover,	   the	  addition	  of	  anti-­‐agrin	  antibodies,	  which	   inhibit	  agrin	  activity,	  to	   co-­‐cultures	   of	   motoneurons	   and	   myotubes	   reversibly	   inhibits	   the	  clustering	   of	   AChRs	   on	   the	   myotubes	   (Reist	   et	   al.,	   1992).	   These	   results	  provide	  strong	  evidence	  for	  agrin	  being	  the	  chemical	  messenger	  secreted	  by	  the	   approaching	   motoneuron	   growth	   cone	   that	   induces	   the	   postsynaptic	  specializations	   as	   originally	   proposed	   by	   the	   ‘agrin	   hypothesis’	   (McMahan,	  1990;	  Nitkin	  et	  al.,	  1987;	  Campagna	  et	  al.,	  1995;	  Wallace,	  1988).	  	   Secreted	   soluble	   agrin	   binds	   to	   the	   γ-­‐chain	   of	   laminin,	   which	  immobilizes	   agrin	   in	   the	   basal	   lamina	   of	   the	   synaptic	   cleft	   (Denzer	   et	   al.,	  1997;	   Kammerer	   et	   al.,	   1999).	   Conditional	   deletion	   of	   agrin	   from	  motoneurons	   in	  adult	  mice	   leads	   to	   the	   loss	  of	  postsynaptic	  specializations,	  demonstrating	  agrin’s	  essential	  role	  not	  only	  in	  the	  formation,	  but	  also	  in	  the	  maintenance	  of	  the	  neuromuscular	  junction	  (Samuel	  et	  al.,	  2012).	  The	  search	  for	   a	   receptor	   of	   agrin	   at	   the	   muscle	   membrane	   lead	   to	   the	   finding	   that	  myotubes	  lacking	  MuSK	  (muscle-­‐specific	  kinase)	  fail	  to	  exhibit	  AChR	  clusters	  in	   response	   to	   addition	   of	   soluble	   agrin,	   providing	   evidence	   for	   the	   kinase	  being	   necessary	   for	   agrin	   signalling	   (Glass	   et	   al.,	   1996).	   Another	   protein,	  LRP4,	   was	   shown	   to	   bind	   directly	   to	   agrin	   and	   inhibition	   of	   expression	   or	  loss-­‐of-­‐function	  mutation	   of	   LRP4	   results	   in	   a	   decrease	   of	  MuSK	   activation	  and	   AChR	   clustering	   in	   muscle	   cells,	   providing	   evidence	   for	   LRP4	   as	   co-­‐receptor	   for	   agrin	   (Zhang	   et	   al.,	   2008;	   Kim	   et	   al.,	   2008).	   MuSK	  phosphorylation,	   which	   is	   necessary	   for	   its	   activity,	   is	   abolished	   in	   the	  absence	  of	  functional	  LRP4	  (Kim	  &	  Martin,	  2015).	  In	  addition,	  null	  mutations	  in	   any	   of	   these	   three	   genes,	   agrin,	   MuSK	   and	   LRP4,	   result	   in	   perinatal	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lethality	   due	   to	   respiratory	   muscle	   insufficiency	   (Gautam	   et	   al.,	   1996;	  DeChiara	  et	  al.,	  1996;	  Weatherbee	  et	  al.,	  2006).	  When	  analysed	  in	  detail,	  the	  neuromuscular	   junctions	   of	   agrin-­‐deficient	   mice	   appear	   disorganized	   and	  smaller	   in	   size	   in	   several	   different	   muscle	   types	   compared	   to	   the	  heterozygous	   control	   mice.	   The	   absence	   of	   postsynaptic	   organizations	   on	  agrin-­‐deficient	  myotubes	   from	  these	  mutant	  mice	  can	  be	  rescued	  ex	  vivo	  by	  adding	   recombinant	   agrin,	   resulting	   in	   the	   formation	   of	   AChR-­‐aggregates.	  This	  evidence	  shows	  that	   the	   formation	  of	   the	  neuromuscular	   junction	   is	   in	  fact	   agrin-­‐dependent	   (Gautam	   et	   al.,	   1996).	   Most	   of	   the	   motor	   nerve	  terminals	  contained	  very	  few	  neurotransmitter-­‐bearing	  vesicles	  compared	  to	  heterozygous	  control	  mice,	  showing	  that	  even	  presynaptic	  specializations	  are	  aberrant	  in	  agrin-­‐deficient	  mice	  (Gautam	  et	  al.,	  1996).	  	  	   Summarizing	  this	  evidence,	   the	  complex	  of	  LRP4	  and	  MuSK	  is	  thought	  to	  be	  activated	  by	  agrin	  binding	  to	  the	  extracellular	  domain	  of	  LRP4,	  which	  in	  turn	  triggers	  MuSK	  kinase	  activity	  and	  starts	  an	  intracellular	  cascade	  leading	  to	   clustering	   of	   AChRs	   and	   implementation	   of	   pre-­‐	   and	   postsynaptic	  specializations	  necessary	  for	  neuromuscular	  synapse	  function.	  In	  addition	  to	  its	  well-­‐studied	   function	   in	   the	  organization	  of	   the	  neuromuscular	   junction,	  additional	   roles	   of	   agrin	   have	   been	   documented,	   noteworthy	   being	   the	  development	  of	  sympathetic	  ganglia,	  another	  cholinergic	  synapse	  (Gingras	  et	  al.,	  2002).	  The	  sympathetic	  ganglions	  of	  agrin-­‐deficient	  mouse	  embryos	  show	  a	   decrease	   in	   the	   alignment	   of	   pre-­‐	   and	   postsynapses	   by	   around	   40%	   in	  addition	  to	  defects	  in	  synaptic	  transmission	  potentiation.	  This	  suggests	  	  that	  agrin	  is	  also	  essential	  for	  the	  function	  of	  interneuronal	  cholinergic	  synapses	  (Gingras	  et	  al.,	  2002).	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1.4.	  Domain	  structure	  and	  expression	  pattern	  of	  agrin	  
Since	   the	   first	   discovery	   of	   agrin	   in	   1987	   (Nitkin	   et	   al.,	   1987),	   several	  homologues	  have	  been	  found	  in	  different	  species,	  including	  chick,	  rat,	  mouse,	  zebrafish	   and	   human,	   and	   the	   sequences	   are	   highly	   conserved	   (Tsen	   et	   al.,	  1995;	  Tsim	  et	  al.,	  1992;	  Rupp	  et	  al.,	  1991;	  Burgess	  et	  al.,	  2000;	  Groffen	  et	  al.,	  1998).	  	  	   The	   agrin	   gene	   is	   transcribed	   into	   an	   mRNA	   of	   app.	   9	   kb	   that	   is	  subjected	   to	   extensive	   posttranscriptional	   modifications,	   giving	   rise	   to	  several	   alternatively	   spliced	   isoforms.	   Additionally,	   alternative	   first	   exon	  usage	   creates	   a	   transmembrane	   (TM)	   N-­‐terminus	   or	   a	   small,	   globular	   N-­‐terminal	   (NtA)	   domain	   (Burgess	   et	   al.,	   2000;	   Neumann	   et	   al.,	   2001).	   This	  results	   in	   two	   different	   agrin	   proteins,	   one	   membrane-­‐integrated	   and	   one	  secreted	   form.	   Motoneurons	   and	   epithelial	   cells	   express	   the	   NtA-­‐isoform	  predominantly,	  where	  the	  secreted	  protein	  integrates	  into	  the	  adjacent	  basal	  lamina	  by	  binding	  to	  the	  γ1	  subunit	  of	  the	  laminin	  heterotrimers	  (Denzer	  et	  al.,	  1997;	  Mascarenhas	  et	  al.,	  2005).	  The	  TM-­‐isoform	  integrates	   into	  plasma	  membranes	  as	  a	   type-­‐II	   transmembrane	  protein	   in	  an	  Ncyto/Cexo	  orientation	  and	   is	   primarily	   expressed	   by	   neurons	   of	   the	   central	   nervous	   system	  (Neumann	   et	   al.,	   2001;).	   The	   different	   N-­‐termini	   are	   followed	   by	   identical	  protein	   sequences,	   consisting	   of	   different	   structural	   domains,	   such	   as	  follistatin-­‐like	   domains	   and	   laminin-­‐EGF-­‐like	   domains.	   The	   core	   protein	  carries	   the	   glycosaminoglycan	   (GAG)	   side	   chain	   attachment	   sites	   on	   the	  extracellular	  domains	  (Winzen	  et	  al.,	  2003).	  The	  C-­‐terminus	  consists	  of	  three	  globular	  laminin-­‐G	  like	  domains,	  which	  harbour	  two	  alternative	  splicing	  sites	  (named	  y	  and	  z	   in	  rodents).	  Splicing	  at	   these	  sites	  generates	  different	  agrin	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isoforms,	   which	   have	   a	   tissue-­‐specific	   distribution.	   Only	   the	   isoforms	  containing	  an	  insert	  of	  8,	  11	  or	  19	  amino	  acids	  at	  the	  z-­‐site	  are	  synaptogenic	  at	  the	  NMJ	  (Ferns	  et	  al.,	  1993;	  Ruegg	  et	  al.,	  1992).	  For	  details	  on	  agrin	  domain	  structure	  and	  the	  splice	  sites	  see	  Figure	  5.	  
	  
Figure	   5:	   Schematic	   representation	   of	   the	   agrin	   protein	   indicating	   the	   different	  
isoforms	   and	   conserved	   domains.	   The	   structural	   domains	   and	   regions	   involved	   in	  
interactions	   with	   other	   proteins	   in	   different	   tissues	   are	   indicated.	   Alternative	   first	  
exon	   usage	   generates	   two	   different	   N-­‐termini:	   The	   NtA-­‐isoform	   is	   functionally	  
important	   for	   NMJ	   development,	   while	   the	   TM-­‐isoform	   is	   expressed	   in	   the	   CNS.	  
Alternative	  splicing	  at	   two	  major	  splice-­‐sites	  (A	  and	  B	  in	  chick,	  y	  and	  z	   in	  mammals)	  
generates	  several	  different	  C-­‐termini	  with	  different	  synaptogenic	  activity	  at	   the	  NMJ.	  
Proteolytic	   processing	   of	   agrin	   by	   neurotrypsin	   in	   the	   CNS	   generates	   two	   soluble	  
fragments	  (cleavage	  sites	  are	  indicated).	  HB-­‐GAM:	  heparin	  binding	  growth-­‐associated	  
molecule	   (pleiotrophin);	   NCAM:	   Neural	   cell	   adhesion	   molecule;	   LRP4:	   low-­‐density-­‐
lipoprotein-­‐receptor-­‐related	   protein	   4;	   SEA-­‐domain:	   Sea	   urchin	   sperm	   protein-­‐
enterokinase-­‐agrin	  domain.	  Adapted	  and	  modified	  from	  Kröger	  and	  Pfister,	  2009.	  
1.5.	  Transmembrane	  agrin	  in	  the	  central	  nervous	  system	  
NtA-­‐agrin	  is	  essential	  for	  the	  formation,	  maintenance	  and	  regeneration	  of	  the	  neuromuscular	   junction	   (Samuel	   et	   al.,	   2012;	   Werle	   and	   VanSaun,	   2003;	  Gautam	  et	  al.,	  1996;	  for	  review	  see	  Tintignac	  et	  al.,	  2015).	  The	  structural	  and	  
INTRODUCTION	  	  
23	  
functional	   similarities	   between	   the	   NMJ	   and	   synapses	   in	   the	   CNS	   let	   us	  assume	   that	   agrin	   may	   play	   a	   similar	   role	   in	   the	   central	   nervous	   system	  during	   interneuronal	   synapse	   formation.	   Neurons	   of	   the	   CNS	   primarily	  express	  the	  transmembrane	  isoforms	  of	  agrin	  (Neumann	  et	  al.,	  2001).	  One	  of	  the	  first	  milestones	  in	  the	  investigation	  of	  agrin’s	  role	  in	  CNS	  synaptogenesis	  was	   the	   observation	   that	   neurons	   of	   the	   developing	   chick	   retina	   express	  agrin	  isoforms	  during	  the	  period	  of	  synaptogenesis,	  after	  which	  expression	  is	  downregulated	   (Kröger	   et	   al.,	   1996).	   Furthermore,	   neuronal	   isoforms	   of	  agrin	  have	  been	  detected	  in	  the	  synaptic	  cleft	  between	  neurons	  of	  the	  chick	  retina	   by	   electron	   microscopy	   (Koulen	   et	   al.,	   1999;	   for	   reviews	   on	   agrin’s	  involvement	   in	   CNS	   synaptogenesis	   see	   Daniels,	   2012	   and	   Kröger	   and	  Schroder,	  2002).	  	  	   Another	  line	  of	  evidence	  was	  provided	  by	  in	  vitro	  studies	  of	  mammalian	  cells,	   which	   show	   a	   formation	   of	   numerous	   filopodia-­‐like	   processes	   in	  response	  to	  clustering	  of	  agrin	  by	  polyclonal	  antibodies	  raised	  against	  the	  C-­‐terminus	   (Annies	   et	   al.,	   2006).	   Since	   filopodia	   can	   be	   the	   precursors	   of	  dendritic	   spines	   (Papa	   et	   al.,	   1995,	   Dailey	   and	   Smith,	   1996),	   it	   was	  hypothesized	   that	   these	   protrusions	   might	   be	   involved	   in	   spine	   synapse	  formation	   (Annies	   et	   al.,	   2006).	   Likewise,	   overexpression	   of	   the	  transmembrane	   isoform,	   but	   not	   of	   the	   secreted	   isoform	   results	   in	   the	  formation	   of	   similar	   filopodia	   in	   neurons	   as	   well	   as	   non-­‐neuronal	   cells	  (McCroskery	  et	  al.,	  2006;	  Ramseger	  et	  al.,	  2009).	  This	  indicates	  that	  the	  basic	  mechanism	  leading	  to	  filopodia	  formation	  in	  response	  to	  TM-­‐agrin	  signalling	  is	   conserved	   between	   species	   and	   cell	   types.	   Similar	   gain-­‐of-­‐function	  phenotypes	   have	   been	   observed	   in	   response	   to	   overexpression	   of	   other	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known	   synaptic	   proteins,	   such	   as	   syndecan-­‐2	   (Granes	   et	   al.,	   1999),	   Gpm6a	  (Alfonso	   et	   al.,	   2005),	   synaptotagmin	   (Johnsson	   and	   Karlsson,	   2012)	   and	  ASIC1a	  (acid-­‐sensing	  ion	  channel	  1a;	  Zha	  et	  al.,	  2006).	  	  	   	  The	  signalling	  cascade	  leading	  to	  filopodia	  formation	  by	  TM-­‐agrin	  was	  determined	  and	  the	  site	  of	  TM-­‐agrin	  responsible	  for	  filopodia	  induction	  was	  mapped	  in	  neurons	  and	  non-­‐neuronal	  cells	  (Porten	  et	  al.,	  2010).	  The	  region	  within	   the	   agrin	   protein,	   which	   is	   responsible	   for	   filopodia	   induction,	   was	  mapped	   to	   the	   7th	   follistatin-­‐like	   domain	   by	   extensive	   deletion	   studies	  (Porten	  et	  al.,),	  demonstrating	  that	  separate	  domains	  within	  the	  agrin	  protein	  mediate	  AChR	  aggregation	  and	  filopodia	  induction.	  Filopodia	  formation	  was	  demonstrated	  to	  be	  reduced	  after	  treatment	  with	  the	  lipid	  raft	  destabilizing	  agent	   methyl-­‐β-­‐cyclodextrin	   in	   a	   dose-­‐dependent	   manner.	   In	   addition,	   the	  addition	  of	  MAP-­‐kinase	   (mitogen-­‐activated	  protein	  kinase)	  phosphorylation	  inhibitors	   to	   cultured	   retinal	   ganglion	   cells	   results	   in	   a	   dose-­‐dependent	  decrease	   in	  the	  number	  of	  processes	   induced	  by	  TM-­‐agrin	  clustering.	  These	  experiments	   show	   that	   filopodia	   formation	   involves	   the	   formation	   of	   lipid	  rafts	  and	  the	  activation	  of	  MAP-­‐kinases	  (Ramseger	  et	  al.,	  2009).	  	   Further	  evidence	  in	  favour	  of	  the	  hypothesis	  that	  agrin	  is	  important	  for	  CNS	   synapse	   formation	   was	   provided	   by	   a	   study	   knocking	   down	   all	   agrin	  isoforms	   in	   neuronal	   culture.	   These	   cells	   showed	   a	   43%	   decrease	   in	   the	  number	   of	   neuronal	   filopodia	   compared	   to	   mock-­‐control	   infected	   cells.	   In	  addition,	   siRNA	   infected	   cells	   showed	   a	   52%	   decrease	   in	   the	   number	   of	  PSD95-­‐	   and	   synaptotagmin-­‐immunoreactivity	   positive	   puncta.	   This	  demonstrates	  that	  not	  only	  filopodia	  but	  also	  synapses	  are	  markedly	  reduced	  in	  the	  absence	  of	  TM-­‐agrin	  in	  mature	  neurons	  (McCroskery	  et	  al.,	  2006).	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   In	  vivo	  studies	  of	  agrin	  loss-­‐of-­‐function	  are	  complicated	  by	  the	  fact	  that	  agrin	   knock-­‐out	   mice	   exhibit	   perinatal	   lethality	   due	   to	   respiratory	   muscle	  insufficiency	   (Gautam	   et	   al.,	   1996).	   A	   creative	   in	   vivo	   approach	   rescuing	  perinatal	  lethality	  by	  re-­‐expressing	  agrin	  in	  motoneurons	  circumvented	  this	  technical	   issue,	   allowing	   the	   analysis	   of	   agrin-­‐deficient	   brains.	   These	   agrin-­‐deficient	  brains	  show	  a	  decrease	  in	  the	  number	  of	  synaptic	  protein	  clusters	  in	  the	  cortex,	  a	  reduced	  number	  of	  spines,	  a	  change	  in	  dendritic	  morphology	  as	  well	  as	  a	  decrease	  in	  the	  frequency	  of	  spontaneous	  postsynaptic	  currents	  at	  glutamatergic	  synapses	  (Ksiazek	  et	  al.,	  2007).	  All	  of	  these	  alterations	  suggest	  a	  reduced	  number	  of	  specifically	  glutamatergic	  synapses.	  Thus,	  these	  results	  clearly	  indicate	  a	  function	  for	  agrin	  during	  glutamatergic	  synapse	  formation	  in	   the	   CNS.	   However,	   the	   mechanism	   how	   agrin	   regulates	   CNS	  synaptogenesis	  remains	  unknown.	  	   Additional	   evidence	   for	   agrin’s	   involvement	   in	   CNS	   synaptogenesis	   is	  provided	   by	   the	   observation	   that	   agrin	   is	   most	   highly	   expressed	   during	  periods	   of	   synaptogenesis,	   which	   in	   mice	   and	   rats	   occurs	   around	   the	   first	  three	   postnatal	   weeks	   (Li	   et	   al.,	   1997;	   O'Connor	   et	   al.,	   1994).	   After	   this	  period,	  agrin	  expression	  is	  downregulated	  and	  only	  remains	  high	  in	  regions	  of	  synaptic	  plasticity	  such	  as	  the	  hippocampus	  and	  the	  olfactory	  bulb.	  In	  the	  adult	  brain,	  agrin	  mRNA	  levels	  increase	  if	  synapse	  rearrangements	  are	  taking	  place,	   such	   as	   after	   traumatic	   brain	   injury,	   or	   after	   induction	   of	   synaptic	  seizures	   (O'Connor	   et	   al.,	   1995;	   Falo	   et	   al.,	   2008).	   In	   vitro	   cell	   cultures	   of	  cortical	  neurons	  were	  also	  analysed	  for	   the	  agrin	  expression	  timeline	  and	  a	  high	   correlation	   between	   agrin	   upregulation	   and	   the	   emergence	   of	  postsynaptic	   potentials	   was	   observed.	   Interestingly,	   the	   isoform	   profile	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differs	   from	   that	   detected	   at	   the	   NMJ,	   in	   that	   all	   z-­‐splice	   site	   isoforms	   are	  expressed,	  z0,	  z8,	  z11	  and	  z19	  (Li	  et	  al.,	  1997).	  The	  z0	  isoform,	  which	  exhibits	  no	   synaptogenic	  potential	   at	   the	  NMJ,	  was	   found	   to	  be	  as	   abundant	   as	   z19,	  albeit	   with	   different	   expression	   timelines.	   In	   agreement	   with	   this	  observation,	  the	  gain-­‐of-­‐function	  phenotype	  of	  agrin,	  filopodia	  production	  in	  hippocampal	   neuron	   cultures,	   was	   shown	   to	   be	   independent	   of	   y-­‐	   and	   z-­‐splice	   site	   isoforms	   (McCroskery	   et	   al.,	   2006;	   Porten	   et	   al.,	   2010).	   In	  more	  detail,	  a	  highly	  conserved	  asparagine	  residue	  within	  the	  7th	  follistatin	  domain	  of	   TM-­‐agrin	   was	   shown	   to	   be	   essential	   for	   the	   initiation	   of	   filopodia	  production	  (Porten	  et	  al.,	  2010).	  This	  indicates	  that	  the	  mechanism	  by	  which	  agrin	   regulates	   synapse	   development	   in	   the	   CNS	   and	   at	   the	   NMJ	   might	  involve	  different	  protein	  domains,	  and	  in	  conclusion	  also	  different	  receptors.	  	  	   Recently,	   a	   set	   of	   experiments	   investigated	   agrin’s	   function	   during	  synaptogenesis	   in	   adult-­‐born	   neurons	   (Burk	   et	   al.,	   2012).	   This	   study	  made	  use	  of	  the	  observation	  that	  neuronal	  precursors	  from	  the	  subventricular	  zone	  (SVZ)	  migrate	  along	  the	  rostral	  migratory	  stream	  (RMS)	  to	  the	  olfactory	  bulb	  (OB),	   differentiating	   along	   the	  way	   and	   finally	   integrating	   into	   the	   granule	  cell	   layer	   or	   periglomerular	   layer	   of	   the	   OB	   as	   GABAergic	   interneurons	  (Altman,	  1969;	  for	  review:	  Ming	  and	  Song,	  2011).	  After	   injecting	  genetically	  labelled	   embryonically	   derived	   agrin-­‐deficient	   or	  WT	   control	   neurons	   into	  the	  SVZ	  of	  adult	  mice,	  the	  investigators	  followed	  their	  fate	  during	  migration	  to	   and	   integration	   into	   the	   OB.	  While	   agrin-­‐deficient	   neuroblasts	   migrated	  correctly	   to	   the	  OB,	   they	   failed	   to	   integrate	   into	   the	   neuronal	   network	   and	  died	  between	  30	  and	  60	  days	  after	  the	  injection	  (Burk	  et	  al.,	  2012).	  Moreover,	  the	  agrin-­‐deficient	  neurons	  never	  developed	  dendritic	  spines	  and	  had	  a	  much	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less	  complex	  dendritic	  structure.	  Since	  the	  formation	  of	  synapses	  is	  essential	  for	  neuronal	  survival	  this	  evidence	  suggests	  that	  agrin	  signalling	  is	  necessary	  for	  integration	  and	  survival	  of	  new	  interneurons	  in	  the	  OB.	  Since	  none	  of	  the	  analysed	  agrin-­‐deficient	  neurons	  survived	  in	  the	  OB	  after	  60	  days,	  the	  study	  shows	   the	   absolute	   necessity	   of	   agrin	   signalling	   in	   CNS	   neurons,	   similar	   to	  the	  neuromuscular	  junction.	  	   It	   is	   unknown	  how	   agrin	  mediates	   its	   effect	   on	   synaptogenesis	   in	   the	  CNS.	   Several	   candidate	   receptors	   need	   to	   be	   considered.	   They	   should	   be	  concentrated	  at	  CNS	  synapses,	  and	  therefore	  include	  LRP4	  (Tian	  et	  al.,	  2006;	  Ksiazek	  et	  al.,	  2007).	  LRP4	  is	  especially	  interesting	  as	  a	  co-­‐player	  in	  synapse	  organization	   in	   the	   CNS,	   since	   it	   has	   been	   shown	   to	   be	   necessary	   for	   LTP	  induction	   in	   the	   hippocampus,	   and	   mice	   lacking	   LRP4	   in	   the	   CNS	   exhibit	  spatial	  learning	  and	  memory	  deficits	  in	  the	  Morris	  water	  maze	  test	  (Gomez	  et	  al.,	   2014).	   Additionally,	   knocking	   down	   LRP4	   in	   embryonically	   derived	  hippocampal	  and	  cortical	  cultures	  at	  day	  three	  in	  vitro	  results	  in	  a	  significant	  decrease	   in	   the	   number	   of	   primary	   dendrites	   as	   well	   as	   a	   decrease	   in	   the	  number	   of	   dendritic	   spines	   and	   synaptic	   specializations	   visualized	   by	  immunostaining	   of	   presynaptic	   proteins	   bassoon	   and	   synaptobrevin-­‐2	  (Karakatsani	  et	  al.,	  2016,	  manuscript	  submitted).	  Overexpression	  of	  LRP4	  at	  day	  three	  in	  vitro	  conversely	  results	  in	  a	  significant	  increase	  in	  the	  number	  of	  primary	  dendrites,	  dendritic	   spines	  and	   immunostaining	  of	   the	  presynaptic	  markers	   (Karakatsani	   et	   al.,	   2016,	   manuscript	   submitted).	   This	   line	   of	  experiments	   performed	   in	   our	   lab	   shows	   a	   necessity	   for	   LRP4	   in	   normal	  dendritic	  arbour	  and	  synapse	  formation.	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   Knock-­‐out	  mice	   lacking	   LRP4	   expression	   in	   glial	   cells	   and	   neurons	   in	  the	   brain	   show	   a	   significant	   decrease	   in	   miniature	   and	   spontaneous	  excitatory	  postsynaptic	  currents	  and	  impairment	  of	  LTP	  in	  the	  hippocampus	  CA1	  region	  (Sun	  et	  al.,	  2016).	   In	  addition,	  astrocyte-­‐specific	  knock-­‐out	  mice	  show	  impaired	  glutamate	  release	  while	  the	  number	  of	  dendritic	  spines	  does	  not	  appear	  to	  be	  altered	  (Sun	  et	  al.,	  2016).	  These	  studies	  taken	  together	  show	  that	  different	  mechanisms	  involving	  neuronal	  and	  astrocytic	  LRP4	  exist	  that	  are	  controlling	  dendrite	  and	  spine	  number	  and	  electrophysiological	  synaptic	  activity.	  
1.6.	  Aim	  of	  this	  study	  
There	   is	   ample	   evidence	   for	   agrin	   being	   important	   for	   synapse	   formation	  and/or	   function	   in	   the	   CNS.	   However,	   the	   precise	   mechanism	   of	   action	   is	  entirely	  unknown.	  This	  study	  was	  designed	  to	  shed	   light	  on	  the	  mechanism	  by	  which	  TM-­‐agrin	   influences	   synapses	   formation	   and	   function	   in	   the	   CNS.	  Ksiazek	  et	  al.	  conclusively	  showed	  a	  30%	  decrease	  in	  glutamatergic	  synapses	  in	  the	  cortex	  of	  agrin-­‐deficient	  brains	  (Ksiazek	  et	  al.,	  2007).	  This	  observation	  can	  either	  be	  explained	  by	  endogenous	  agrin	  having	  a	  synapse-­‐inducing	  or	  a	  synapse-­‐strengthening	   effect.	   In	   addition,	   overexpression	   of	   the	  transmembrane	   isoform	   of	   agrin	   results	   in	   the	   formation	   of	   filopodia	   in	  neurons	  as	  well	  as	  non-­‐neuronal	  cells	  (McCroskery	  et	  al.,	  2006;	  Ramseger	  et	  al.,	   2009).	   To	   analyse	   whether	   TM-­‐agrin	   overexpression	   induces	   the	  formation	   of	   filopodia	   in	   vivo	   as	   well	   and	   to	   try	   to	   understand	   how	   agrin	  influences	   CNS	   synapses,	   I	   designed	   a	   TM-­‐agrin	   overexpressing	   mouse	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model.	   Specifically,	   I	   aimed	   at	   addressing	   the	   following	   unanswered	  questions:	  	   1.	  Does	  the	  overexpression	  of	  TM-­‐agrin	  induce	  filopodia-­‐like	  processes	  
in	  vivo?	  	   2.	   Does	   overexpression	   of	   TM-­‐agrin	   in	   glutamatergic	   neurons	   affect	  their	  existing	  synapses	  in	  the	  adult?	  	   I	   chose	   the	   CreERT2-­‐system	   of	   inducible	   gene	   expression,	   since	   this	  approach	  ensures	  precise	  tissue-­‐specific	  induction	  of	  expression	  at	  a	  flexible	  time	  point	   chosen	  by	   the	   researcher.	  The	  majority	  of	  neurons	   in	   the	  cortex	  and	   hippocampus,	   the	   CNS	   regions	   most	   extensively	   studied	   for	   TM-­‐agrin	  expression	   and	   function,	   are	   glutamatergic	   pyramidal	   neurons.	   Therefore,	  the	  CamKIIα-­‐promoter	  was	  chosen	  to	  drive	  Cre	  expression,	  since	  its	  activity	  is	  restricted	  to	  glutamatergic	  pyramidal	  neurons	  of	  the	  forebrain	  (Dittgen	  et	  al.,	  2004;	  Erdmann	  et	  al.,	  2007).	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2.	  Materials	  and	  Methods	  
2.1.	  Strategy	  for	  generation	  of	  the	  TM-­‐agrin	  x	  CamKIICreERT2	  mouse	  
line	  
To	  date,	  full-­‐length	  TM-­‐agrin	  had	  only	  been	  cloned	  into	  an	  expression	  vector	  from	   chick	   cDNA	   (Neumann	   et	   al.,	   2001).	   In	   order	   to	   exclude	   any	   artificial	  phenotype	   caused	   by	   the	   overexpression	   of	   a	   species-­‐foreign	   protein,	   I	  cloned	  mouse	  TM-­‐agrin	  (msTMagrin).	  The	  msTMagrin	  cDNA	  was	  recombined	  in	  four	  pieces	  originating	  from	  mouse	  head	  mRNA	  into	  a	  transient	  expression	  vector	  taking	  advantage	  of	  the	  yeast	  (Saccharomyces	  cerevisiae)	  homologous	  recombination	   system	   (Suzuki	   et	   al.,	   1983).	   Homologous	   recombination	   in	  yeast	  has	  two	  significant	  advantages	  over	  traditional	  cloning.	  One,	  yeast	  can	  combine	  several	  pieces	  of	  double-­‐stranded	  DNA	   in	  one	  recombination	  step.	  Two,	  recombination	  cloning	  is	  dependent	  on	  stretches	  of	  30	  to	  40	  base	  pairs	  of	  direct	  homology	  within	  the	  linear	  DNA,	  rather	  than	  exact	  restriction	  sites.	  Thus,	  it	  is	  more	  flexible	  for	  the	  researcher,	  and	  more	  efficient	  than	  traditional	  cloning	  using	  restriction	  enzymes	  and	  ligases.	  	  
2.2.	  Cloning	  and	  assembly	  of	  mouse	  transmembrane	  agrin	  cDNA	  
The	   5’	   region	   of	   the	   agrin	   cDNA	   coding	   for	   the	  N-­‐terminal	   transmembrane	  domain	   as	   well	   as	   the	   3’	   exons	   coding	   for	   the	   C-­‐terminal	   domains	   were	  amplified	   from	   embryonic	   mouse	   head	   cDNA	   (strain	   Bl6N,	   12.5	   days	  postnatal).	   The	   RNA	  was	   purified	   from	   two	   different	  mouse	   heads	   by	   Susi	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Pfeiffer	   (Helmholtz	   Zentrum,	   Neuherberg,	   Germany)	   with	   Trizol	   and	  Phenol/Chloroform	   extraction,	   followed	   by	   Ethanol	   precipitation	   and	  resuspension	  in	  ddH2O.	  The	  RNA	  was	  transcribed	  into	  cDNA	  using	  the	  iscript	  kit	  (Bio-­‐Rad,	  Hercules,	  USA).	  The	  5’	  region	  of	  the	  agrin	  cDNA	  coding	  for	  the	  transmembrane	   part	   of	   agrin	   were	   amplified	   using	   primers	   prAS31	   and	  prAS26	  (for	  primer	  sequences	  and	  PCR	  protocols	  see	  Table	  2).	  The	  3’	  part	  of	  agrin	   was	   amplified	   in	   two	   pieces	   using	   primer	   pairs	   prAS27/prAS28	   and	  prAS29/prAS32,	  respectively.	  All	  PCR	  products	  were	  purified	  by	  agarose	  gel	  electrophoresis	   using	   the	   PCR	   Clean-­‐up	   kit	   (Macherey-­‐Nagel,	   Düren,	  Germany)	   according	   to	   the	  manufacturer’s	   instructions,	   and	   eluted	   in	   25µl	  ddH2O.	  	   The	  remaining	  exons	  coding	  for	  the	  middle	  domains	  of	  the	  protein	  were	  obtained	  by	   restriction	  digest	  of	   the	  pCR-­‐XL-­‐TOPO-­‐BC150703.1-­‐Agrin	  clone	  (Figure	   6,	   Imagene	   Source	   Bioscience,	   Nottingham,	   UK)	   using	   restriction	  enzymes	   SfiI	   and	   ApaLI	   (New	   England	   Biolabs,	   Ipswich,	   USA).	   Since	   SfiI	  restriction	  sites	  are	  partially	  blocked	  by	  methylation,	   the	  source	  vector	  was	  first	  transformed	  into	  a	  dcm-­‐	  dam-­‐	  E.coli	  strain	  (New	  England	  Biolabs)	  and	  re-­‐purified.	   The	   bacterial	   transformation	   was	   performed	   as	   follows:	   The	  plasmid	  DNA	   (1µg	   in	  5µl)	  was	   incubated	  on	   ice	   for	  40min	  with	  10µl	  of	   the	  competent	  bacteria,	  followed	  by	  heat-­‐shock	  at	  42˚C	  for	  30s.	  After	  incubation	  at	  37˚C	  for	  60min,	  the	  cells	  were	  selected	  overnight	  on	  agar	  plates	  containing	  kanamycin.	   Plasmid	   DNA	   from	   kanamycin-­‐resistant	   colonies	   was	   purified	  using	  the	  Zyppy	  Plasmid	  miniprep	  Kit	  (Zymoresearch,	  Irvine,	  USA)	  following	  the	  manufacturer’s	  instructions.	  The	  plasmid	  was	  then	  digested	  using	  200ng	  DNA,	  6	  units	  SfiI	  and	  3	  units	  ApaLI	  in	  NEB4	  buffer	  supplemented	  with	  BSA	  at	  
MATERIALS	  AND	  METHODS	   	  
32	  
a	   final	   concentration	   of	   100µg/ml.	   The	   4029	   bp	   restriction	   fragment	  containing	   the	   middle	   exons	   of	   the	   agrin	   cDNA	   was	   excised	   from	   a	   0.8%	  agarose-­‐ethidium	   bromide	   gel	   on	   a	   blue	   light	   table,	   purified	   using	   the	  NucleoSpin®	  Gel	   and	   PCR	   Clean-­‐up	   kit	   (Macherey-­‐Nagel)	   according	   to	   the	  manufacturer’s	  instructions,	  and	  eluted	  in	  30µl	  ddH2O.	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Figure	  6:	  Vector	  maps	  of	  the	  plasmids	  used	  for	  cloning	  in	  this	  study.	  The	  middle	  piece	  
of	   the	   TM-­‐agrin	   cDNA	   was	   obtained	   by	   restriction	   digest	   from	   PCR-­‐XL-­‐TOPO	  
BC150703.1	  and	  joined	  with	  3	  agrin	  cDNA	  PCR	  fragments	  and	  the	  pMESyeastcassette	  
backbone	   to	  yield	  pAS12.	  The	  TM-­‐agrin	   cDNA	  was	  amplified	   from	  pAS12	  and	  cloned	  
into	   the	   pRosaAI9	   backbone	   by	   ligation	   to	   yield	   the	   targeting	   vector	   pAS20.	   Cre	  
recombinase	   activity	   excises	   the	   stop	   cassette	   in	   pAS20	   and	   activates	   the	   CAG	  
promoter.	  Relevant	  restriction	  sites	  are	  annotated.	  ZeocinR:	  Zeocin	  resistance;	  kanR:	  
Kanamycin	   resistance;	   amp:	   Ampicillin	   resistance;	   CEN6:	   yeast	   centromer	   region;	  
ARSH4:	   yeast	   autonomous	   replication	   sequence;	   URA3:	   uracil	   auxotrophy;	   IRES:	  
internal	  ribosome	  entry	  site;	  hygro:	  Hygromycin	  resistance;	  neo:	  Neomycin	  resistance;	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Amplification	  of	  agrin	  5’	  region	  from	  mouse	  cDNA	  (510	  bp)	  
prAS31	   CGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCACCATGGGCTATCCATATGACGTTCCAGATTACGCTCCTCCTCTGCCACTGGAACACAGACC	  
prAS26	   CAGGTCACATTGGCACAGGGGTCC	  
Pipetting	   Template1µl	   Primers	  each	  1µl	   Buffer	  5µl	   dNTPs	  2µl	   Taq	  polymerase0.25µl	   DeepVent	  0.25µl	   H2O	  39.8µl	  
Cycling	   94˚C	  30s	   65˚C	  -­‐57˚C	  touchdown	  45s	   72˚C	  1min	   25	  cycles	  after	  touchdown	  
Amplification	  of	  first	  agrin	  3’	  region	  piece	  from	  mouse	  cDNA	  (655	  bp)	  
prAS27	   GCTGTGGTTCAAAGCTCTGGTGTGG	  
prAS28	   CCTTGCGGGATTTCGGAGATTCC	  
Pipetting	   Template	  1µl	   Primers	  each	  1µl	   Buffer	  5µl	   dNTPs2µl	   Taq	  polymerase	  0.25µl	   DeepVent	  polymerase	  0.25µl	   H2O	  39.8µl	  
Cycling	   94˚C	  30s	   65˚C	  -­‐	  57˚C	  touchdown	  45s	   72˚C	  1min	   25	  cycles	  after	  touchdown	  
Amplification	  of	  second	  agrin	  3’	  region	  from	  mouse	  cDNA	  (965	  bp)	  
prAS29	   GAATCTCCGAAATCCCGCAAGGTCC	  
prAS32	   GATCCCGGGCCCGCGGTACCGTCGACTGCATCACAGATCCTCTTCTGAGATGAGTTTTTGTTCGAGAGTGGGGCAGGGTCTTAGCTCTG	  GAGAGTGGGGCAGGGTCTTAGCTCTG	  
Pipetting	   Template	  1µl	   Primers	  each	  1µl	   Buffer	  5µl	   dNTPs2µl	   Taq	  polymerase	  0.25µl	   DeepVent	  polymerase	  0.25µl	   H2O	  39.8µl	  
Cycling	   94˚C	  30s	   65˚C	  -­‐57˚C	  touchdown	  45s	   72˚C	  1min	   25	  cycles	  after	  touchdown	  
Amplification	  of	  agrin	  cDNA	  from	  pAS12	  with	  FseI	  sites	  (18167	  bp)	  
prAS60	   CTAGATCGAATTCGGCCGGCCGCCACCATGGGCTATCCATATGACGTTCCAGAT	  
prAS61	   CGAATTCCTGCAGGGCCGGCCTCACAGATCCTCTTCTGAGATGAGTTTTTGT	  
Sequencing	  primers	  
prAS45	   CTGGTTGTTGTGCTGTCTCA	   Sequencing	  pAS12	  forward	  
prAS46	   CCGTCGACTGCATCACAGAT	   Sequencing	  pAS12	  reverse	  
prAS47	   TTGGACATCAACAACCAGCA	   Sequencing	  pAS12	  internal	  prAS48	   ACACCGGCCTTATTCCAAGC	   Sequencing	  pAS12	  internal	  
Table	   2:	   Sequences	   and	   protocols	   for	   DNA	   oligonucleotides	   used	   for	   cloning	   and	  
sequencing.	   The	   part	   of	   the	   sequence	   homologous	   to	   the	   template	   is	   highlighted	   in	  
red,	   added	   sequences	   (linkers,	   restrictions	   sites)	   are	   highlighted	   in	   blue.	   All	   PCR	  
protocols	  included	  an	  initial	  denaturation	  step	  at	  94˚C	  for	  1min	  and	  a	  final	  elongation	  
step	  at	  72˚C	  for	  10min.	  Concentrations	  of	  primer	  stock	  solutions	  (Invitrogen	  Thermo	  
Fisher	   Scientific,	   Waltham,	   USA):	   100µM.	   Mouse	   head	   cDNA	   concentration	   of	   stock	  
solution:	   1.2µg/µl.	   Concentration	   of	   dNTP	   stock	   solution	   (New	   England	   Biolabs):	  
10mM.	   Concentration	   of	   DeepVent®	   polymerase	   (New	   England	   Bioloabs):	   2000	  
units/ml.	   Concentration	   of	   Taq	   polymerase	   (New	   England	   Biolabs):	   5000	   units/ml.	  
PCR	   cycler:	   C1000	   Touch	   Thermal	   Cycler	   (Bio-­‐Rad).	   The	   total	   volume	   per	   vial	   for	  
cloning	  PCR	  protocols	  was	  50µl.	  The	   pMES	   vector	   (Swartz	   et	   al.,	   2001)	  was	   chosen	   as	   backbone	   for	   testing	  overexpression	  of	  the	  agrin	  construct	  in	  vitro,	  since	  it	  also	  includes	  IRES-­‐GFP,	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which	   facilitates	   the	   assessment	   of	   transfection	   efficiency	   (Figure	   6	   vector	  map).	   For	   the	   vector	   to	   be	   used	   for	   yeast	   recombination	   cloning,	   a	   yeast	  cassette	   including	   the	   following	   contents	   was	   added	   (for	   vector	   map	   see	  Figure	   6):	   ARSH4	   (yeast	   autonomous	   replication	   sequence),	   URA3	   (ORF	  encoding	   the	   enzyme	   necessary	   for	   making	   uracil,	   used	   for	   selection	   on	  medium	  lacking	  uracil)	  and	  CEN6	  (yeast	  centromere,	  which	  ensures	  proper	  distribution	   of	   the	   centromeric	   plasmid	   during	   the	   cell	   cycle).	   The	   pMES-­‐yeast-­‐cassette	  plasmid	  was	  linearized	  using	  EcoRI	  (2.8µg	  DNA,	  3	  units	  EcoRI,	  in	  NEB4	  buffer,	   incubation	   for	  1h	  at	  37˚C),	  and	   the	  restriction	  sites	  blunted	  with	   Klenow	   polymerase	   (New	   England	   Biolabs)	   using	   20	   units	   Klenow	  polymerase	  and	  33.3µM	  dNTPs	   (New	  England	  Biolabs)	   in	  NEB2	  buffer.	  The	  blunting	  reaction	  was	  stopped	  after	  15min	  incubation	  at	  25˚C	  by	  addition	  of	  EDTA	  (250mM	  in	  50%	  glycerol)	  and	  incubation	  at	  75˚C	  for	  20min.	  	  	   For	  homologous	  recombination	  cloning,	  the	  yeast	  strain	  CAY29	  (MATa,	  ura3-­‐52)	  was	  prepared	  for	  transformation	  using	  the	  Lithium-­‐Acetate	  (LiOAc)	  protocol	   (Gietz	  &	  Woods,	   2002).	   In	   short,	   a	   yeast	   colony	   from	  an	  YPD-­‐agar	  plate	   (peptone	  20g/L,	   glucose	  20g/L,	   yeast	   extract	  10g/L,	   agar	  20g/L)	  was	  inoculated	   in	   2ml	   of	   two	   times	   concentrated	   YPD	   media	   (peptone	   40g/L,	  glucose	  40g/L,	  yeast	  extract	  20g/L)	  media	  and	  grown	  overnight	  at	  30˚C	  with	  moderate	  shaking.	  This	  saturated	  culture	  was	  then	  diluted	  in	  fresh,	  two	  times	  concentrated	  YPD	  media	  to	  OD600	  =	  0.15	  and	  grown	  for	  three	  generations	  to	  log	  phase	   (OD600	  =	  1.0	   -­‐	  1.2).	  The	   cells	  were	  harvested	  by	   centrifugation	  at	  2500	  x	  g	   for	  2min	  at	  RT	  and	  washed	  once	  with	  10ml	  ddH2O	  and	  once	  with	  5ml	  LiOAc	  (100mM,	  pH8)	  using	  the	  same	  centrifugation	  parameters.	  Finally,	  the	  cell	  pellet	  was	  resuspended	  in	  50µl	  LiOAc	  (100mM,	  pH8),	  and	  the	  linear	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DNA	   fragments	   to	  be	   recombined	  were	  added	   to	   the	   cells	   (20µl	   for	  each	  of	  the	   four	  agrin	   fragments	  and	  0.7µg	   in	  10µl	  vector	  DNA)	   together	  with	  10μl	  carrier	   DNA	   (10mg/ml	   salmon	   sperm	   DNA)	   and	   300μl	   39%	   PEG	   4000	   in	  LiOAc	   (100mM,	   pH8).	   After	   1min	   of	   vortexing,	   the	   transformation	  mixture	  was	   incubated	   at	   42˚C	   for	   40min.	   The	   cell	   suspension	   was	   plated	   onto	   SC	  plates	   (synthetic	   complete	  medium,	   Formedium,	   Norfolk,	   United	   Kingdom)	  lacking	   uracil	   for	   selection	   of	   cells	   containing	   the	   plasmid.	   A	   vector-­‐only	  control	  transformation	  was	  performed	  on	  the	  side,	  showing	  a	  100-­‐fold	  higher	  efficiency	   of	   recombination	   when	   the	   inserts	   were	   included	   in	   the	  transformation.	  	   Plasmids	  that	  have	  recombined	  in	  yeast	  need	  to	  be	  re-­‐transformed	  into	  
E.coli	   in	   order	   to	   produce	   the	   plasmid	   in	   high	   enough	   quantity	   to	   make	  testing	  of	   the	   colonies	  possible.	   For	   recovery	  of	   the	  plasmid	   from	   the	  yeast	  cells,	  I	  took	  advantage	  of	  a	  modified	  plasmid	  prep	  protocol	  using	  the	  buffers	  and	   filter	   columns	   contained	   in	   a	   plasmid	   miniprep	   kit	   (Qiagen,	   Hilden,	  Germany).	   To	   this	   end,	   all	   the	   yeast	   colonies	   from	   one	   plate	   were	  resuspended	  in	  10ml	  TE	  pH8	  buffer.	  This	  suspension	  was	  washed	  once	  with	  10ml	  TE	  pH8	  buffer	  by	  centrifugation	  (as	  above)	  and	  1ml	  was	  transferred	  to	  an	  Eppendorf	   tube	   and	  pelleted	   again	   by	   centrifugation.	   The	   cells	  were	   re-­‐suspended	  in	  200µl	  P1	  buffer	  (Miniprep	  kit,	  Qiagen),	  100µl	  lyticase	  solution	  (5U/µl	   in	   TE	   pH8,	   Sigma-­‐Aldrich,	   Gallen,	   Switzerland)	   was	   added	   and	   the	  mixture	   was	   incubated	   at	   37˚C	   to	   digest	   the	   yeast	   cell	   wall.	   After	   a	   2h	  incubation,	  300µl	  P2	  buffer	  was	  added	  and	  the	  mixture	  was	  incubated	  at	  RT	  for	  10min,	   after	  which	  420µl	  N3	  buffer	  was	  added	  and	   the	  debris	   from	   the	  lysed	   cells	   was	   pelleted	   at	   20,000	   x	   g	   at	   4˚C	   for	   10min.	   The	   supernatant	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containing	   the	  plasmid	  and	  the	  genomic	  DNA	  were	   transferred	   to	  a	  column	  inside	  a	  collection	  tube,	  centrifuged	  at	  20,000	  x	  g,	  and	  washed	  with	  500µl	  PB	  buffer	  and	  700µl	  PE	  buffer	  by	  centrifugation	  for	  1min	  at	  20,000	  x	  g	  each	  time.	  The	  column	  was	  dried	  with	  another	  centrifugation	  and	  the	  DNA	  was	  eluted	  with	  30µl	  EB	  buffer	  by	  heating	  the	  tube	  to	  65˚C	  for	  5min.	  	  	   After	   the	   plasmid	  was	   recovered	   from	   yeast,	   it	   was	   transformed	   into	  
E.coli	   and	   10	   colonies	   were	   screened	   with	   restriction	   digests,	   the	   positive	  clones	  tested	  by	  restriction	  digest	  and	  confirmed	  by	  sequencing	  (sequencing	  primers	  prAS45-­‐prAS48,	  Table	  2).	  	  
2.3.	  Validation	  and	  expression	  of	  mouse	  TM-­‐agrin	  in	  cell	  culture	  
HEK293T	  cells	  (human	  embryonic	  kidney,	  Graham	  et	  al.,	  1977)	  were	  chosen	  for	  validation	  of	  transient	  expression,	  since	  these	  cells	  show	  high	  expression	  rates.	   For	  Western	   blot	   analysis	   of	   the	   expressed	   protein,	   one	   T25	   flask	   of	  HEK293T	   cells	   was	   grown	   overnight	   to	   about	   90%	   confluence,	   and	  transfected	  with	  5µg	  of	  plasmid	  DNA	  using	  the	  Superfect	  transfection	  reagent	  (Qiagen)	   according	   to	   the	   manufacturer’s	   instructions.	   24	   hours	   later,	   the	  cells	   were	   harvested	   in	   1ml	   of	   lysis	   buffer	   (20mM	   HEPES	   pH7.5,	   150mM	  NaCl,	   10%	   glycerol,	   1%	   NP-­‐40,	   1mM	   PMSF,	   1	   protease	   inhibitor	   tablet	  (cOmplete	  Tablets,	  Mini	  EDTA-­‐free,	  EASYpack,	  Roche,	  Basel,	  Switzerland)	  per	  10ml)	  by	  scraping,	  incubation	  on	  ice	  for	  10min	  and	  centrifugation	  for	  15min	  at	  21,000	  x	  g	  and	  4˚C.	  The	  cell	   lysates	  were	   subjected	   to	  electrophoresis	   in	  polyacrylamide	  gels	  (Miniprotean	  TGX	  4-­‐15%	  gradient,	  Bio-­‐Rad)	  at	  120V	  and	  transferred	   to	   nitrocellulose	   membranes	   (Protran,	   Schleicher	   &	   Schuell,	  Sigma-­‐Aldrich).	   The	  membranes	  were	   then	  blocked	  overnight	   in	   10%	   skim	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milk	  powder	   in	  TBS-­‐T	  (100mM	  Tris-­‐HCl	  pH8,	  8.8g/L	  NaCl,	  0.1%	  Tween-­‐20)	  and	   incubated	  with	  primary	  antibody	  diluted	   in	  TBS-­‐T	   containing	  5%	  skim	  milk	  powder	  (rabbit	  anti-­‐mouse	  agrin,	  rat	  anti-­‐HA,	  Table	  5)	  for	  1h,	  washed	  3	  times	  for	  10min	  with	  TBS-­‐T,	  and	  incubated	  1h	  with	  horseradish	  peroxidase-­‐coupled	  secondary	  anti-­‐rabbit	  or	  anti-­‐rat	  antibody.	  	   The	  membranes	  were	  washed	   three	   times	  with	   TBS-­‐T	   for	   10min	   and	  then	   incubated	   with	   horseradish	   peroxidase	   substrate	   (Luminol	   Enhancer	  Solution	  and	  Stable	  Peroxide	  Solution	  in	  equal	  parts,	  PIERCE,	  Thermo	  Fisher	  Scientific,	  Waltham,	  USA)	  and	  the	  luminescence	  signal	  captured	  on	  film.	  	   In	  order	  to	  confirm	  correct	  expression	  and	  insertion	  of	  TM	  agrin	  in	  the	  cell	  membrane,	  and	  to	  confirm	  the	  filopodia-­‐inducing	  phenotype	  of	  TM-­‐agrin	  overexpression,	   the	   cells	  were	   transfected	  with	   the	   full-­‐length	  msTM-­‐agrin	  overexpression	  construct	  in	  the	  pMES	  vector	  and	  stained	  with	  antibodies	  for	  immunofluorescent	  microscopy.	   The	   cells	  were	   plated	   in	   6-­‐well	   plates	   and	  transfected	   as	   above.	   After	   24	   hours,	   the	   cells	   were	  washed	  with	   PBS	   and	  fixed	  with	   100µl	   2%	   formaldehyde	   for	   10min.	   After	  washing	  with	   PBS,	   the	  cells	  were	  blocked	  in	  staining	  solution	  containing	  5%	  BSA,	  0.3%	  Triton	  X-­‐100	  and	  10%	  sheep	  serum	  in	  PBS	  for	  1h.	  The	  cells	  were	  incubated	  overnight	  with	  primary	   antibody	   diluted	   in	   staining	   solution	   (rabbit	   anti-­‐mouse	   agrin,	   rat	  anti-­‐HA,	  mouse	  anti-­‐c-­‐myc,	  Table	  5)	  and	  with	  secondary	  antibody	  for	  1h	  after	  two	   washes.	   After	   50min,	   2mg/ml	   DAPI	   was	   added.	   After	   two	   additional	  washes,	   the	   cells	   were	   embedded	   on	   glass	   slides	  with	  Mowiol	   solution	   (to	  31ml	   240mM	   Tris-­‐HCl	   pH	   8.5	   add	   6g	   Mowiol	   4-­‐88	   and	   18.9g	   Glycerol).	  Epifluorescent	   microscopic	   analysis	   of	   the	   immunostained	   cells	   was	  performed	  with	  an	  Axio	  Imager	  M2	  (Zeiss,	  Oberkochen,	  Germany).	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2.4.	  Cloning	  of	  targeting	  construct	  for	  knock-­‐in	  mouse	  
After	   validation	   of	   the	   expression	   of	   TM-­‐agrin	   in	   vitro,	   the	   cDNA	   was	  transferred	  to	  the	  targeting	  vector	  pAI9	  (Madisen	  et	  al.,	  2010)	  by	  restriction	  digest	   and	   subsequent	   ligation.	   To	   this	   end,	   the	   agrin	   cDNA	  was	   amplified	  from	  pAS12	  by	   long-­‐range	  PCR	  (Table	  2	   for	  primer	  sequences),	  adding	  FseI	  restriction	  sites	  in	  the	  primer	  overhang	  sequences.	  The	  PCR	  product	  and	  the	  pAI9	   vector	   were	   digested	   with	   FseI	   (New	   England	   Biolabs):	   3.5µg	   PCR	  product	  with	  7	  units	  FseI	  and	  100µg/ml	  BSA	  in	  NEB	  buffer	  4;	  2µg	  vector	  with	  6	   units	   FseI	   and	   100µg/ml	   in	   NEB	   buffer	   4;	   incubation	   at	   37˚C	   for	   1h	   and	  inactivation	  at	  65˚C	  for	  20min.	  After	  the	  restriction	  digest,	  the	  vector	  was	  de-­‐phosphorylated	  with	  5	  units	  of	  antarctic	  phosphatase	  (New	  England	  Biolabs)	  by	   incubation	   at	   37˚C	   for	   30min	   and	   subsequent	   inactivation	   at	   65˚C	   for	  10min.	  Both	  the	  vector	  and	  the	  PCR	  product	  insert	  were	  purified	  by	  agarose	  gel	  electrophoresis	  using	  the	  PCR	  Clean-­‐up	  kit	  (Macherey-­‐Nagel)	  according	  to	  the	  manufacturer’s	  instructions,	  and	  each	  eluted	  with	  30µl	  ddH2O.	  	  	   Ligation	   of	   insert	   and	   vector	   was	   performed	   at	   an	   estimated	   ratio	   of	  twice	  the	  molar	  amount	  of	  insert	  to	  vector	  using	  the	  Quick-­‐Ligation	  Kit	  (New	  England	  Biolabs)	  following	  the	  manufacturer’s	  instructions.	  After	  incubation	  at	   room	   temperature	   for	   5min,	   chemically	   competent	   TOP10	   E.coli	   were	  transformed	  with	  5µl	  of	  the	  ligation	  reaction	  mixture	  by	  incubation	  on	  ice	  for	  15min,	  heat	  shock	  (42˚C)	  for	  90s,	  incubation	  on	  ice	  for	  5min,	  recovery	  at	  37˚C	  for	  1h,	  and	  plating	  on	  agar	  plates	  containing	  ampicillin	  for	  selection.	  	  	   Plasmid	  DNA	  from	  ampicillin-­‐resistant	  colonies	  was	  purified	  using	  the	  Zyppy	   Plasmid	   miniprep	   Kit	   (Zymoresearch)	   following	   the	   manufacturer’s	  instructions.	  Positive	  clones	  were	  verified	  by	  restriction	  digest	  using	  FseI	  (1	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unit	   for	  200ng	  plasmid	  DNA	   in	  NEB	  buffer	  4	   supplemented	  with	  100µg/ml	  BSA,	   New	   England	   Biolabs)	   to	   cut	   out	   the	   insert	   or	   SacI	   (1	   unit	   for	   200ng	  plasmid	  DNA	  in	  SacI	  buffer,	  New	  England	  Biolabs),	  which	  cuts	  several	  times	  inside	   the	   insert.	   Correct	   amplification	  and	  orientation	  was	   confirmed	  with	  sequencing	   using	   primers	   prAS28	   and	   prAS26	   for	   forward	   and	   reverse	  sequencing	  including	  the	  tags,	  and	  prAS15,	  prAS16	  and	  prAS104	  for	  coverage	  of	   a	   large	   part	   of	   the	   internal	   sequence.	   This	   cloning	   step	   resulted	   in	   the	  targeting	  vector	  pAS20	  (Figure	  6).	  	  
2.5.	  Validation	  and	  expression	  of	  targeting	  construct	  in	  cell	  culture	  
The	   generation	   of	   a	   knock-­‐in	   mouse	   is	   a	   time-­‐consuming	   process.	   This	  includes	   electroporation	   into	   embryonic	   stem	   (ES)	   cells,	   genotyping,	  validation	  of	   expression	  of	   the	   integrated	   construct,	   and	   injection	  of	   the	  ES	  cells	   into	   foster	   mouse	   females.	   Therefore,	   it	   is	   advisable	   to	   thoroughly	  validate	  any	  construct	  to	  be	  used	  in	  the	  generation	  of	  knock-­‐in	  mouse	  lines.	  To	   ensure	   that	   the	   cDNA	   will	   be	   correctly	   expressed	   only	   after	   Cre	  recombinase	  activation,	  the	  targeting	  construct	  activation	  was	  validated	  both	  in	  the	  test	  tube	  and	  in	  HEK293T	  cell	  culture.	  	  	   The	   TM-­‐agrin	   targeting	   construct	   pAS20	  was	   activated	   by	   excision	   of	  the	  stop-­‐cassette	  with	  Cre	  recombinase	  (New	  England	  Biolabs)	  using	  3	  units	  on	  200ng	  plasmid	  DNA	   in	   the	  supplied	  Cre	  buffer	  by	   incubation	  at	  37˚C	   for	  30min,	   followed	   by	   inactivation	   at	   70˚C	   for	   10min.	   Chemically	   competent	  
E.coli	   were	   transformed	   with	   5µl	   of	   the	   reaction	   mixture	   (transformation	  protocol	  page	  30)	  and	  incubated	  overnight	  at	  37˚C	  on	  agar	  plates	  containing	  ampicillin.	   The	   resulting	   plasmid	   pAS21	   clones	   were	   purified	   using	   the	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Qiagen	  Miniprep	  kit	   (Qiagen)	   following	   the	  manufacturer’s	   instructions	  and	  verified	   by	   restriction	   digests	   with	   MfeI	   (New	   England	   Biolabs).	   Digestion	  with	  MfeI	   resulted	   in	   the	   expected	  band	  of	  20,434	  bp	  versus	   four	  bands	  of	  14,898	   bp,	   5900	   bp	   and	   two	   times	   252	   bp	   for	   the	   control	   plasmid	   pAS20,	  which	  was	  not	  incubated	  with	  the	  Cre	  recombinase.	  	  	   The	   conditional	   targeting	   construct	  was	   co-­‐transfected	   into	  HEK293T	  cells	  with	  and	  without	  pNLSCre	  (expressing	  Cre	  recombinase	  with	  a	  nuclear	  localization	   signal,	   pPGK-­‐Cre-­‐bpA;	   Gu	   et	   al.,	   1993)	   to	   test	   the	   baseline	  expression	  and	  the	  expression	  after	  Cre	  activity	  in	  vitro.	  To	  this	  end,	  6	  x	  106	  cells	   on	   PDL-­‐coated	   coverslips	   were	   transfected	   with	   the	   following	  combinations	  of	  plasmids	  (0.8µg)	  in	  a	  24-­‐well	  format:	  	  1) pAS20	  (TM-­‐agrin	  in	  pAI9	  targeting	  vector)	  alone	  	  2) pAS20	  and	  pNLSCre,	  	  3) pAI9	  (empty	  targeting	  vector)	  and	  pNLSCre	  4) pAS12	  (TM-­‐agrin	  in	  pMES	  vector)	  5) pMES	  (empty	  vector	  for	  transient	  expression)	  Lipofectamine	  (2µl	  per	  well,	  Invitrogen	  Thermo	  Fisher	  Scientific)	  was	  used	  to	  transfect	  HEK293T	  cells	   according	   to	   the	  manufacturer’s	   instructions.	  After	  24	  hours	  of	  expression,	  the	  cells	  were	  washed	  with	  PBS	  and	  fixed	  with	  100µl	  2%	  formaldehyde	  in	  PBS	  for	  10min.	  After	  washing	  twice	  with	  PBS,	  to	  reduce	  unspecific	  immunoreactive	  signals,	  unspecific	  binding	  sites	  on	  the	  cells	  were	  blocked	  using	   staining	   solution	   containing	  5%	  BSA,	   0.3%	  Triton	  X-­‐100	  and	  10%	   sheep	   serum	   in	   PBS	   for	   1h.	   The	   cells	   were	   incubated	   overnight	   with	  primary	   antibody	   diluted	   in	   staining	   solution	   (rabbit	   anti-­‐mouse	   agrin,	   rat	  anti-­‐HA,	   mouse	   anti-­‐c-­‐myc,	   Table	   5	   for	   dilutions	   and	   sources)	   and	   with	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secondary	  antibody	  for	  1h.	  After	  50min	  incubation,	  2mg/ml	  DAPI	  was	  added	  to	  the	  antibody	  solution.	  After	  two	  more	  washes,	  the	  cells	  were	  embedded	  on	  glass	   slides	   with	   Mowiol	   and	   epifluorescent	   microscopic	   analysis	   of	   the	  immunostained	  cells	  was	  performed	  on	  an	  Axio	  Imager	  M2	  (Zeiss).	  
2.6.	  Generation	  of	  knock-­‐in	  mice,	  breeding	  of	  mice,	  and	  genotyping	  
Electroporation	  of	   the	   linearized	  targeting	  construct	  pAS20	   into	  E14	  mouse	  embryonic	   stem	   cells,	   verification	   of	   correctly	   targeted	   clones	   by	   PCR	   and	  injection	   of	   the	   ES	   cells	   carrying	   the	   TM-­‐agrin	   knock-­‐in	   into	   mouse	  blastocysts	  was	  performed	  by	  Susanne	  Pfeiffer	  in	  collaboration	  with	  Dr.	  Joel	  Schick’s	  laboratory	  at	  the	  Helmholtz	  Zentrum	  Munich.	  	   	  Female	  mice	   that	   were	   implanted	   with	   the	   injected	   blastocysts	   from	  BDF-­‐1	  donor	  females	  (black	  coat,	  Charles	  River)	  were	  bred	  to	  BL6J	  males	  and	  chimeras	  showing	  at	   least	  70%	  chimerism	  (estimated	  by	  brown	  coat	  colour	  showing	   E14	   stem	   cell	   transmission)	   were	   picked	   for	   breeding	   to	   test	  germline	   transmission.	   The	   TM-­‐agrin	   knock-­‐in	   mice	   were	   bred	   to	   a	  CamKIICreERT2	   transgenic	   line	   (Erdmann	   et	   al.,	   2007),	   in	   which	   Cre	  recombinase	   activity	   can	   be	   conditionally	   switched	   on	   by	   tamoxifen	  administration.	  All	  the	  mice	  analysed	  in	  this	  study	  were	  bred	  to	  BL6J	  mice	  for	  at	   least	   3	   generations.	   Agrn//CamKIICre/WT	   mutant	   mice	   and	  WT/WT//CamKIICre/WT	  control	  siblings	  were	  given	  3	  injections	  in	  week	  5	  (Monday-­‐Wednesday-­‐Friday)	  with	   2mg	   tamoxifen	   (Sigma-­‐Aldrich)	   in	   100µl	  Mygliol	  (Caelo,	  Hilden,	  Germany)	  and	  analysed	  between	  week	  7	  and	  week	  11.	  For	  Western	  blot	  analysis	  of	  protein	  levels	  and	  qPCR,	  the	  mice	  were	  fed	  a	  diet	  containing	  400mg/kg	  tamoxifen	  (LASCRdietTM	  CreActive	  TAM400,	  LasVendi,	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Soest,	   Germany)	   for	   2	   weeks,	   during	   which	   their	   growth	   rate,	   weight	   and	  behaviour	  was	  monitored,	  and	   then	  had	  access	   to	   regular	   food	   for	  3	  weeks	  for	  recovery	  and	  expression.	  	   The	  tails	  of	  the	  mouse	  litters	  were	  clipped	  3	  weeks	  after	  birth	  and	  the	  mouse	  tail	  tips	  were	  lysed	  using	  100µl	  50mM	  NaOH	  by	  incubation	  at	  99˚C	  for	  30min	   and	   neutralization	   by	   addition	   of	   30µl	   1M	   Tris-­‐HCl	   pH	   7.5.	   The	  CamKIICreERT2	  allele	  was	  analysed	  with	  primers	  prAS116	  and	  pRAS118	  and	  the	  TM-­‐agrin	  allele	  was	  analysed	  using	  primers	  prAS15	  and	  prAS104	  (Table	  3).	  The	  genotyping	  of	  all	  mice	  used	  in	  experiments	  was	  confirmed	  at	  the	  time	  of	  tissue	  preparation.	  
Genotyping	  of	  TM-­‐agrin	  knock-­‐in	  allele	  (product:	  1376	  bp)	  
prAS15	   TACTCCTCTACAATGGGCAG	  
prAS104	   GCCACAACTCCTCATAAAGA	  
Pipetting	   Template	  1µl	   Primers	  each	  0.1µl	   Buffer	  2.5µl	   dNTPs	  0.7µl	   Taq	  polymerase	  0.3µl	   H2O	  20.3µl	  
Cycling	   95˚C	  15s	   57˚C	  45s	   72˚C	  90s	   40	  cycles	  




prAS118	   GCTTGCAGGTACAGGAGGTAGT	  
Pipetting	   Template	  1µl	   Primers	  each	  0.1µl	   Buffer	  2.5µl	   dNTPs	  0.5µl	   Taq	  polymerase	  0.2µl	   H2O	  20.6µl	  
Cycling	   95˚C	  15s	   62˚C	  45s	   72˚C	  45s	   35	  cycles	  
Table	  3:	   Sequences	  and	  protocols	   for	  DNA	  oligonucleotides	  used	   in	   genotyping.	  PCR	  
protocols	  included	  an	  initial	  denaturation	  step	  at	  95˚C	  for	  3min	  and	  a	  final	  elongation	  
step	  at	  72˚C	  for	  10min.	  Concentration	  of	  dNTP	  stock	  solution	  (New	  England	  Biolabs):	  
10mM.	  Concentration	  of	  Taq	  polymerase	  (New	  England	  Biolabs):	  5000	  units/ml.	  PCR	  
cycler:	  C1000	  Tough	  Thermal	  Cycler	  (Bio-­‐Rad).	  	  
2.7.	  Quantitative	  Western	  blot	  analysis	  of	  protein	  levels	  
The	   mice	   were	   anaesthetized	   with	   carbon	   dioxide	   and	   killed	   by	   cervical	  dislocation.	   The	   extracted	   brains	   were	   snap-­‐frozen	   in	   liquid	   nitrogen	   and	  lysed	  for	  initial	  determination	  of	  agrin	  levels.	  For	  detailed	  analysis	  of	  protein	  levels	  in	  the	  cortex	  and	  hippocampus,	  brains	  were	  further	  dissected	  and	  the	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subregions	   separately	   snap-­‐frozen.	   The	   tissue	   was	   homogenized	   by	  homogenization	   in	   lysis	   buffer	   on	   ice	   (10mM	  Tris-­‐HCl	   pH7.5,	   10mM	  EDTA,	  0.5mM	   PMSF	   one	   cOmplete	   tablet,	   Roche,	   per	   50ml)	   using	   a	   glass	   pistil	  homogenizer	  (Figure	  7).	  The	   lysate	  was	  centrifuged	  at	  2500	  x	  g	  and	  4˚C	   for	  30min	  and	  the	  pellet	  containing	  cell	  debris	  and	  nuclei	  was	  discarded.	  	  
	  













Denaturation in SDS-bu!er 
at 95˚C for 3min
Denaturation in SDS-bu!er containing
 2M Urea at 37˚C for 10min
Centrifugation at 4˚C and 2500xg for 30min 
Centrifugation at 4˚C 
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membrane	   fraction	   was	   denatured	   by	   adding	   8M	   urea	   to	   the	   SDS	   sample	  buffer	  and	  the	  sample	  was	  heated	  at	  37˚C	  for	  10min.	  	  	   The	   proteins	   were	   separated	   in	   10%	   polyacrylamide	   gels	   by	  electrophoresis	   in	   running	   buffer	   (25mM	   Tris	   base,	   192mM	   Glycine,	   0.1%	  SDS)	   at	   constant	   80V	   and	   transferred	   onto	   nitrocellulose	   membranes	  (Protran,	  Schleicher	  &	  Schuell,	  Thermo	  Fisher	  Scientific)	  at	  constant	  140mA	  for	  2h.	  The	  membranes	  were	  blocked	  in	  10%	  skim	  milk	  powder	  TBS	  (100mM	  Tril-­‐HCl	   pH8,	   8.8g/L	  NaCl)	   overnight	   and	   incubated	  with	  primary	   antibody	  (for	  antibodies	  used	  in	  quantitative	  Western	  blotting,	  see	  Table	  5)	  diluted	  in	  5%	  horse	  serum	  TBS-­‐T	  (100mM	  Tril-­‐HCl	  pH8,	  8.8g/L	  NaCl,	  0.1%	  Tween-­‐20)	  for	   3h.	   After	   three	   10min	  washing	   steps	  with	   TBS-­‐T,	   the	  membranes	  were	  incubated	   with	   secondary	   anti-­‐rabbit	   or	   anti-­‐mouse	   antibody	   for	   1h,	   and	  again	   washed	   3	   x	   10min.	   For	   antibodies	   used	   in	   quantitative	   Western	  blotting,	  see	  Table	  5.	  For	  quantitative	  analysis	  of	  protein	  levels,	  the	  Odyssey	  infrared	   scanner	   system	   (Licor,	   Lincoln,	   USA)	  was	   used	   for	   imaging	   of	   the	  protein	  bands	  and	   the	   integrated	  pixel	  density	  of	  each	  band	  was	  quantified	  using	  ImageJ	  software	  (National	  Institute	  of	  Health,	  Bethesda,	  USA).	  
2.8.	  Nissl	  histology	  
Mice	   were	   intracardially	   perfused	   with	   4%	   paraformaldehyde	   in	   PBS	   for	  20min	  after	  anaesthetization	  with	  CO2	  and	  cervical	  dislocation.	  Whole	  brains	  were	   removed	   and	   post-­‐fixed	   in	   4%	   paraformaldehyde	   overnight.	   Fixed	  brains	  were	  washed	  once	  with	  PBS	  and	  then	  cryoprotected	  with	  30%	  sucrose	  in	  H2O	  for	  48	  hours.	  To	  ensure	  proper	  alignment	  of	  the	  sagittal	  sections,	  the	  brains	   were	   cut	   at	   the	   midline	   and	   both	   hemispheres	   were	   embedded	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separately	  in	  O.C.T.	  compound	  (Tissue-­‐Tek,	  Sakura,	  Torrance,	  USA)	  with	  the	  cut	  surface	  facing	  down.	  Starting	  at	  the	  midline	  section,	  50µm	  sections	  were	  cut	  using	  a	  cryostat	  (Leica	  Microsystems,	  Wetzlar,	  Germany).	  Sections	  were	  cut	  precisely	  parallel	  to	  the	  midsagittal	  plane	  and	  every	  section	  was	  counted.	  	  	   The	  sections	  were	  stained	  with	  Cresyl	  Violet	  following	  the	  Cold	  Spring	  Harbour	   protocol	   for	   Nissl	   stains	   (Paul	   et	   al.,	   2008).	   After	   imbedding	  with	  Permount	  mounting	  medium	   (Thermo	   Fisher	   Scientific),	   the	   sections	  were	  imaged	  using	  bright	  field	  microscopy.	  
2.9.	  Golgi	  histology	  
Mice	  were	  killed	  by	  cervical	  dislocation	  after	  anaesthetization	  by	  CO2	  and	  the	  brains	  were	  removed.	  The	  brains	  were	  stained	  using	  the	  FD	  Rapid	  Golgi	  stain	  kit	   (FD	   Neurotechnologies,	   Columbia,	   USA)	   following	   the	   manufacturer’s	  instructions.	   After	   3	  week	   incubation	  with	   solutions	   A,	   B	   and	   C,	   the	   brains	  were	   snap-­‐frozen	   in	   isopentane.	   After	   1min	   the	   specimen	   were	   mounted	  directly	  on	  tissue	  holders	  using	  distilled	  water	  on	  dry	  ice	  and	  cut	  into	  200µm	  sections.	  Staining	  of	   the	  sections	  was	  done	  according	   to	   the	  FD	  Rapid	  Golgi	  stain	   kit	   manual.	   After	   imbedding	   with	   Permount	   mounting	   medium,	  brightfield	   microscopic	   analysis	   was	   performed	   on	   an	   Axio	   Imager	   M2	  (Zeiss).	  
2.10.	  Immunohistochemistry	  
Agrn/Cre	   and	   WT/Cre	   mice	   were	   injected	   with	   tamoxifen	   in	   week	   5	   and	  perfused	  with	  4%	  PFA	  in	  week	  8.	  Whole	  brains	  were	  removed	  and	  post-­‐fixed	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in	  4%	  paraformaldehyde	  overnight.	  Fixed	  brains	  were	  washed	  once	  with	  PBS	  and	  then	  cryoprotected	  using	  30%	  sucrose	  in	  H2O	  for	  48	  hours.	  Whole	  brains	  were	   embedded	   in	   Tissue-­‐Tek	   (Tissue-­‐Tek,	   Sakura)	   and	   cut	   sagittally	   on	   a	  cryostat	   into	   20µm	   thick	   sections.	   The	   sections	   were	   mounted	   onto	  gelatine/chromealumn-­‐coated	  glass	  slides	  and	  dried	  for	  30min.	  	  	   The	  dry	  sections	  were	  surrounded	  by	  Roti®-­‐Liquid	  Barrier	   (Carl	  Roth,	  Karlsruhe,	  Germany),	  washed	  once	  with	  PBS,	  and	  treated	  with	  proteinase	  K	  (20µg/ml	  in	  10mM	  Tris-­‐HCl	  pH7.5	  1mM	  EDTA)	  at	  37˚C	  for	  10min	  to	  ensure	  accessibility	   of	   the	   synaptic	   antigens.	   After	   this	   pre-­‐treatment,	   the	   sections	  were	   blocked	   and	   stained	   as	   previously	   described	   (Tsen	   et	   al.,	   1995)	  with	  antibodies	  raised	  against	  PSD95	  and	  bassoon.	  Confocal	  microscopic	  analysis	  of	  the	  immunostained	  mouse	  brain	  sections	  was	  performed	  on	  laser	  scanning	  confocal	  microscope	   (Imager	  Z1,	   LSM710	  Axio,	   Zeiss)	   and	   the	   images	  were	  analysed	   using	   ImageJ	   (National	   Institute	   of	   Health).	   Perfusion,	  cryosectioning,	   staining	   and	   imaging	   of	   the	   mutant	   and	   control	   littermate	  mice	   were	   done	   blind	   and	   side-­‐by-­‐side	   using	   identical	   parameters	   and	  settings.	  	  	   To	   determine	   if	   a	   correlation	   between	   TM-­‐agrin	   overexpression	   and	  density	   and	   size	   of	   individual	   synaptic	   puncta	   exists,	   the	   confocal	   images	  were	  analysed	  blind	  using	  identical	  settings	  of	  the	  microscope	  and	  processed	  using	   the	   ImageJ	   software	   (National	   Institute	   of	   Health).	   The	   images	   were	  processed	   as	   follows:	   the	   look-­‐up-­‐tables	   were	   changed	   to	   grey	   scale	   and	  inverted,	   then	   an	   identical	   threshold	   was	   applied	   across	   the	   entire	   set	   of	  images,	  chosen	  to	  show	  the	  high	  intensity	  as	  well	  as	  the	  low	  intensity	  staining	  (compare	  image	  analysis	  method:	  Pribiag	  et	  al.,	  2014).	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   The	  threshold	  binary	  images	  were	  used	  for	  fraction	  area	  quantification.	  To	   measure	   the	   area	   fraction	   covered	   by	   synaptic	   staining,	   a	   threshold	  between	   the	   Agrn/Cre	   and	   WT/Cre	   staining	   was	   set	   for	   the	   entire	  experiment,	   and	   the	   fraction	   area	   covered	   by	   threshold	   staining	   was	  measured	  with	  ImageJ	  software	  (National	  Institute	  of	  Health,	  Bethesda,	  USA).	  Fraction	  area	  measurements	  were	  collected	  from	  three	  mice	  per	  genotype	  in	  12	   to	   36	   images	   per	   mouse.	   All	   parameters,	   including	   scanning	   laser	  intensity,	  were	  identical	  across	  experiments.	  
2.11.	  RNA	  extraction	  and	  quantitative	  PCR	  
For	   detailed	   analysis	   of	   expression	   levels	   in	   the	   cortex	   and	   hippocampus,	  mouse	   brains	   were	   prepared	   as	   described	   in	   section	   2.6.	   and	   further	  dissected	   in	   PBS	   using	   a	   stereo	   binocular	   microscope	   (Leica	   MZ6,	   Leica	  Microsystems).	   The	  brain	   subregions	  were	   separately	   snap-­‐frozen	   in	   liquid	  nitrogen.	  	  	   To	   extract	   and	   preserve	   total	   RNA,	   30mg	   of	   tissue	  were	   ground	  with	  pestles	   fitting	  microtubes	  (Eppendorf	  micropestles,	  Sigma-­‐Aldrich)	   in	   liquid	  nitrogen	  and	   RNA	   was	   extracted	   using	   the	   SV	   Total	   RNA	   Isolation	   System	  (Promega,	  Madison,	  USA).	  The	  RNA	  was	  eluted	  with	  100µl	  nuclease-­‐free	  H2O	  and	   the	  quality	  was	  assessed	  using	  a	  Nanodrop	  spectrophotometer.	  To	   test	  the	   integrity	   of	   the	   total	   extracted	   RNA	  by	   agarose	   gel	   electrophoresis,	   the	  samples	   were	   prepared	   as	   follows:	   8µl	   RNA,	   4µl	   nuclease	   free	   H2O,	   10µl	  formamide,	  3.2µl	  37%	  formaldehyde	  8µl	  of	  4.5%	  ethidium	  bromide,	  6µl	  DNA	  sample	   buffer	   (NEB),	   heated	   at	   65˚C	   for	   10min	   and	   electrophoresed	   on	   an	  agarose	  gel	  containing	  1%	  agarose	  and	  6.7%	  Formaldehyde	   in	  MOPS	  buffer	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(20mM	  MOPS,	  5mM	  Na	  acetate,	  1mM	  EDTA).	  After	  the	  quality	  of	  the	  RNA	  was	  confirmed,	  the	  RNA	  was	  reverse	  transcribed	  into	  cDNA	  using	  the	  Quantitect	  Reverse	   Transcription	   Kit	   (Qiagen)	   following	   the	   manufacturer’s	  instructions.	  	  	   For	   assessing	   expression	   levels	   of	   genes	   possibly	   affected	   by	  transmembrane	  agrin	  overexpression,	  the	  following	  intron-­‐spanning	  primers	  were	  designed	  using	  the	  online	  Universal	  ProbeLibrary	  Assay	  Design	  Center	  (Roche	  and	  Diagnostics,	  2009).	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Genes	   Primers	   Product	  
Agrn	  	   5’:	   GCTACTTCTACGTTGGGCTTTG	   114	  nt	  
(agrin)	   3’:	   TGCAGAGTGCCAATGATCTC	   	  
Bsn	  	   5’:	   TTTAACCCAACACCGCATCT	   67	  nt	  
(bassoon)	   3’:	   GCCGCTTAGTTTGGCAGTT	   	  
Dlg3	  	  
(SAP-­‐102)	  
5’:	  	   AACCGGGACTGGTATGAGC	  3’:	  	   TGCCATTCACCGATAGGC	   85	  nt	  
Gria1	  	  
(AMPA	  receptor	  subunit	  1)	  
5’:	  	   AGGGATCGACATCCAGAGAG	  3’	  :	  	   TGCACATTTCCTGTCAAACC	   63	  nt	  
Grin1	  	   5’:	  	   GCTGGAGGAGCGTGAGTC	   66	  nt	  
(NMDA	  receptor	  subunit	  1)	   3’	  :	  	   AGCAGAGCCGTCACATTCTT	   	  
Vamp2	   5’:	  	   CCAAGCTCAAGCGCAAAT	   112	  nt	  
(Synaptobrevin)	   3’	  :	  	   GGGATTTAAGTGCTGAAGTAAACG	   	  
Syp	   5’:	  	   CAAGGCTACGGCCAACAG	   72	  nt	  
(Synaptophysin)	   3’	  :	  	   TCGTGGGCTTCACTGACC	   	  
Gabra1	   5’:	  	   GCCCACTAAAATTCGGAAGC	   83	  nt	  
(GABAA	  receptor,	  subunit	  α)	   3’	  :	  	   CTTCTGCTACAACCACTGAACG	   	  
Gphn	   5’:	  	   TGGTCTCATCAGTTATTCCCATC	   72	  nt	  
(Gephyrin)	   3’	  :	  	   CGAGAAATGATGGAGTCTGGA	   	  
Unc13a	   5’:	  	   CAATGCCTTGGCAGATGATA	   96	  nt	  
(Munc13-­‐1)	   3’	  :	  	   GGGTCTTCAAAGGAACACTGG	   	  
Unc13b	   5’:	  	   TGCCTTGGCAGATGATAATG	   86	  nt	  
(Munc13-­‐2)	   3’	  :	  	   AGCCCAAATAGGTCCAGTGA	   	  
Hprt	   5’:	   TCCTCCTCAGACCGCTTTT	   90	  nt	  
(HPRT)	   3’:	  	   CCTGGTTCATCATCGCTAATC	   	  
Unc13c	   5’:	  	   TCTGACACCAAGACAATGTGC	   72	  nt	  
(Munc13-­‐3)	   3’:	  	   CCTCCTGCATGAAAATATTGCT	   	  
Dlg4	   5’:	  	   ACTCCTGCTCCAGCTTCGT	   93	  nt	  
(PSD95)	   3’:	  	   GCTCCCTGGAGAATGTGCTA	   	  
Dag1	   5’:	  	   CTGCTGCTGCTCCCTTTC	   99	  nt	  
(Dystroglycan)	   3’:	  	   CCAGGCAGTGTTGAAAACCT	   	  
Syt1	  
(Synaptotagmin-­‐1)	  
5’:	  	   ACCTTACTCAACTGGCATTTGTT	  3’:	  	   AGACTGCGGATGTTGGTTGT	   92	  nt	  
Nlgn2	  
(Neuroligin-­‐2)	  
5’:	  	   CCTACGTGCAGAACCAGAGC	  3’:	  	   TCGCCTCGTCACGTTTTT	   93	  nt	  
Pipetting	   cDNA	  (10ng/µl):	  6µl	  	  Primers	  (2.5µM):	  2µl	  each	  
Quantification	   95˚C	  5min	  
Melting	  curve	   95˚C	  5min	  
Table	  4:	  qPCR	  primers	  and	  specifications.	  Primers	  were	  designed	  intron-­‐spanning	  in	  
all	  cases.	  All	  primers	  were	  purchased	  from	  Thermo	  Fisher	  Scientific.	  nt:	  nucleotides.	  	  	   Quantitative	   PCR	   analysis	   was	   performed	   on	   a	   Light	   Cycler	   480	  (Roche),	   using	   Sybr	   green	   dye	   (SensiMix	   SYBR	  No-­‐ROX	  Mastermix,	   Bioline,	  London,	  UK)	  in	  a	  96-­‐well	  format	  with	  a	  volume	  of	  20µl	  per	  well,	  adding	  10µl	  of	   SensiMix	   per	   reaction	   (primer	   sequences:	   Table	   4).	   To	   ensure	   primer	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binding	   specificity	   and	   efficiency,	   a	  melting	   curve	   assay	  was	   performed	   on	  the	   product	   after	   each	   round	   of	   acquisition.	   The	   data	   was	   only	   further	  analysed	   when	   the	   corresponding	   PCR	   product	   showed	   one	   melting	   point	  peak,	  indicating	  specific	  binding	  and	  generation	  of	  only	  one	  specific	  product.	  In	  addition,	  the	  samples	  were	  analysed	  on	  a	  3%	  agarose	  gel	  to	  visualize	  the	  DNA	  bands.	  The	  analyses	  were	  performed	  in	  triplicates.	  
2.12.	  Antibody	  specifications	  
The	   following	   antibodies	  were	  use	   in	   this	   study,	   for	   immunocytochemistry,	  immunohistochemistry	  and	  Western	  blot:	  
Primary	  antibodies	   Source	   Species	   Dilution	  
anti-­‐mouse	  agrin	  (204)	   Eusebio	  et	  al.,	  2003	   Rabbit	   1:2000	  WB,	  1:500	  IF	  
anti-­‐HA	  (3F10)	   Roche	   Rat	   1:3000	  WB,	  1:250	  IF	  
anti-­‐c-­‐myc	  (9E10)	   Dr.	  Elisabeth	  Kremmer	   Mouse	   1:10	  WB	  
anti-­‐PSD95	  (MA1-­‐045)	   Thermo	  Fisher	  Scientific	   Mouse	   1:500	  IF	  
anti-­‐bassoon	  (SAP7f)	   Jastrow	  et	  al.,	  2006	   Rabbit	   1:1000	  IF	  
anti-­‐cre	  (ab137240)	   Abcam,	  Cambridge,	  UK	  	   Rabbit	   1:50	  IF	  
	   	   	   	  
Secondary	  antibodies	   	   	   	  
anti-­‐rabbit-­‐IgG	  (HRP)	   Invitrogen	  Thermo	  Fisher	  Scientific	  	   Goat	   1:3000	  WB	  
anti-­‐rat-­‐IgG	  (HRP)	   Abcam	   Donkey	   1:2000	  WB	  
anti-­‐mouse-­‐IgG	  (HRP)	   Invitrogen	  Thermo	  Fisher	  Scientific	  	   Goat	   1:3000	  WB	  
anti-­‐mouse-­‐IgG	  (IRDye680)	  	   Li-­‐Cor,	  Cambridge,	  UK	  	   Donkey	   1:20,000	  WB	  
anti-­‐rabbit-­‐IgG	  (IR800CW)	   Li-­‐Cor	   Donkey	   1:20,000	  WB	  
anti-­‐rabbit-­‐IgG	  (Alexa488)	   Invitrogen	  Thermo	  Fisher	  Scientific	  	   Goat	   1:1000	  IF	  
anti-­‐mouse	  IgG	  (Cy3)	   Jackson,	  West	  Grove,	  USA	   Goat	   1:1000	  IF	  	  
Table	  5:	  Antibodies	  used	  in	  this	  study.	  HRP:	  horseradish	  peroxidase;	  ms:	  mouse;	  WB:	  
Western	   blot;	   IF:	   immunofluorescence.	   For	   simplicity	   and	   since	   concentrations	   of	  
polyclonal	  antibodies	  often	  are	  not	  known,	  dilution	  is	  given.	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3.	  Results	  
3.1.	  Expression	  of	  mouse	  transmembrane	  agrin	  in	  vitro	  
To	   investigate	   if	   the	   cDNA	   construct	   coding	   for	  mouse	   TM-­‐agrin	   elicits	   the	  same	   in	   vitro	   phenotype	   as	   chick	   TM-­‐agrin	   I	   validated	   it	   in	   vitro	   by	  overexpressing	  the	  cDNA	  in	  HEK293T	  cells.	  The	  primers	  designed	  for	  the	  C-­‐terminal	   part	   of	   agrin	   amplified	   the	   isoform	  containing	   the	   y4	   splice	   insert	  and	  missing	  the	  z-­‐	  splice	  insert	  (TM-­‐agrin0,4,0).	  Since	  the	  in	  vitro	  phenotype	  of	  filopodia	   production	   by	   TM-­‐agrin	   overexpression	   has	   been	   shown	   to	   be	  independent	  of	   the	  z-­‐splice	   insert	   (McCroskery	  et	  al.,	  2006),	   this	   cDNA	  was	  used	  for	  further	  analysis.	  The	  pMES	  transient	  expression	  vector	  was	  chosen,	  since	   it	   contains	   an	   IRES-­‐GFP	   sequence,	   which	   allows	   easy	   distinction	   of	  transfected	  cells.	  	  Figure	  8	  shows	  Western	  blot	  analysis	  using	  antibodies	  raised	  against	  the	  C-­‐terminal	  extracellular	  domain	  of	  mouse	  agrin	  (Eusebio	  et	  al.,	  2003)	  and	  anti-­‐HA-­‐tag	  antibodies.	  	  
Figure	   8:	   Western	   blot	   showing	   agrin	  
immunoreactivity	   in	   HEK293T	   cell	  
lysates.	   HEK293T	   cells	   were	  
transfected	  with	  pAS12	  plasmid	  coding	  
for	   HAmsTM-­‐agrinMyc	   or	   the	   empty	  
vector	   pMES.	   Both	   the	   HA	   and	   agrin	  
antibodies	   detected	   the	   expected	   high	  
molecular	   smear	   above	   250kDa.	   The	  
mouse	   agrin	   antibody	   detected	   an	  
unspecific	  band	  at	  70kDa	  and	  an	  agrin-­‐
specific	   cleavage	   product	   around	  
90kDa.	   The	   anti-­‐myc	   antibody	   did	   not	  

























RESULTS	   	  
53	  
Both	   antibodies	   reveal	   a	   broad	   smear	   with	   a	   molecular	   mass	   of	  approximately	   500	   kDa,	   representing	   the	   staining	   pattern	   previously	  described	  for	  chick	  agrin	  (Kroger	  &	  Mann,	  1996).	  	   HEK293T	   cells	   transfected	   with	   the	   mouse	   TM-­‐agrin0,4,0	   construct	  demonstrated	  that	  this	  cDNA	  obtained	  from	  total	  mouse	  brain	  tissue	  elicited	  similar	  filopodia-­‐like	  protrusion,	  as	  the	  chick	  TM-­‐agrin	  cDNA	  in	  vitro	  (Figure	  9).	  This	  demonstrated	  the	  suitability	  of	  the	  mouse	  cDNA	  for	  analysis	  of	  TM-­‐agrin	  function	  in	  vivo.	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Figure	  9:	   Immunostained	  HEK293T	  cells	  showing	   transmembrane	  agrin	  distribution	  
and	   filopodia.	   (A–D):	   pMESmsTMagrin-­‐transfected	   cells	   showed	   high	   agrin	  
immunoreactivity	   (A)	   and	   numerous	   filopodia	   (D	   and	   inlet),	   compared	   to	   vector	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   In	   addition,	   the	   Western	   blot	   analysis	   showed	   that	   mouse	   TM-­‐agrin	  overexpressed	   in	   HEK293T	   cells	   is	   of	   the	   same	   molecular	   weight	   as	   its	  endogenous	  counterpart	  (	  Figure	  8).	  	   After	   confirming	   the	   appropriate	   expression	   of	   TM-­‐agrin	   in	  HEK293T	  cells,	  the	  msTM-­‐agrin	  cDNA	  was	  transferred	  to	  a	  targeting	  vector	  backbone,	  which	   facilitates	   insertion	   of	   the	   construct	   into	   the	   ROSA26	   locus.	   The	  ROSA26	  locus	  has	  been	  used	  many	  times	  in	  the	  past	  for	  inserting	  expression	  constructs,	   since	   the	   locus	   shows	   high	   efficiency	   for	   homologous	  recombination	  and	  homozygous	  ROSA26	  knock-­‐out	  mice	  do	  not	  exhibit	  any	  detectable	  phenotype	  (Zambrowicz	  et	  al.,	  1997).	  	  
	  
Figure	  10:	   Insertion	  of	   the	  knock-­‐in	  conditional	  msTMagrin	  construct	  and	  activation	  
of	  expression	  by	  Cre-­‐recombinase.	  The	  construct	  was	   inserted	   into	   the	  Rosa26	   locus	  
by	   homologous	   recombination	   in	   ES	   cells	   using	   two	   stretches	   of	   direct	   homology	  
flanking	   the	   insertion	   cassette.	   Before	   Cre-­‐recombinase	   exposure,	   expression	   is	   off	  
due	  to	  a	  stop	  cassette	  (3	  polyA	  sequences)	  flanked	  by	  loxP	  sites.	  After	  excision	  of	  the	  
stop	  cassette,	  TM-­‐agrin	  expression	  mediated	  by	  the	  CAG	  enhancer	   is	   turned	  on.	  Neo:	  
Neomycin	  resistance	  for	  selection	  in	  ES	  cells.	  	   The	   CreERT2-­‐Tamoxifen	   inducible	   expression	   system	  was	   chosen	   for	  the	   generation	   of	   this	   TM-­‐agrin	   overexpression	   mouse	   line,	   since	   the	  expression	  can	  be	  tightly	  controlled	  in	  time	  and	  space	  and	  since	  reproducibly	  high	  expression	  levels	  have	  been	  reported	  with	  many	  CreERT2	  driver	  lines.	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   Since	   transmembrane	   agrin	   has	   been	   reported	   to	   be	   localized	   to	  glutamatergic	  synapses	  in	  the	  cortex	  and	  hippocampus	  (Ksiazek	  et	  al.,	  2007),	  I	   chose	   to	   cross	   to	   the	   CamKIICreERT2	  mouse	   line	   as	   the	   CreERT2	   driver	  allele,	   which	   shows	   high	   expression	   in	   excitatory	   neurons	   in	   these	   areas	  (Erdmann	  et	  al.,	  2007).	  	   To	  test	  the	  baseline	  expression	  and	  the	  expression	  after	  Cre	  activity	  in	  
vivo,	  the	  conditional	  targeting	  construct	  was	  co-­‐transfected	  with	  and	  without	  a	   pNLSCre	   vector	   (expressing	   Cre	   recombinase	   with	   a	   nuclear	   localization	  signal,	   pPGK-­‐Cre-­‐bpA;	  Gu	  et	   al.,	   1993).	  Most	   important	   for	  proceeding	  with	  the	   generation	   of	   a	   conditionally	   expressing	   knock-­‐in	   mouse	   line,	  overexpression	  from	  the	  targeting	  vector	  was	  shown	  to	  be	  dependent	  on	  Cre	  expression	  (Figure	  11).	   In	  addition,	   I	  observed	  a	   large	  number	  of	   filopodia-­‐like	  processes	  on	  the	  HEK293T	  cells	  that	  were	  transfected	  with	  the	  targeting	  vector	  and	  pNLSCre.	  	  	   These	   results	   showed	   that	   the	   construct	   contains	   full-­‐length	   murine	  TM-­‐agrin	   and	   the	   cDNA	   expression	   is	   strictly	   Cre-­‐dependent.	   Most	  importantly,	   mouse	   TM-­‐agrin	   cDNA	   overexpression	   induces	   similar	  filopodia-­‐like	   processes	   as	   chick	   TM-­‐agrin.	   In	   summary,	   my	   results	  demonstrate	  that	  the	  vector	  I	  designed	  is	  suitable	  to	  investigate	  the	  function	  TM-­‐agrin	  overexpression	  in	  vivo.	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Figure	   11:	   Immunostained	  HEK293T	   cells	   expressing	   the	   pAS20	   targeting	   construct	  
alone	   (D-­‐F)	   and	   the	   targeting	   construct	   co-­‐transfected	  with	   pNLSCre	   (A-­‐	   C).	  Without	  
NLSCre,	   the	   cells	   showed	   little	   agrin	   immunoreactivity	   (D).	   Transfected	   cells	  
expressing	  msTMagrin	  under	  Cre-­‐control	  showed	  high	  agrin	  immunoreactivity.	  In	  the	  
absence	   of	   pNLSCre,	   no	   cells	   expressing	   the	   msTMagrin	   construct	   were	   found,	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3.2.	  Levels	  of	  Cre	  induction	  and	  levels	  of	  agrin	  protein	  expression	  
Transient	  expression	  of	   recombinant	  proteins	   in	  cell	   culture	  usually	   results	  in	   high	   protein	   levels,	   as	   seen	   in	   Western	   blotting	   and	   by	  immunocytochemistry.	   We	   expected	   that	   high	   levels	   of	   TM-­‐agrin	   in	   vivo	  might	   be	   needed	   to	   see	   an	   effect	   caused	   by	   TM-­‐agrin.	   The	   first	   available	  mouse	   litters	   were	   used	   to	   assess	   the	   level	   of	   agrin	   protein	   level	   in	   total	  mouse	   brain	   by	   quantitative	  Western	   blotting.	   As	   shown	   in	   Figure	   12,	   the	  overexpression	  levels	  differed	  between	  control	  and	  TM-­‐agrin	  overexpressing	  mice	  about	  three-­‐fold	  depending	  on	  the	  method	  of	  tamoxifen	  administration.	  When	   mice	   were	   injected	   with	   tamoxifen	   three	   times	   during	   week	   5	   and	  whole	  brain	  membrane	  extracts	  prepared	  in	  week	  9,	   I	  achieved	  agrin	   levels	  in	   Agrn/Cre	   mice	   almost	   11-­‐fold	   higher	   than	   in	   the	   WT/Cre	   control	   mice	  (Figure	  12).	  Notably,	  the	  agrin	  protein	  levels	  in	  Agrn/WT	  mice	  were	  as	  low	  as	  in	   the	  WT/Cre	  mice,	   showing	   that	   the	  TM-­‐agrin	   overexpression	   cassette	   in	  the	  Rosa26	  locus	  resulted	  in	  tight	  control	  over	  expression	  in	  the	  absence	  of	  Cre.	  When	  tamoxifen	  was	  administered	  by	   feeding	   for	   two	  weeks,	   the	  agrin	  protein	   levels	   increased	   with	   the	   time	   given	   for	   recovery	   on	   regular	   food	  after	  the	  tamoxifen	  containing	  food.	  This	  might	  be	  explained	  by	  agrin	  protein	  accumulating	   over	   time	   after	   the	   start	   of	   expression.	   After	   three	   weeks	   of	  recovery,	  I	  achieved	  an	  approximately	  7-­‐fold	  increase	  in	  agrin	  protein	  levels	  in	  the	  brain	  when	  compared	  to	  WT/Cre	  control.	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Figure	  12:	  Western	  blot	  analysis	  of	  whole	  brain	  membrane	   fractions	  of	  WT/Cre	  and	  
Agrn/Cre	  mice.	   A)	   Arrows	   point	   to	   full-­‐length	   agrin	   protein	   and	   a	   lower	  molecular	  
weight	  band	  with	  a	  size	  to	  be	  expected	  for	  the	  Neurotrypsin	  cleavage	  product	  of	  agrin.	  
B)	  Quantification	  of	  the	  mean	  pixel	  intensity	  of	  agrin	  immunoreactivity	  determined	  by	  
infrared	  signal	  detected	  in	  Western	  blots	  by	  Licor	  Odyssey	  scanner.	  Error	  bars	  of	  the	  
scatter	   plots	   depict	   standard	   error	   of	   the	   mean	   (SEM).	   Statistical	   analysis	   on	   the	  
Gaussian	   distributed	   values	   was	   performed	   by	   one-­‐way	   ANOVA	   (p	   <	   0.022).	   C)	  
Combined	  Western	   blot	   analysis	   of	   normalized	  Tamoxifen	   administration	   protocols.	  
From	   left	   to	   right:	   Animals	   were	   injected	   3	   times	   in	   week	   5	   (Monday-­‐Wednesday-­‐
Friday)	   with	   2mg	   tamoxifen	   (Sigma-­‐Aldrich)	   in	   100µl	   Mygliol	   (Caelo)	   and	   Western	  
blot	  analysis	  of	  whole	  brain	  membrane	  extracts	  was	  performed	  in	  week	  10,	  showing	  
the	   mean	   pixel	   intensity	   of	   agrin	   immunoreactivity	   to	   be	   increased	   10-­‐fold	   in	   the	  
Agrn/Cre	  mutants	   compared	   to	  WT/Cre	   control	   animals	   (Student’s	   t-­‐test	  p	  =	  0.022).	  
On	   average,	   19	   weeks	   after	   injection	   the	   animals	   showed	   a	   34-­‐fold	   increase	   in	   the	  
cortex	   membrane	   preparations	   (p	   =	   0.0291)	   and	   a	   4.4-­‐fold	   increase	   in	   the	  
hippocampus	   (p	   =	   0.012).	   When	   Tamoxifen	   was	   given	   in	   food	   pellets,	   the	   animals	  
showed	   a	   2-­‐fold	   increase	   in	   agrin	   immunoreactivity	   after	   2	   weeks	   of	   tamoxifen	  
containing	  diet	  (p	  =	  0.0045).	  This	  yield	  could	  be	  improved	  by	  recovery	  on	  regular	  diet	  
for	  2	  weeks,	   resulting	   in	  agrin	  protein	   levels	  7.3-­‐fold	  higher	   than	   in	  WT/Cre	  control	  
animals	  (p	  <	  0.0001).	  In	  subsequent	  Western	  blot	  and	  qPCR	  experiments,	  this	  feeding	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analysing	   individual	   neurons	   as	   well	   as	   entire	   neuronal	   networks,	   it	   is	  important	  to	  have	  an	  estimate	  of	  how	  many	  neurons	  in	  the	  network	  express	  the	   knock-­‐in	   construct.	   Therefore,	   I	   examined	   the	   percentage	   of	   cells	  expressing	   the	   recombinant	   TM-­‐agrin	   protein	   compared	   to	   non-­‐expressing	  cells.	   Since	  TM-­‐agrin	   localizes	   to	   synapses	   and	   these	   are	   very	   numerous	   in	  the	   brain,	   it	   was	   not	   possible	   to	   estimate	   the	   rate	   of	   induction	   by	   agrin	  staining.	   Instead,	   I	   made	   use	   of	   the	   fact	   that	   CreERT2	   translocates	   to	   the	  nucleus	   after	   tamoxifen	   administration	   and	   analysed	   nuclear	   localized	   Cre	  staining	  in	  cortex	  layer	  3	  and	  in	  the	  hippocampal	  CA1	  region	  (Figure	  13).	  In	  the	  hippocampus	  CA1	  region,	  the	  nuclei	  of	  glutamatergic	  cells	  are	  located	  in	  the	  nuclear	  layer	  and	  therefore	  are	  easily	  distinguishable	  from	  other	  cells.	  In	  this	  region,	  the	  percentage	  of	  cells	  positive	  for	  nuclear	  Cre	  immunoreactivity	  was	  around	  72%	  (Figure	  13).	  In	  contrast,	  in	  the	  cortex	  it	  was	  not	  possible	  to	  differentiate	   between	   glutamatergic	   neurons	   and	   other	   cell	   types	   within	  layer	   2-­‐3.	   The	   percentage	   of	   all	   cells	   positive	   for	   nuclear	   Cre	  immunoreactivity	  was	  determined	  around	  40%	  (Figure	  13).	  It	  is	  reasonable	  to	   assume	   that	   72%	   is	   the	   better	   estimate	   of	   the	   true	   ratio	   of	   CreERT2	  induction	   in	   glutamatergic	   neurons.	   These	   results	   showed	   that	   72%	   of	   the	  pyramidal	  cell	  somata	  in	  the	  CA1	  region	  of	  the	  hippocampus	  as	  well	  as	  40%	  of	  cell	  somata	  in	  cortex	  layer	  2-­‐3	  expressed	  Cre	  recombinase.	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   Nuclei	  total	   Cre-­‐positive	  nuclei	   Cre	  induction	  
Cortex	   842	   333	   40%	  
CA1	  nuclear	  layer	   95	   68	   72%	  
Figure	  13:	  Estimation	  of	  Cre	  induction	  in	  cortex	  (A-­‐C)	  and	  hippocampus	  CA1	  nuclear	  
layer	  (D-­‐F)	  of	  Agrn/Cre	  mice.	  Note	  that	   in	  hippocampus	  CA1,	  all	   the	  nuclei	  examined	  
belong	   to	   glutamatergic	   pyramidal	   cells,	   whereas	   in	   the	   cortex,	   DAPI	   staining	   of	   all	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Next,	  I	  tested	  whether	  the	  subcellular	  localization	  of	  recombinant	  agrin	  is	  the	  same	  as	  endogenous	  agrin.	  Figure	  14	  shows	  that	  anti-­‐agrin	  immunoreactivity	  in	  both	  genotypes	  was	  punctate,	  consistent	  with	  the	  concentration	  of	  agrin	  at	  synapses.	  Moreover,	   as	   expected,	   the	   intensity	  was	   higher	   in	   the	   Agrn/Cre	  mice	  compared	  to	  the	  WT/Cre	   littermates.	  NtA-­‐agrin	   is	  part	  of	  blood	  vessel	  endothelial	  cells.	  The	  antibody	  used	  in	  this	  study	  detects	  NtA-­‐agrin	  as	  well	  as	  TM-­‐agrin	  and	  hence	  blood	  vessel	  staining	  can	  be	  used	  as	  internal	  control	  of	  antibody	  specificity.	  The	  intensity	  of	  the	  blood	  vessel	  staining	  was	  similar	  in	  both	  groups.	  These	  results	  show	  that	  the	  recombinant	  TM-­‐agrin	  exhibited	  a	  punctate	  localization	  comparable	  to	  endogenous	  agrin.	  
	  
Figure	  14:	  Distribution	  and	  intensity	  of	  anti-­‐agrin	  immunoreactivity	  in	  WT/Cre	  (A-­‐C)	  
and	  Agrn/Cre	  (D-­‐F)	  mice.	  WT/Cre	  and	  Agrn/Cre	  mice	  were	  injected	  with	  tamoxifen	  in	  
week	  5	  and	  perfused	  with	  4%	  PFA	  in	  week	  8.	  20µm	  Cryosections	  were	  immunostained	  
with	   antibodies	   raised	   against	   the	   C-­‐terminal	   of	   agrin.	   A-­‐C:	   WT/Cre	   mouse	   brain	  
sections	  showing	  cortex	  layer	  2-­‐3.	  D-­‐F:	  Agrn/Cre	  mouse	  brain	  sections	  showing	  cortex	  
layer	  2-­‐3.	  White	  arrows:	  Agrin	  immunoreactivity	  in	  the	  basal	  lamina	  of	  blood	  vessels	  
showed	   comparable	   intensity	   between	   Agrn/Cre	   and	   WT/Cre	   mice.	   Red	   arrows:	  
Synapse-­‐like	   staining	   of	   agrin	   was	   more	   intense	   in	   Agrn/Cre	   mice	   than	   in	   WT/Cre	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3.3.	  Initial	  characterization	  of	  TM-­‐agrin	  overexpressing	  mice	  
To	  investigate	  if	  TM-­‐agrin	  overexpression	  affects	  non-­‐neuronal	  organs	  or	  the	  peripheral	   nervous	   system,	   a	   primary	   phenotypic	   screen	   of	   the	   TM-­‐agrin	  mice	   was	   performed	   in	   collaboration	   with	   the	   German	   mouse	   clinic	  (Helmholtz	   Zentrum	   Neuherberg,	   Munich).	   The	   following	   aspects	   were	  analysed:	   Nociception,	   bone	   and	   cartilage,	   metabolism,	   cardiovascular	  system,	  eye	  function,	  clinical	  chemistry	  and	  haematology,	  immunology,	  lungs,	  pathology,	  neurology	  and	  general	  behaviour	  (overview	  of	  tests:	  Fuchs	  et	  al.,	  2009).	   The	   screen	   revealed	   no	   apparent	   behavioural	   or	   physiological	  phenotype	  (results	  not	  shown).	  The	  weight	  of	  the	  mice	  did	  not	  differ	  in	  males	  and	  in	  females	  to	  control	  animals	  (Figure	  15).	  	  
	  
Figure	   15:	  Weight	   of	   whole	   animals	   and	   brains	   of	  WT/Cre	   and	   Agrn/Cre	  mice.	   The	  
animals	  were	  injected	  at	  5	  weeks	  and	  sacrificed	  between	  8	  and	  10	  weeks.	  The	  weights	  
of	  whole	  animals	  (A	  and	  D),	  whole	  brains	  (B	  and	  E)	  and	  the	  ratio	  between	  animal	  and	  
brain	  weights	  (C	  and	  F)	  do	  not	  differ	  significantly	  in	  males	  or	  females.	  Error	  bars	  of	  the	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   Previous	   studies	   of	   agrin	   knock-­‐out	  mice,	   whose	   perinatal	   death	  was	  rescued	   by	   motoneuron-­‐specific	   agrin	   expression,	   showed	   a	   significant	  reduction	  in	  brain	  size,	  although	  the	  number	  of	  cells	  was	  unchanged	  (Ksiazek	  et	  al.,	  2007).	  To	  test	  whether	  agrin	  overexpression	  also	  had	  an	  effect	  on	  brain	  size	   I	  weighed	   the	  mouse	  brains	  and	  analysed	   the	   forebrain	  volume	   in	  MRI	  images.	  The	  weight	  of	   the	  mouse	  brains	  did	  not	  differ	  significantly	  between	  the	   Agrn/Cre	   and	   Agrn/WT	   groups	   in	   males	   and	   females	   (Figure	   15).	  Likewise,	   the	   volume	   of	   cortex	   and	   hippocampus	   showed	   no	   significant	  difference	   when	   analysed	   by	   MRI	   (Figure	   16).	   MRI	   studies	   were	   done	   in	  collaboration	   with	   Dr.	   Luciana	   Afonso	   (Helmholtz	   Zentrum	   Neuherberg,	  Munich).	  Moreover,	   the	  general	   layering	  of	  the	  cortex	  and	  the	  hippocampus	  was	   unaltered,	   demonstrating	   no	   excessive	   cell	   death	   and	   cellular	  rearrangements	  in	  the	  CNS.	  Collectively,	  these	  results	  demonstrate	  that	  TM-­‐agrin	  does	  not	  cause	  substantial	  degeneration	  or	  proliferation	  in	  these	  areas	  of	  the	  CNS.	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Figure	  16:	  Volume	  of	  mouse	  cortex	  and	  hippocampus	  determined	  by	  visual	  analysis	  of	  
Nissl	   stainings	   (B)	   and	   quantifications	   of	   MRI	   images	   (A).	   Analysis	   of	   6-­‐7	   mice	   per	  
group,	   20	   MRI	   optical	   sections	   each,	   showed	   no	   statistical	   difference	   in	   forebrain	  
volume	  in	  males	  and	  females	  (C	  and	  D).	  
3.4.	  Expression	  levels	  of	  synapse-­‐associated	  candidate	  genes	  













































































RESULTS	   	  
66	  
expressing	   the	   TM-­‐agrin	   allele,	   the	  mice	   showed	   a	   significant	   regulation	   of	  several	  of	  the	  analysed	  mRNAs	  (Table	  6).	  	   Primers	   specific	   for	   the	   transmembrane	   isoform	   of	   agrin	   showed	   the	  expected	   increase	   in	   TM-­‐agrin	   mRNA	   in	   the	   overexpressing	   animals.	   The	  increase	  in	  TM-­‐agrin	  mRNA	  was	  on	  average	  17-­‐fold.	  This	  correlates	  well	  with	  the	  7-­‐fold	  increase	  in	  agrin	  protein	  levels	  observed	  in	  whole	  brain	  membrane	  preparations	   of	   mice	   fed	   with	   tamoxifen	   and	   sacrificed	   after	   5	   weeks	   of	  induction	  (Figure	  12).	  	  	   Among	  the	  members	  of	  the	  active	  zone	  of	  both	  inhibitory	  and	  excitatory	  synapses,	  whose	  expression	  was	  tested	  with	  qPCR,	  Munc13-­‐1	  (mouse	  unc13	  homologue	   A,	   C.	   elegans)	   and	   Munc13-­‐2	   (mouse	   unc13	   homologue	   B,	   C.	  
elegans)	  were	  significantly	  downregulated.	   In	  contrast,	   several	  postsynaptic	  proteins	  of	  glutamatergic	  synapses	  were	  significantly	  upregulated,	  including	  the	  Grin1	  cDNA,	  coding	  for	  the	  NMDA-­‐receptor	  subunit	  NR1.	  The	  Dlg4	  gene,	  coding	  for	  the	  glutamatergic	  postsynapse	  scaffolding	  protein	  PSD95,	  showed	  a	   trend	   towards	   upregulation,	   which	   was	   however	   not	   significant	   due	   to	  variation	  between	  the	  animals.	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   WT/Cre	   Agrn/Cre	   Fold	  regulation	   p-­‐value	   R2	  
Agrin	   0,49±	  0,02	   8,4	  ±	  1,83	   17	   0,05	   	  
Presynaptic	  
Munc13-­‐1	   0,004	  ±	  0,0006	   0,001	  ±	  0,0007	   0,17	   0,03	   0,86	  
Munc13-­‐2	   0,0007	  ±	  0,0002	   0,0001	  ±	  9,6e-­‐005	  0,27	   0,03	   0,84	  
Munc13-­‐3	   0,052	  ±	  0,021	   0,021	  ±	  0,007	   0,40	   0,17	   0,64	  
Synaptotagmin-­‐1	   0,9	  ±	  0,06	   1,7	  ±	  0,56	   1,89	   0,28	   0,98	  
Bassoon	   12	  ±	  3,7	   10	  ±	  7,4	   0,23	   0,85	   0,98	  
Synaptophysin	   27	  ±	  6,4	   24	  ±	  24	   0,9	   0,91	   0,27	  
Synaptobrevin	   7,1	  ±	  0,80	   6,01	  ±	  2,96	   0,85	   0,77	   0,57	  
Postsynaptic	  
PSD-­‐95	   73	  ±	  31	   170	  ±	  61	   2,3	   0,28	   0,91	  
SAP-­‐102	   1,40	  ±	  0,62	   1,40	  ±	  0,28	   1	   0,99	   0,04	  
Dystroglycan	   0,08	  ±	  0,01	   0,48	  ±	  0,11	   6,29	   0,02	   0,17	  
Gephyrin	   0,07	  ±	  0,002	   0,002	  ±	  0,0003	   0,04	   <	  0,0001	   0,14	  
Neuroligin-­‐2	   2,7	  ±	  0,25	  	  	   1,1	  ±	  0,42	   0,41	   0,03	   0,68	  Neurotransmitter	  Receptors	  
NMDAR1	   26	  ±	  5,6	   70	  ±	  5,6	   2,7	   0,005	   0,86	  
AMPAR1	   12	  ±	  1,6	   11	  ±	  2,3	   0,95	   0,84	   0,73	  
GABA1	   36	  ±	  3,0	   5,7	  ±	  3,1	   0,24	   0,001	   0,62	  
Table	   6:	   qPCR	   analysis	   of	   different	   candidate	   genes	   showing	   regulation	   of	   several	  
genes	  involved	  in	  inhibitory	  and	  excitatory	  synapse	  formation	  and	  function.	  The	  qPCR	  
experiments	   and	   analysis	  were	   performed	  by	  Gerry	  Handara.	   All	   qPCR	   experiments	  
were	   done	   in	   technical	   triplicates	   with	   HPRT	   as	   housekeeping	   control	   gene,	   and	   at	  
least	   3	   mice	   per	   genotype	   were	   tested.	   Results	   are	   given	   in	   mean	   value	   of	   cycle	  
difference	  between	  housekeeping	  and	  gene	  of	  interest	  ±	  SEM.	  p-­‐values	  are	  the	  results	  
of	   student’s	   t-­‐test	   on	   the	   Gaussian	   distributed	  mean	   values	   performed	   in	   GraphPad	  
prism.	   Linear	   regression	   analysis	   was	   performed	   using	   Excel	   (R2	   =	   coefficient	   of	  
determination).	  Results	  with	  significant	  p-­‐values	  (<	  0.05)	  or	  significant	  correlation	  (R	  
>	  0.8)	  are	  highlighted	  red.	  After	  correlation	  analysis,	  however,	  it	  was	  clear	  that	  PSD95	  expression	  levels	  paralleled	   TM-­‐agrin	   expression	   levels,	   meaning	   that	   the	   animals	   showing	  high	  agrin	  overexpression	  levels	  also	  showed	  high	  PSD95	  mRNA	  levels	  (R2	  =	  0.91).	  	  	   Interestingly,	  most	  genes	  associated	  with	  inhibitory	  postsynapses	  were	  significantly	   downregulated:	   gephyrin,	   a	   scaffolding	   protein	   for	   GABA-­‐	   and	  glycine	   receptor	   complexes	   (Kneussel	   and	   Betz,	   2000;	   Yu	   et	   al.,	   2007),	  Neuroligin-­‐2,	   an	   adhesion	   protein	   involved	   in	   inhibitory	   synapse	  maintenance	  (Reissner	  et	  al.,	  2008)	  and	  Gabra1,	  encoding	  the	  α1	  subunit	  of	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the	  GABAA	  receptor.	  The	  only	  exception	  to	  this	  was	  dystroglycan,	  which	  is	  an	  agrin	  binding	  protein	  at	  the	  neuromuscular	  junction	  and	  has	  been	  shown	  to	  be	   concentrated	   at	   GABAergic	   synapses	   (Levi	   et	   al.,	   2002;	   Pribiag	   et	   al.,	  2014).	  Dystroglycan	  expression	  was	   significantly	  upregulated	  more	   than	  6-­‐fold	   and,	   thus,	   behaved	   opposite	   to	   the	   other	   constituents	   of	   inhibitory	  synapses.	   In	   conclusion,	   TM-­‐agrin	   overexpression	   in	   the	   murine	   cortex	  caused	   significant	   upregulation	   of	   several	   genes	   associated	   with	  glutamatergic	   synaptic	   transmission	   and	   a	   concomitant	   downregulation	   of	  several	   genes	   associated	   with	   GABAergic	   transmission.	   In	   addition,	  presynaptic	  proteins	  involved	  in	  vesicle	  exocytosis	  Munc12-­‐1	  and	  Munc13-­‐2	  were	   downregulated.	   Thus,	   TM-­‐agrin	   overexpression	   in	   glutamatergic	  neurons	  also	  affects	  other	  neurons	  and	  changes	  the	  expression	  level	  of	  pre-­‐	  as	  well	  as	  postsynaptic	  proteins.	  
3.5.	  Synapse	  density	  and	  size	  
Agrin	   knock-­‐out	  mice,	  whose	   perinatal	   death	  was	   rescued	   by	  motoneuron-­‐specific	   agrin	   expression,	   showed	   a	   30%	   reduction	   in	   the	   number	   of	  synaptophysin	  positive	  puncta	  in	  the	  cortex,	  although	  the	  number	  of	  neurons	  was	  unchanged	  (Ksiazek	  et	  al.,	  2007).	  To	  determine	  if	  overexpression	  of	  TM-­‐agrin	   similarly	   affects	   synapses	   in	   the	   CNS,	   the	   number	   and	   intensity	   of	  PSD95	   (glutamatergic	   postsynaptic)	   and	   bassoon	   (general	   presynaptic)	  imunoreactive	   puncta	   were	   quantified	   in	   immunohistochemically	   stained	  cryosections	  of	  Agrn/Cre	  and	  WT/Cre	  brains.	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Figure	  17:	  Density	  of	  synaptic	  marker	  immunoreactivity.	  Synaptic	  puncta	  staining	  in	  
cortex	   and	   hippocampus	   of	   Agrn/Cre	   and	   WT/Cre	   mice	   injected	   with	   tamoxifen	   in	  
week	  5	  and	  perfused	  with	  4%	  PFA	  in	  week	  8.	  Cryosections	  were	  immunostained	  with	  
antibodies	   against	   bassoon	   and	   PSD95	   to	   visualize	   pre-­‐	   and	   postsynaptic	   puncta.	   A:	  
Overview	   of	   Cortex	   sagittal	   section,	   boxed	   area	   indicates	   region	   of	   analysis.	   B-­‐H:	  
Magnification	   of	   cortex	   layer	   2-­‐3	   region	   of	   analysis	   in	   WT/Cre	   mice	   and	   Agrn/Cre	  
mice.	   I:	   Overview	   of	   hippocampus	   sagittal	   section,	   boxed	   area	   indicates	   region	   of	  
analysis.	   J-­‐Q:	   Magnification	   of	   hippocampus	   CA1	   region	   of	   analysis	   in	  WT/Cre	  mice	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identical	   settings	  were	   greyscaled	   and	   analysed	  with	   ImageJ	   software	   (ICTN	   plugin,	  
National	  Institute	  of	  Health);	  R:	  Bassoon	  cortex	  WT/Cre;	  S:	  Bassoon	  CA1	  Agrn/Cre.	  T-­‐
V:	  The	  number	  of	  synaptic	  puncta	  does	  not	  differ	  significantly	  between	  the	  groups	  for	  
neither	   synaptic	  marker.	   Error	   bars	   depict	   SEM	   of	   3	  mice	   per	   genotype	   in	   12	   to	   38	  
individual	  images.	  Scale	  bar	  A	  and	  I:	  200µm.	  Scale	  bar	  B-­‐H	  and	  J-­‐Q:	  10µm.	  	  Figure	  17	  shows	  the	  quantifications	  of	  anti-­‐bassoon	  and	  anti-­‐PSD95	  positive	  puncta	   in	   the	  cortex	  and	  hippocampus	  CA1	  region.	  No	  significant	  change	   in	  the	  number	  of	  synapses	  was	  detected	  (Figure	  17	  T-­‐V).	  	   After	   sorting	   of	   the	   individual	   results	   according	   to	   genotype	   and	  double-­‐blind	   analysis	   it	   became	   evident	   that	   the	   area	   covered	   by	   above-­‐threshold	   anti-­‐PSD95	   immunoreactivity	   and	   the	   staining	   intensity	   were	  significantly	  larger	  in	  the	  Agrn/Cre	  mice	  compared	  to	  the	  corresponding	  area	  in	  WT/Cre	  mice	  (Figure	  18).	  Higher	  magnification	  revealed	  that	  most	  of	  the	  individual	   PSD95-­‐immunopositive	   puncta	   were	   larger	   and	   more	   intensely	  stained	  in	  the	  cortex	  of	  Agrn/Cre	  mice	  than	  of	  WT/Cre	  control	  mice	  (Figure	  18).	  The	  same	  observation	  was	  made	   in	  the	  hippocampal	  CA1	  area	  of	   these	  mice	  (not	  shown).	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Figure	  18:	  Fraction	  area	  covered	  by	  synaptic	  marker	  immunoreactivity.	  The	  fraction	  
area	  covered	  by	  threshold	  PSD95	  immunoreactivity	  (glutamatergic	  postsynapse)	  was	  
significantly	  increased	  in	  Agrn/Cre	  mice	  hippocampus	  CA1	  and	  cortex,	  indicating	  that	  
PSD95	  positive	  densities	  were	  denser	  and	  bigger.	  Bassoon	  immunoreactivity	  (general	  
presynapse)	  was	  not	   significantly	  affected	  by	  TM-­‐agrin	  overexpression.	  A)	  Overview	  
of	   Cortex	   sagittal	   section,	   boxed	   area	   indicates	   region	   of	   analysis.	   B)	   Overview	   of	  
hippocampus	   sagittal	   section,	   boxed	   area	   indicates	   region	   of	   analysis.	   C-­‐J)	  
Magnification	  of	  synaptic	  staining	  of	  cortex	  layer	  2-­‐3.	  K-­‐P)	  Original	  images	  (K	  and	  N),	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Quantifications	   of	   fraction	   area	   covered	   by	   anti-­‐PSD95	   immunoreactivity	   in	   cortex	  
and	   hippocampus.	   Fraction	   area	  measurements	  were	   collected	   from	   three	  mice	   per	  
genotype	  in	  12	  to	  36	  images	  per	  mouse.	  The	  PSD95	  immunostaining	  showed	  an	  about	  
3-­‐fold	  increase	  in	  the	  fraction	  of	  area	  covered	  in	  the	  Agrn/Cre	  mutant	  compared	  to	  the	  
WT/Cre	  control	  (54.6%	  vs.	  20%;	  p	  =	  0.00017	  for	  cortex	  and	  72%	  vs.	  22%,	  p	  =	  0.0125	  
for	   hippocampus).	   S)	   Combined	   graph	   of	   bassoon	   and	   PSD95	   immunoreactivity	  
fraction	   area	   in	   cortex	   and	   hippocampus.	   The	   fraction	   area	   covered	   by	   bassoon	  
staining	  did	  not	  differ	  significantly	  between	  Agrn/Cre	  and	  WT/Cre	  mice.	  Depicted	  are	  
the	   mean	   values	   per	   mouse	   with	   standard	   error	   of	   the	   mean.	   Scale	   bar	   A	   and	   B:	  
200µm.	  Scale	  bar	  A-­‐J:	  5µm.	  Scale	  bar	  K	  and	  N:	  20µm.	  	  	   In	   conclusion,	   the	   overexpression	   of	   TM-­‐agrin	   did	   not	   significantly	  affect	   synapse	  number	   in	   the	   cortex	  and	  hippocampus,	  but	   instead	  affected	  the	  size	  and	  density	  of	  the	  glutamatergic	  postsynaptic	  densities,	  as	  indicated	  by	  a	  3-­‐fold	  increase	  in	  the	  fraction	  area	  covered	  by	  PSD-­‐95	  immunoreactivity	  in	  Agrn/Cre	  mice	  compared	  to	  WT/Cre	  mice.	  
3.6.	  Dendritic	  spine	  density	  and	  morphology	  
Dendritic	   spines	   are	   postsynaptic	   specializations	   of	   excitatory	   synapses	   in	  the	   brain.	   To	   view	   them	   in	   detail	   using	   light	   microscopy	   I	   used	   the	   Golgi	  impregnation	  method,	  originally	  developed	   in	  1873	  by	  Camillo	  Golgi	   (Golgi,	  1873).	  Even	  today	  this	  method	  remains	  a	  useful	  tool	  for	  analysing	  dendritic	  spine	   morphology,	   since	   only	   1-­‐5%	   of	   neurons	   are	   stained	   (Golgi,	   1989).	  Golgi	   silver	   impregnation	   was	   performed	   on	   10-­‐week	   old	   Agrn/Cre	   and	  WT/Cre	  mice	  that	  had	  been	  injected	  with	  Tamoxifen	  in	  week	  5.	  The	  results	  of	  an	   analysis	   of	   4	   to	   6	   mice	   per	   genotype	   and	   up	   to	   102	   measurements	   of	  individual	   spine	   head	   size	   as	   well	   as	   number	   and	   type	   is	   summarized	   in	  Figure	  19.	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   WT/Cre	   Agrn/Cre	   Significance	   N	   n	  
Cortex	  Spines	  per	  100µm	  dendrite	   77	  ±	  6.8	   70	  ±	  13.9	   n.s.	  (p	  =	  0.69)	   4	   3	  Stubby	  spines	  %	   36	  ±	  6.9	   47	  ±	  7.9	   n.s.	  (p	  =	  0.37)	   4	   3	  Thin	  spines	  %	   10	  ±	  4.3	   14	  ±	  5.7	   n.s.	  (p	  =	  0.59)	   4	   3	  Mushroom	  spines	  %	   43	  ±	  8.9	   49	  ±	  3.7	   n.s.	  (p	  =	  0.55)	   3	   3	  Total	  spine	  head	  size	  in	  µm	   0.67	  ±	  0.029	   1.2	  ±	  1.18	   *	  (p	  =	  0.048)	   4	   52	  Stubby	  spine	  head	  size	  in	  µm	   0.61	  ±	  0.017	   1.2	  ±	  0.22	   n.s.	  (p	  =	  0.063)	   4	   24	  Thin	  spine	  head	  size	  in	  µm	   0.50	  ±	  0.026	   0.94	  ±	  0.14	   *	  (p	  =	  0.044)	   4	   5	  Mushroom	  spine	  head	  size	  in	  µm	   0.74	  ±	  0.026	   1.2	  ±	  0.19	   n.s.	  (p	  =	  0.079)	   4	   25	  
	  
Hippocampus	  CA1	  Spines	  per	  100µm	  dendrite	   110	  ±	  18	   65	  ±	  2.7	   n.s.	  (p	  =	  0.094)	   6	   4	  Stubby	  spines	  in	  %	   42	  ±	  3.7	   54	  ±	  2.9	   *	  (p	  =	  0.034)	   6	   4	  Thin	  spines	  in	  %	   8.8	  ±	  3.1	   8.3	  ±	  2.8	   n.s.	  (p	  =	  0.92)	   6	   4	  Mushroom	  spines	  in	  %	   44	  ±	  1.5	   33	  ±	  2.9	   *	  (p	  =	  0.044)	   6	   4	  Total	  spine	  head	  size	  in	  µm	   1.1	  ±	  0.22	   1.4	  ±	  0.18	   n.s.	  (p	  =	  0.43)	   4	   102	  Stubby	  spine	  head	  size	  in	  µm	   1.1	  ±	  0.20	   1.2	  ±	  0.20	   n.s.	  (p	  =	  0.27)	   4	   52	  Thin	  spine	  head	  size	  in	  µm	   0.76	  ±	  0.17	   1.0	  ±	  0.11	   n.s.	  (p	  =	  0.20)	   4	   8	  Mushroom	  spine	  head	  size	  in	  µm	   1.3	  ±	  0.24	   1.3	  ±	  0.20	   n.s.	  (p	  =	  0.96)	   4	   27	  
Figure	  19:	  Morphology	  and	  density	  of	  dendritic	   spines	   in	   the	  hippocampus	  CA1	  and	  
cortex:	  Golgi	  stainings	  of	  hippocampus	  (A-­‐C)	  and	  cortex	  (D-­‐F)	  of	  Agrn/Cre	  and	  WT/Cre	  
heterozygous	  mice.	  The	  mice	  were	  injected	  with	  tamoxifen	  in	  week	  5	  and	  sacrificed	  in	  
week	  10.	  150µm	  cryosections	  were	  analysed	  by	  light	  microscopy	  and	  blinded	  images	  
with	   identical	   settings	  were	  quantified	   in	   regard	   to	  dendritic	   spine	  density	  on	  basal	  
dendrites	   of	   pyramidal	   cells,	   the	   portion	   of	   the	   dendrite	   after	   the	   third	   branching	  
point	   from	   the	   soma.	   A)	   Overview	   of	   hippocampus	   area,	   box	   indicates	   the	   area	   of	  
analysis	   (DG:	   dentate	   gyrus).	   B	   and	   C)	   Magnifications	   of	   basal	   dendrites	   (m:	  
mushroom	   spine,	   s:	   stubby	   spine).	   B)	   Overview	   of	   cortical	   layers	   2-­‐5.	   E	   and	   F)	  
Magnifications	   of	   layer	   3	   pyramidal	   neurons	   basal	   dendrites.	   Table:	   Summary	   of	  
dendritic	   spine	   quantifications	   including	   SEM,	   Student’s	   t-­‐test	   p-­‐values,	   mice	   per	  
genotype	   (N)	   and	   average	  measurements	   per	  mouse	   (n).	   Scale	   bar	   A	   and	   D:	   50µm;	  
scale	  bar	  B,	  D,	  E	  and	  F:	  5µm.	  The	   total	   spine	  head	  size	  and	   the	   thin	  spine	  head	  size	  was	   increased	   in	   the	  cortex.	  The	  number	  of	  stubby	  spines	  was	  increased	  in	  Agrn/Cre	  mice	  versus	  WT/Cre	  mice,	  whereas	  the	  number	  of	  mushroom-­‐like	  spines	  was	  decreased.	  In	   conclusion,	   the	   results	   of	   the	   detailed	   analysis	   of	   the	   synapse	   structure	  revealed	  changes	  in	  spine	  morphology,	   i.e.	  a	  shift	   from	  mushroom	  spines	  to	  stubby	  spines	  and	  an	  increase	  in	  the	  dendritic	  spine	  head	  size.	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4.	  Discussion	  
The	   heparan	   sulfate	   proteoglycan	   agrin	   is	   essential	   for	   the	   formation,	  maintenance	   and	   regeneration	   of	   the	   synapse	   between	   a	   motoneuron	  terminal	  and	  its	  target	  muscle	  fiber	  (Samuel	  et	  al.,	  2012;	  Werle	  and	  VanSaun,	  2003;	  Gautam	  et	   al.,	   1996;	   for	   review	   see	  Tintignac	   et	   al.,	   2015).	  However,	  agrin’s	   role	   in	   the	   developing	   and	   adult	   CNS	   is	   much	   less	   clear.	   Previous	  studies	   from	   our	   laboratory	   have	   shown	   that	   TM-­‐agrin	   overexpression	   in	  various	   cell	   culture	   systems	   including	   neurons,	   causes	   the	   cells	   to	   extend	  filopodia-­‐like	  processes.	   It	  was	  hypothesized	   that	   these	  processes	  might	  be	  precursors	  for	  dendritic	  spine	  synapses	  (McCroskery	  et	  al.,	  2006;	  Ramseger	  et	   al.,	   2009;	   Porten	   et	   al.,	   2010;	   Fiala	   et	   al.,	   1998).	   In	   agreement	   with	   the	  hypothesis	   that	   TM-­‐agrin	   is	   important	   for	   dendritic	   spine	   formation,	   mice	  depleted	   for	   agrin	   in	   the	  CNS	   show	  a	   reduction	   in	   the	  number	   of	   dendritic	  spines	  and	  a	  reduction	  in	  synaptic	  protein	   immunoreactivity	  (Ksiazek	  et	  al.,	  2007).	  	   To	  investigate	  whether	  TM-­‐agrin	  acts	  as	  a	  synapse-­‐inducing	  factor	  or	  a	  synapse-­‐strengthening	   factor	   in	   the	   CNS	   in	   vivo	   and	   to	   collect	   further	  evidence	  for	  a	  role	  of	  agrin	  during	  synaptogenesis	  and	  synapse	  maintenance,	  I	   generated	   and	   characterized	   a	   TM-­‐agrin	   overexpressing	   mouse.	   Mice	  overexpressing	   a	   specific	   cDNA	   constitute	   a	   valuable	   addition	   to	   knock-­‐out	  mice	   to	   understand	   fully	   the	   function	   of	   a	   protein	   of	   interest,	   especially	   in	  cases	   where	   the	   knock-­‐out	   is	   lethal,	   restricting	   complete	   analysis	   of	   the	  knock-­‐out	  phenotype.	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   Analysis	   of	   the	   mice	   showed	   that	   TM-­‐agrin	   overexpression	   in	   adult	  glutamatergic	  neurons	  leads	  to	  larger	  postsynaptic	  densities	  of	  glutamatergic	  synapses	   and	   more	   intense	   immunofluorescense	   staining	   of	   the	   PSD95	  scaffolding	  protein	  compared	  to	  those	  from	  littermate	  controls.	  	   In	  addition,	  on	  basal	  dendrites	  of	  pyramidal	  neurons	  of	  cortex	  layer	  2-­‐3,	  the	  total	  spine	  head	  size	  and	  the	  thin	  spine	  head	  size	  showed	  an	  increase	  in	  TM-­‐agrin	   overexpressing	   mice	   compared	   to	   control.	   Basal	   dendrites	   of	  hippocampus	  CA1	  pyramidal	   neurons	   showed	   an	   increase	   in	   stubby	   spines	  accompanied	  with	  a	  decrease	   in	  mushroom	  spines	  on	  their	  basal	  dendrites.	  The	   gene	   expression	   profile	   also	   revealed	   that	   genes	   relating	   to	  glutamatergic	   synapse	   function	   were	   upregulated,	   while	   gene	   expression	  relating	  to	  GABAergic	  synapse	  function	  was	  downregulated.	  Thus,	  apparently	  TM-­‐agrin	   affects	   excitatory	   and	   inhibitory	   synapses	   in	   a	   directly	   opposing	  manner.	  	  
4.1.	  The	  TM-­‐agrin	  overexpressing	  mouse	  overall	  phenotype	  
What	  is	  the	  overall	  phenotype	  of	  the	  TM-­‐agrin	  overexpressing	  mice?	  	  	   The	  TM-­‐agrin	  cDNA	  cloned	  from	  total	  mouse	  brain	  showed	  an	  increase	  in	   filopodia	   formation	   in	   HEK293T	   cells	   (see	   Figure	   9).	   In	   addition,	   the	  targeting	  vector	  showed	  strict	  dependence	  on	  Cre	  expression	  and	  high	  agrin	  immunoreactivity	   (Figure	   11).	   After	   the	   mice	   had	   been	   generated,	   I	   first	  confirmed	   that	   the	   double	   mutant	   mice	   (Agrn/Cre,	   WT/Cre	   as	   control)	  overexpressed	  the	  TM-­‐agrin	  allele	  after	  tamoxifen	  administration.	  I	  observed	  up	   to	   11-­‐fold	   higher	   agrin	   protein	   levels	   compared	   to	   the	  WT/Cre	   control	  mice,	  depending	  on	  the	  method	  of	  tamoxifen	  administration.	  Approximately	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70	   %	   of	   the	   pyramidal	   neurons	   showed	   nuclear	   Cre	   immunoreactivity	  (Figure	   13).	   The	   initial	   phenotyping	   of	   the	   mouse	   line	   confirmed	   that	   the	  mice	   were	   fertile	   and	   healthy,	   and	   the	   average	   survival	   rate	   was	   not	  apparently	   influenced	   by	   the	   TM-­‐agrin	   overexpressing	   allele.	   Additionally,	  the	   mice	   did	   not	   show	   any	   difference	   in	   body	   weight,	   brain	   weight	   and	  forebrain	   volume	   (Figure	   15,	   Figure	   16).	   A	   large	   phenotypic	   screen	  performed	   in	   collaboration	  with	   the	  German	  Mouse	  Clinic	   did	  not	   result	   in	  any	   obvious	   phenotype	   connected	   to	   the	   vascular	   system,	   various	   organ	  systems,	  eye	   function,	  nociception	  and	  general	  behaviour	  (data	  not	  shown).	  Collectively,	  these	  data	  demonstrate	  that	  the	  mice	  represent	  a	  suitable	  model	  system	  to	  investigate	  the	  function	  of	  TM-­‐agrin	  in	  the	  CNS	  by	  overexpression	  in	  a	  time-­‐	  and	  spatially-­‐controlled	  manner.	  
4.2.	  Changes	  in	  postsynaptic	  cluster	  morphology	  and	  dendritic	  spine	  
morphology	  
Our	   initial	   hypothesis	   was	   that	   TM-­‐agrin	   overexpression	   would	   promote	  filopodia	   formation	   and	   by	   this	   stimulate	   synapse	   formation	   and	   hence	  increase	  synapse	  and	  dendritic	  spine	  density.	  In	  contrast	  to	  this	  hypothesis,	  I	  did	  not	  observe	  a	  significant	  change	  in	  the	  number	  of	  PSD-­‐positive	  clusters	  in	  the	   cortex	   or	   hippocampus	   of	   the	   TM-­‐agrin	   CamKIICre	   mice	   compared	   to	  their	  control	  littermates	  (Figure	  17).	  Likewise,	  the	  total	  number	  of	  dendritic	  spines	  did	  not	  apparently	  change	  in	  the	  cortex	  and	  hippocampus	  (Figure	  19).	  Most	   importantly,	   I	   did	  not	   observe	   an	   increase	   in	   the	  number	  of	   filopodia	  extending	   from	   adult	   hippocampal	   or	   cortical	   neurons.	   A	   number	   of	  explanations	  for	  the	  lack	  of	  filopodia	  is	  possible:	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   a)	  The	  rapid	  turnover	  of	  the	  filopodia	  might	  preclude	  their	  detection.	  	  	   b)	   The	   expression	   level	   of	   TM-­‐agrin	  might	   not	   be	   sufficiently	   high	   in	  
vivo	  to	  induce	  filopodia	  formation.	  	  	   c)	  The	  filopodia	  only	  form	  on	  embryonic	  neurons	  but	  not	  on	  neurons	  of	  adult	  brains	  in	  response	  to	  TM-­‐agrin	  overexpression.	  	   However,	  when	  I	  analysed	  the	  anti-­‐PSD95	  positive	  synaptic	  puncta	  and	  the	   dendritic	   spine	   morphology	   in	   more	   detail	   I	   observed	   that	   individual	  postsynaptic	  puncta	  were	  more	   intensely	  stained	  and	   larger	   (Figure	  18).	   In	  order	   to	   put	   this	   observation	   into	   a	   quantifiable	   format,	   I	   compared	   the	  fraction	   area	   of	   the	   image	   that	   is	   covered	   by	   above-­‐threshold	   staining	  intensity	   (compare	   image	   analysis	   method:	   Pribiag	   et	   al.,	   2014).	   This	  combines	   the	   size	   and	   the	   staining	   intensity	   of	   the	   puncta	   simultaneously	  while	  at	  the	  same	  time	  applying	  a	  threshold	  over	  the	  whole	  experiment.	  This	  way	  it	  is	  possible	  to	  estimate	  the	  density	  and	  size	  of	  the	  individual	  puncta	  in	  many	   specimens	   of	   cortical	   and	   hippocampal	   sections.	   TM-­‐agrin	  overexpressing	  mice	  showed	  a	  3-­‐fold	   increase	   in	   fraction	  area	   in	   the	  cortex	  and	  hippocampus	  compared	  to	  their	  control	   littermates.	  Presynaptic	  puncta	  visualized	   by	   anti-­‐bassoon	   immunoreactivity	   showed	   a	   trend	   towards	   a	  similar	   increase,	   but	   due	   to	   high	   variability	   within	   the	   cohort	   of	   the	   same	  genotype,	   this	   trend	   was	   not	   significant	   (Figure	   18).	   Another	   factor	  influencing	   significance	   is	   that	   bassoon	   is	   present	   at	   active	   zones	   of	   both	  inhibitory	   and	   excitatory	   synapses,	   whereas	   PSD95	   antibodies	   only	   stain	  excitatory	  postsynaptic	  densities.	  As	  mentioned	  earlier,	  we	  assume	  agrin	   to	  have	   a	   more	   pronounced	   effect	   on	   excitatory	   synapses	   than	   on	   inhibitory	  synapses.	  Therefore,	  it	  can	  be	  expected	  that	  PSD95	  immunoreactivity	  is	  more	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significantly	  changed	  compared	   to	  bassoon	  and	   this	  might	  explain,	  why	   the	  values	  for	  bassoon	  immunoreactivity	  did	  not	  reach	  statistical	  significance.	  	   To	   study	   dendritic	   spine	   morphology,	   I	   analysed	   hippocampal	   and	  cortical	   dendrites	   in	   more	   detail	   using	   the	   Golgi	   Silver	   impregnation	  technique	   (Golgi,	   1873).	   The	   Golgi	   staining	  method	   has	   the	   advantage	   that	  only	   a	   small	   subset	   of	   neurons	   is	   stained,	   which	   allows	   tracing	   individual	  neurons	  and	  documenting	  their	  precise	  morphology.	  However,	  the	  technique	  requires	   brightfield	  microscopy	   and	   the	   sections	   cannot	   be	   analysed	   using	  confocal	  imaging.	  Therefore,	  the	  resolution	  is	  limited	  and	  it	  is	  not	  possible	  to	  simultaneously	   visualize	   Cre-­‐positive	   neurons.	   In	   order	   to	   record	   a	   good	  estimate	   of	   dendritic	   spine	   morphology,	   I	   counted	   and	   measured	   a	   large	  number	  of	  individual	  dendritic	  spines.	  Dendrites	  of	  pyramidal	  neurons	  show	  less	   variable	  morphology	   in	   spines	   in	  distal	   compared	   to	  parts	  proximal	   to	  the	  soma.	  Therefore,	  for	  better	  reproducibility,	  I	  restricted	  the	  quantification	  of	  spine	  morphology	  on	  dendritic	  branches	  of	  basal	  dendrites	  after	  the	  third	  branching	   point.	   Most	   parameters	   (e.g.	   percentage	   of	   thin	   spines,	   stubby	  spine	  head	  size)	  on	  basal	  dendrites	  of	  pyramidal	  neurons	  of	  cortex	  layer	  2-­‐3	  did	  not	  show	  significant	  differences	  in	  TM-­‐agrin	  overexpressing	  compared	  to	  control	  animals	  (quantification	  table	  in	  Figure	  19).	  However,	  the	  total	  spine	  head	  size	  and	  the	  thin	  spine	  head	  size	  showed	  an	  increase	  in	  diameter	  in	  TM-­‐agrin	   overexpressing	   mice	   compared	   to	   littermate	   controls.	   Hippocampus	  CA1	  pyramidal	  neurons	  showed	  an	  increase	  in	  the	  number	  of	  stubby	  spines	  compared	   to	   a	   decrease	   in	   the	   number	   of	  mushroom	   spines	   on	   their	   basal	  dendrites.	   As	  mentioned	   earlier,	   the	   development	   of	   spines	   proceeds	   from	  filopodia	   to	   stubby	   spines	   to	  mushroom	   spines.	   Since	   I	   analysed	   TM-­‐agrin	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overexpressing	  mice	  5	  weeks	  after	  Cre	  induction,	  the	  relative	  increase	  in	  the	  number	  of	  stubby	  spines	  results	  could	  indicate	  that	  TM-­‐agrin	  overexpression	  halts	   the	   maturation	   of	   dendritic	   spines	   from	   stubby	   spines	   to	   mushroom	  spines.	   However,	   the	   distinction	   between	   stubby	   spines	   and	   mushroom	  spines	  is	  largely	  defined	  by	  estimating	  the	  thickness	  of	  the	  spine	  neck.	  Stubby	  spines	  have	  a	  thicker	  neck	  compared	  to	  the	  diameter	  of	  their	  head	  (Fiala	  et	  al.,	  1998).	  This	  visual	  analysis	  is	  difficult	  and	  might	  lead	  to	  errors.	  Therefore,	  another	   interpretation	   of	   these	   results	   could	   be	   that	   TM-­‐agrin	  overexpression	   increases	   the	   thickness	  of	   the	  neck	  making	   thin	  spines	   look	  more	  like	  stubby	  spines.	   In	  any	  case,	  overexpression	  of	  TM-­‐agrin	  influences	  the	  morphology	  of	  spines	  and,	   thus,	   influences	  excitatory	  synapse	  structure	  and	  should	  –	  as	  a	  consequence	  –	  influence	  its	  function.	  	  
4.3.	  Expression	  profile	  correlated	  to	  inhibitory	  and	  excitatory	  synapse	  
function	  
The	  gene	  expression	  profile	  of	  cortical	  lysates	  of	  Agrn/Cre	  and	  WT/Cre	  was	  analysed	   in	   order	   to	   assess	   whether	   TM-­‐agrin	   overexpression	   affects	  glutamatergic	   and	  GABAergic	   synaptic	  protein	   related	   gene	   expression	   in	   a	  similar	   manner.	   Together	   with	   the	   master’s	   student	   Gerry	   Handara,	   I	  determined	  if	  TM-­‐agrin	  overexpression	  had	  an	  influence	  on	  the	  expression	  of	  synapse-­‐associated	   genes.	   We	   included	   genes	   that	   are	   associated	   with	  glutamatergic	   as	  well	   as	   GABAergic	   transmission,	   such	   as	   genes	   coding	   for	  scaffolding	   proteins	   and	   receptors.	   We	   used	   qRT-­‐PCR	   to	   be	   able	   to	  distinguish	  even	  fine	  differences	  between	  the	  expression	  profiles.	  Our	  initial	  results	  confirmed	  the	  Western	  blot	  analysis	  and	  showed	  that	  TM-­‐agrin	  mRNA	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is	   significantly	  upregulated	   (on	   average	  17-­‐fold).	   In	   order	   to	  understand	   in	  detail	  how	  the	  expression	  profiles	  of	  the	  synapse-­‐associated	  genes	  are	  linked	  to	  TM-­‐agrin	  overexpression,	  and	  to	  investigate	  if	  the	  variation	  of	  the	  amount	  of	  TM-­‐agrin	  overexpression	  is	  paralleled	  by	  a	  similar	  variation	  in	  the	  mRNA	  expression	   of	   synapse-­‐associated	   proteins,	   we	   performed	   linear	   regression	  analysis	  determining	  the	  coefficient	  of	  determination	  (R2,	  ranging	  from	  0	  to	  1).	   For	   instance,	   a	   high	   coefficient	   of	   determination	   (R2	   =	   0,98)	   between	  synaptotagmin	   expression	   and	   agrin	   overexpression	   shows	   that	   the	  variability	  of	  expression	  of	  the	  two	  genes	  is	  linearly	  linked.	  In	  this	  case,	  there	  is	   a	   statistical	   correlation	   between	   a	   high	   agrin	   level	   and	   the	   level	   of	  synaptotagmin	  upregulation	   in	   the	   individual	  mouse.	   The	   expression	   levels	  change	  significantly	  in	  parallel.	  As	  one	  increases,	  the	  other	  one	  increases	  too.	  This	  allowed	  us	  to	  observe	  the	  linear	  connection	  between	  the	  two	  expression	  profiles,	   even	   though	   the	   level	   of	   upregulation	   of	   synaptotagmin	   by	   itself	  compared	  to	  control	  (1.98-­‐fold)	  is	  not	  statistically	  significant.	  	  	   Our	  results	  showed	  that	  the	  expression	  of	  several	  genes	  associated	  with	  glutamatergic	   synaptic	   transmission	   were	   upregulated,	   while	   other	   genes	  associated	   with	   GABAergic	   transmission	   were	   downregulated.	   Specifically,	  the	   NR1	   subunit	   of	   NMDA	   receptors	   was	   2-­‐fold	   upregulated	   and	   PSD95	  showed	   a	   trend	   towards	   upregulation,	   which	   strongly	   correlated	   with	   the	  agrin	   level	   in	   the	   individual	   mouse	   (R2=0.91).	   In	   contrast,	   the	   expression	  level	  of	  Gria1,	  encoding	  the	  AMPA	  receptor	  subunit	  1,	  did	  not	  differ	  between	  TM-­‐agrin	  overexpressing	  and	  littermate	  control	  mice.	  Gabra1,	  coding	  for	  the	  α1	   subunit	   of	   the	  GABAA	   receptor,	   showed	  a	  5-­‐fold	  decrease	   in	   expression.	  Likewise,	   the	  GABA	  receptor-­‐associated	   scaffolding	  protein	   gephyrin	   (Yu	  et	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al.,	   2007)	   showed	   a	   25-­‐fold	   decrease	   in	   expression,	   and	   neuroligin-­‐2,	   an	  adhesion	  protein	  specific	  for	  inhibitory	  synapses	  (Reissner	  et	  al.,	  2008),	  was	  2.5-­‐fold	  downregulated.	  	  	   Another	   protein	   showing	   regulation	   on	   the	   expression	   level	   was	  dystroglycan,	  which	  was	   6-­‐fold	   increased	   in	   TM-­‐agrin	   overexpressing	  mice	  compared	  to	  control.	  The	  increased	  expression	  of	  dystroglycan	  in	  the	  cortex	  of	   TM-­‐agrin	   overexpressing	   mice	   constitutes	   the	   only	   exception	   to	   the	  general	   downregulation	   of	   GABAergic	   synapse-­‐associated	   proteins	   in	   this	  mouse.	   Dystroglycan	   has	   been	   shown	   to	   bind	   agrin	   (Bowe	   et	   al.,	   1994;	  Campanelli	   et	   al.,	   1994)	   and	   agrin-­‐immunoreactivity	   has	   been	   reported	   to	  colocalize	  with	  GABAergic	  postsynapses	  (Pribiag	  et	  al.,	  2014).	  Dystroglycan	  is	  a	   glycoprotein	   that	   is	   expressed	   as	   a	   precursor,	   which	   is	   cleaved	   into	   an	  extracellular	   protein	   (α-­‐dystroglycan)	   and	   a	   transmembrane	   protein	   (β-­‐dystroglycan)	  (Ibraghimov-­‐Beskrovnaya	  et	  al.,	  1992).	  Within	  the	  dystrophin-­‐associated	   glycoprotein	   complex	   dystroglycan	   links	   the	   cytoskeleton	   to	   the	  extracellular	  matrix.	  Dystroglycan	  is	  important	  for	  the	  stabilization	  of	  AChRs	  in	   the	  postsynaptic	   density	   of	  muscle	   fibers	   (Cote	   et	   al.,	   1999).	   It	   has	   been	  shown	   to	   bind	   to	  NtA-­‐agrin	   at	   the	  NMJ	   via	   agrin’s	   C-­‐terminal	   LG1	   and	  LG2	  domains	  (Campanelli	  et	  al.,	  1994;	  Bowe	  et	  al.,	  1994)	  and	  it	  is	  also	  expressed	  in	   the	   retina	   and	   the	   brain,	   where	   is	   has	   been	   reported	   to	   colocalize	   with	  GABAA-­‐receptors	   (Blank	   et	   al.,	   1997;	   Levi	   et	   al.,	   2002;	   Pribiag	   et	   al.,	   2014).	  Additionally,	  the	  LG-­‐domain-­‐containing	  synaptic	  adhesion	  proteins	  α-­‐	  and	  β-­‐neurexins	  were	  identified	  as	  presynaptic	  binding	  partners	  of	  α-­‐dystroglycan	  by	   affinity	   chromatography	   of	   brain	   homogenates	   (Sugita	   et	   al.,	   2001).	  Prolonged	   elevation	   of	   excitatory	   neuronal	   activity	   increases	   dystroglycan	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expression,	   which	   restores	   homeostasis	   (Pribiag	   et	   al.,	   2014).	   It	   will	   be	  interesting	   to	   see	  whether	  neuronal	   activity	   is	   indeed	   increased	   in	   the	  TM-­‐agrin	  overexpressing	  mouse	  brains.	  
4.4.	  Effect	  of	  TM-­‐agrin	  overexpression	  in	  the	  adult	  on	  existing	  synapses	  	  
Returning	  to	  the	  initial	  questions	  I	  posed	  earlier,	  the	  results	  obtained	  answer	  them	  as	  follows:	  1.	   Does	   the	   overexpression	   of	   TM-­‐agrin	   induce	   filopodia-­‐like	   processes	   in	  
vivo?	  	  	   No,	   TM-­‐agrin	   overexpression	   does	   not	   induce	   filopodia-­‐like	   processes	  
in	  vivo	  as	  it	  does	  in	  vitro.	  	  2.	   Does	   overexpression	   of	   TM-­‐agrin	   in	   glutamatergic	   neurons	   affect	   their	  existing	  synapses	  in	  the	  adult?	  	  	   Yes,	  rather	  than	  resulting	  in	  the	  formation	  of	  more	  synapses,	  TM-­‐agrin	  overexpression	  in	  adult	  glutamatergic	  synapses	  in	  vivo	  results	  in	  a	  change	  in	  the	  existing	  synapses,	   specifically	   in	  more	   intensely	  stained	  PSD95	  clusters,	  increased	   head	   size	   of	   dendritic	   spines	   and	   upregulation	   of	   glutamatergic	  synapse	  associated	  gene	  expression.	  Additionally,	  the	  overall	  dendritic	  spine	  head	  size	  was	   increased	  and	   I	  observed	  an	   increase	   in	   stubby	  spines	  and	  a	  decrease	   in	   mushroom	   spines.	   Also,	   expression	   of	   genes	   associated	   with	  glutamatergic	   synapses	   was	   observed	   to	   be	   upregulated,	   while	   the	  expression	   of	   genes	   related	   to	   GABAergic	   synapses	   was	   shown	   to	   be	  downregulated.	  How	  does	  TM-­‐agrin	  mediate	  these	  changes	  in	  adult	  synapses?	  Specifically:	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   1.	  Could	  the	  changes	   in	  dendritic	  spine	  head	  size	  and	  morphology,	   the	  increase	   in	   glutamatergic	   postsynapse	   staining	   intensity	   and	   regulation	   of	  expression	   profiles	   of	   synapse	   associated	   genes	   be	   the	   result	   of	   synapse	  strengthening?	   What	   would	   be	   the	   mechanism	   underlying	   the	   synapse	  strengthening?	  	  	   2.	   Does	   TM-­‐agrin	   overexpression	   only	   affect	   the	   neuron	   that	   is	  expressing	   the	   allele	   (cis-­‐effect	   or	   purely	   postsynaptic	   effects)	   or	   the	  neighbouring	  wildtype	  cells	  as	  well	  (trans-­‐effect	  or	  presynaptic	  effects)?	  	  These	  questions	  will	  be	  addressed	  in	  the	  following	  paragraphs.	  	  	   Ksiazek	  et	  al.	  demonstrated	  a	  decrease	  in	  excitatory	  synapse	  formation	  and	   a	   reduced	   mEPSP	   number	   in	   the	   murine	   cortex	   resulting	   from	   CNS-­‐specific	   agrin	   depletion	   (Ksiazek	   et	   al.,	   2007).	   Since	   the	   developmental	  progression	  of	  the	  agrin-­‐depletion	  was	  not	  analysed,	  the	  results	  can	  either	  be	  explained	   by	   endogenous	   agrin	   having	   a	   synapse-­‐inducing	   or	   a	   synapse-­‐strengthening	   effect.	   If	   TM-­‐agrin	   has	   a	   synapse-­‐inducing	   effect,	   we	   would	  predict	  an	  increase	  in	  the	  number	  of	  synapses	  after	  TM-­‐agrin	  overexpression	  in	   a	   system	   that	   allows	   plasticity.	   If	   TM-­‐agrin,	   however,	   has	   a	   synapse-­‐strengthening	  effect,	  meaning	  allowing	  more	  neurotransmitter	  to	  be	  released	  or	  more	  receptors	  available	   in	   the	  same	  number	  of	   synapses,	  we	  expect	  no	  change	   in	   synapse	   number,	   but	   an	   increase	   in	   the	   spontaneous	   and	   the	  glutamate-­‐evoked	  postsynaptic	  currents.	  	  	   I	   did	   not	   observe	   a	   significant	   increase	   in	   the	   number	   of	   synapses	  visualized	   by	   anti-­‐PSD95	   and	   anti-­‐bassoon	   immunoreactivity	   as	   a	  consequence	   of	   TM-­‐agrin	   overexpression	   (Figure	   17).	   However,	   the	  individual	   anti-­‐PSD95	   positive	   puncta	   were	   bigger	   and	   more	   intensely	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stained	   (Figure	   18).	   Likewise,	   in	   the	   Golgi-­‐stained	   sections,	   the	   dendritic	  spine	  heads	  of	  cortical	  layer	  2-­‐3	  pyramidal	  neurons	  were	  bigger	  on	  average	  (Figure	  19).	   In	  previous	  studies,	   it	  was	  shown	  that	   the	  size	  of	   the	  dendritic	  spine	  directly	   correlates	  with	   the	  number	  of	  NMDA	   receptors	   incorporated	  into	   the	   PSD	   (Takumi	   et	   al.,	   1999).	   In	   agreement	  with	   this,	   our	   expression	  analysis	   showed	   that	   the	  mRNA	   levels	   of	   the	   NMDA	   receptor	   subunit	   NR1	  were	  2-­‐fold	  higher	   in	  TM-­‐agrin	  overexpressing	  mouse	  cortices	  compared	  to	  control	  mice.	   In	  addition,	  preliminary	  data	  comparing	  the	  intensity	  and	  size	  of	   NMDAR1	   immunoreactivity-­‐positive	   clusters	   showed	   a	   trend	   towards	   a	  similar	   increase	   in	   fraction	   area	   as	   the	   PSD95-­‐immunoreactivity	   (data	   not	  shown).	  In	  summary,	  my	  results	  in	  adult	  CNS	  neurons	  would	  favour	  the	  idea	  of	  a	  synapse-­‐strengthening	  effect	  of	  TM-­‐agrin	  rather	  than	  a	  synapse-­‐inducing	  effect,	  since	  the	  number	  of	  synapses	  seems	  to	  be	  unchanged.	  	   Long-­‐term	   memory	   formation	   involves	   both	   de	   novo	   synaptogenesis,	  structural	   plasticity	   (Leuner	   et	   al.,	   2003)	   and	   synapse	   strengthening,	  functional	   plasticity	   (reviewed	   in	   Bernardinelli	   et	   al.,	   2014).	   Structural	  plasticity	  results	  in	  increased	  spine	  number	  while	  functional	  plasticity	  results	  in	  an	  increase	   in	  spine	  size	  and	  synaptic	  activity,	  meaning	  higher	  frequency	  of	  individual	  EPSPs.	  The	  possibility	  that	  agrin	  might	  be	  involved	  in	  regulating	  synapse	   strength	   is	   not	   unprecedented:	   PSD95	   upregulation	   has	   been	  implicated	  in	  synapse-­‐strengthening	  after	  training	  (Radwanska	  et	  al.,	  2011).	  Nikonenko	   et	   al.	   observed	   a	   8-­‐fold	   increase	   in	   total	   PSD	   area	   and	   a	   5-­‐fold	  increase	  in	  the	  number	  of	  perforated	  PSDs	  in	  response	  to	  increased	  levels	  of	  PSD95	  protein	  (Nikonenko	  et	  al.,	  2008).	   Interestingly,	   these	  processes	  were	  accompanied	  by	  an	  overall	  reduction	  in	  spine	  number.	  A	  larger	  postsynaptic	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glutamatergic	  density	  with	  more	  clustered	  PSD95	  and	  more	  PSD95-­‐scaffold-­‐associated	   NMDA-­‐receptors	   would	   be	   expected	   to	   exhibit	   more	   excitatory	  activity,	  meaning	  higher	  frequency	  of	  individual	  EPSPs,	  as	  has	  been	  observed	  after	   induction	   of	   LTP.	   This	   will	   be	   interesting	   to	   test	   in	   the	   future,	  performing	  extensive	  electrophysiological	  profiling.	  	   The	   results	   of	   the	   overexpression	   of	   TM-­‐agrin	   in	   the	   CNS	   should	   be	  compared	  to	  a	   line	  of	  experiments	   involving	  neuroligin-­‐1	  overexpression	   in	  the	   mouse	   CNS.	   Overexpression	   of	   Neuroligin-­‐1,	   a	   postsynaptic	   adhesion	  protein	  of	  glutamatergic	  synapses,	  leads	  to	  an	  increase	  in	  average	  spine	  head	  size,	  stabilisation	  of	  existing	  synapses	  in	  the	  adult	  in	  addition	  to	  formation	  of	  new	  synapses	  (Dahlhaus	  et	  al.,	  2010).	  This	  is	  in	  part	  consistent	  with	  our	  data	  in	   the	   cortex,	  where	   I	   observed	   an	   increase	  of	   overall	   dendritic	   spine	  head	  size	  (Figure	  19).	  Later,	  it	  was	  shown	  that	  the	  cytoplasmic	  tail	  of	  neuroligin-­‐1	  can	   modulate	   this	   synaptogenic	   effect	   by	   activating	   intracellular	   signalling	  cascades	  in	  addition	  to	  an	  adhesive	  effect	  (Hoy	  et	  al.,	  2013).	  While	  full-­‐length	  neuroligin-­‐1	   increases	   maturation	   of	   existing	   glutamatergic	   synapses,	  truncated	  neuroligin-­‐1,	  missing	  the	  cytoplasmic	  tail,	  increased	  the	  number	  of	  postsynapses	   and	   flexibility	   in	   memory	   tasks.	   These	   studies	   show	   that	  changes	   in	   synaptic	   protein	   levels	   can	   lead	   to	   increased	   maturation	   of	  existing	  synapses	  as	  well	  as	  an	   increased	  number	  of	  new	  synapses.	  We	  can	  conclude	   that	   TM-­‐agrin	  might	   act	   in	   a	   similar	   manner,	   possibly	   increasing	  maturation	   of	   existing	   synapses.	  What	   could	   be	   the	  mechanism	   of	   synapse	  strengthening	  by	  TM-­‐agrin,	  meaning	  maturation	  of	  existing	  synapses?	  	   Extensive	   in	   vitro	   studies	   of	   truncated	   forms	   of	   TM-­‐agrin	   have	   been	  performed	  to	  map	  the	  domains	  responsible	  for	  the	  filopodia-­‐inducing	  activity	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(McCroskery	  et	  al.,	  2006;	  Porten	  et	  al.,	  2010;	  Lin	  et	  al.,	  2010).	  The	  filopodia-­‐inducing	  phenotype	  of	  TM-­‐agrin	  overexpressing	  cells	  was	  independent	  of	  the	  cytoplasmic	   part	   of	   the	   protein.	   Additionally,	   the	   intracellular	   part	   of	   TM-­‐agrin	  shows	  little	  sequence	  conservation	  between	  mouse	  TM-­‐agrin	  and	  chick	  TM-­‐agrin	   (Neumann	   et	   al.,	   2001),	   but	   both	   induce	   the	   same	   in	   vitro	  phenotype	   in	   response	   to	   overexpression	   (Figure	   9).	   Therefore,	   the	  cytoplasmic	  tail	  of	  agrin	  is	  likely	  not	  to	  be	  involved	  in	  the	  filopodia-­‐inducing	  phenotype.	   Instead,	  agrin	  might	  be	  binding	  extracellularly	   to	  other	  proteins	  or	  dimerizing	  with	  itself.	  	   One	   possible	   mechanism	   underlying	   the	   potential	   synapse-­‐strengthening	   effect	   could	   be	   that	   TM-­‐agrin	   is	   acting	   via	   trans-­‐synaptic	  adhesion,	   by	   increasing	   binding	   between	   the	   synaptic	  membranes,	   thereby	  stabilizing	   synapses	   and	   by	   this	   favour	   particularly	   the	   stubby	   spine	  structure.	  Adhesion	  between	   the	  pre-­‐	  and	  postsynaptic	  membrane	  plays	  an	  important	  role	   in	  synaptogenesis	  as	  well	  as	   in	   the	  strengthening	  of	  existing	  synapses.	   Rather	   than	   a	   signaling	   ligand	   binding	   to	   a	   receptor,	   adhesion	  molecules	  span	  the	  synaptic	  cleft	  and	  give	  the	  synapse	  stability	  and	  in	  some	  cases,	  specificity	  (for	  review	  on	  synaptic	  adhesion	  molecules	  see	  Yang	  et	  al.,	  2014).	  One	  example	  of	  adhesion	  molecules	  involved	  in	  synaptic	  organization	  is	  the	  interaction	  between	  neurexins	  on	  the	  presynaptic	  side	  and	  neuroligins	  on	   the	   postsynaptic	   side,	   which	   is	   important	   for	   synapse	   maturation	   and	  function	  but	  not	  essential	  for	  de	  novo	  synapse	  formation	  between	  an	  axonal	  growth	  cone	  and	   its	   target	  neuron	   (Varoqueaux	  et	   al.,	   2006,	   for	   review	  see	  Sudhof,	  2008).	  Specificity	  for	  the	  synapse	  type	  is	  given	  by	  different	  isoforms	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of	   neuroligin	   being	   localized	   only	   to	   either	   inhibitory	   or	   excitatory	  postsynapses	  (Varoqueaux	  et	  al.,	  2006).	  	  	  	   Since	  agrin	   is	  expressed	  only	  as	  a	   transmembrane	  protein	   in	   the	  CNS,	  and	   concentrated	   at	   synapses,	   it	   can	   be	   assumed	   that	   a	   subpopulation	   of	  agrin	   spans	   the	   synaptic	   cleft	   acting	  as	   a	   trans-­‐synaptic	   adhesion	  molecule,	  comparable	   to	   the	   HSPG	   syndecan	   (Ethell	   &	   Yamaguchi,	   1999;	   Lin	   et	   al.,	  2007).	  Supporting	  this	  idea	  is	  the	  fact	  that	  agrin’s	  precise	  localization	  within	  the	   synaptic	   cleft	   is	  not	  known.	  Ksiazek	  et	  al.	   found	  anti-­‐agrin	   immunogold	  particles	  close	  to	  the	  pre-­‐	  and	  the	  postsynaptic	  side	  in	  electron	  micrographs	  (Koulen	  et	  al.,	  1999;	  Ksiazek	  et	  al.,	  2007).	  	  	   However,	  the	  agrin	  protein	  is	  approximately	  95nm	  long	  (Denzer	  et	  al.,	  1997)	  and	  can	  hence	  span	   the	  synaptic	  cleft	   several	   times,	  which	   is	  usually	  only	  20-­‐30nm	  wide	  (Gray,	  1959a).	  This	  makes	  the	  precise	  determination	  of	  localization	  difficult,	  and	  the	  possibility	  remains	  that	  it	  is	  distributed	  to	  both	  synaptic	  partners.	  	  	   In	  addition,	  McCroskery	  et	  al.	  found	  that	  depletion	  of	  agrin	  by	  siRNA	  in	  hippocampal	   neuronal	   cultures	   results	   in	   a	   decrease	   in	   the	   number	   of	  synapses	   also	   in	   cells	   where	   only	   the	   presynaptic	   neuron	   is	   infected	   with	  agrin	  siRNA	  lentivirus.	  However,	  the	  decrease	  is	  not	  as	  pronounced	  as	  in	  cells	  that	   show	   suppression	   of	   agrin	   on	   the	   dendritic	   postsynaptic	   side	  (McCroskery	  et	  al.,	  2006).	  	  	   Taken	  together,	  this	  suggests	  that	  TM-­‐agrin	  is	  needed	  on	  both	  sides	  of	  the	   synapse	   for	   proper	   synapse	   formation	   and	   might	   act	   as	   an	   adhesion	  molecule	   across	   the	   synaptic	   cleft.	   If	   TM-­‐agrin	   indeed	   acts	   as	   an	   adhesion	  molecule,	   it	  would	  be	  interesting	  to	  determine	  if	   it	  binds	  to	  itself	  across	  the	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synaptic	   cleft	   or	   if	   other	   extracellular	   matrix	   proteins	   are	   involved	   in	   the	  trans-­‐synaptic	  interaction.	  	  
4.5.	  Cis-­‐	  versus	  trans-­‐effects	  of	  TM-­‐agrin	  overexpression	  
TM-­‐agrin	  overexpression	  does	  not	  apparently	  have	  a	  synapse-­‐inducing	  effect	  in	   the	   adult	   CNS,	   since	   we	   do	   not	   observe	   an	   increase	   in	   the	   number	   of	  synapses	  in	  the	  brain	  areas	  following	  TM-­‐agrin	  overexpression.	  Instead,	  it	  is	  more	  likely	  that	  TM-­‐agrin	  overexpression	  in	  adult	  neurons	  leads	  to	  synapse-­‐strengthening	   specific	   to	   glutamatergic	   synapses,	   since	   the	   glutamatergic	  postsynaptic	  density	  clusters	  appeared	  significantly	  larger	  and	  more	  intense	  and	   NMDAR1	   receptor	   mRNA	   shows	   upregulation	   in	   the	   TM-­‐agrin	  overexpressing	  mice.	  	  	   Most	  genes	  tested	  tested	  that	  are	  associated	  specifically	  with	  inhibitory	  synapses	  were	   significantly	   downregulated	   in	   the	   TM-­‐agrin	   overexpressing	  mice.	   However,	   TM-­‐agrin	   controlled	   by	   CamKIICre	   only	   shows	  overexpression	   in	   glutamatergic	   neurons.	   This	   leads	   to	   the	   next	   question,	  whether	  the	  observed	  phenotype	  is	  a	  result	  of	  cis-­‐or	  trans-­‐effects.	  	  	   Our	   gene	   expression	   analysis	   results	   suggest	   a	   selective	   influence	   of	  TM-­‐agrin	   overexpression	   on	   excitatory	   and	   inhibitory	   central	   nervous	  system	   synapses.	   If	   only	   excitatory	   synapses	   are	   strengthened	   by	   potential	  TM-­‐agrin	   mediated	   adhesion,	   why	   do	   we	   observe	   a	   downregulation	   in	  inhibitory	   synapse	   associated	   gene	   expression?	   Is	   the	   TM-­‐agrin-­‐mediated	  effect	  on	  synapses	  due	  to	  a	  ci-­‐s	  or	  a	  trans-­‐	  activity?	  	  	   Out	   of	   all	   cortical	   cells,	   only	   the	   glutamatergic	   pyramidal	   neurons	  express	   the	   CamKII	   gene	   and,	   thus,	   only	   pyramidal	   neurons	   should	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overexpress	  CamKII	  promoter-­‐driven	  TM-­‐agrin	  (Erdmann	  et	  al.,	  2007,	  Burgin	  et	   al.,	   1990).	   In	   agreement	  with	   this,	   quantification	  of	  Cre	  positive	  neurons	  showed	   Cre	   immunoreactivity	   only	   in	   the	   pyramidal	   cell	   layer	   of	   the	  hippocampus	   CA1	   region	   (Figure	   13).	   However,	   the	   overexpression	  apparently	   affected	   GABAergic	   synapses	   as	  well,	   judging	   by	   the	   expression	  analysis	  showing	  downregulation	  of	  several	  genes	  associated	  with	  GABergic	  synapses.	   Four	   different	   synapse-­‐types	   can	   be	   distinguished,	   if	   we	   assume	  that	   TM-­‐agrin	   principally	   has	   the	   ability	   to	   locate	   to	   both	   the	   pre-­‐	   and	   the	  postsynaptic	  membrane:	  	  	   1.	   A	   glutamatergic	   synapse	   between	   two	   mutant	   pyramidal	   neurons,	  presumably	  exhibiting	  high	   levels	  of	  TM-­‐agrin	  on	  both	  sides	  of	   the	  synaptic	  cleft	  (Figure	  20,	  synapse	  1).	  	  	   2.	  A	  GABAergic	  synapse	  between	  a	  wildtype	  inhibitory	  interneuron	  and	  a	  mutant	   pyramidal	   neuron,	   exhibiting	   high	   levels	   of	   TM-­‐agrin	   only	   on	   the	  postsynaptic	  side	  (Figure	  20,	  synapse	  2).	  	  	   3.	  A	  glutamatergic	  synapse	  between	  a	  mutant	  pyramidal	  neuron	  and	  a	  wildtype	   inhibitory	   interneuron,	   exhibiting	   high	   levels	   of	   TM-­‐agrin	   only	   on	  the	  presynaptic	  side	  (Figure	  20,	  synapse	  3).	  	  	   4.	  A	  GABAergic	  synapse	  between	  two	  wildtype	  inhibitory	  interneurons,	  which	   only	   exhibits	   endogenous	   levels	   of	   TM-­‐agrin	   on	   both	   sides	   of	   the	  synaptic	  cleft	  (Figure	  20,	  synapse	  4).	  	  	   It	   is	   unclear	   at	   this	   stage,	   which	   of	   the	   four	   potential	   TM-­‐agrin	  localizations	   causes	   the	   effects	   of	   TM-­‐agrin	   overexpression.	   The	   most	  straightforward	   interpretation	   of	   the	   effect	   of	   TM-­‐agrin	   overexpression	   on	  synapse	  structure	  is	  that	  TM-­‐agrin	  affects	  only	  the	  postsynapses	  on	  TM-­‐agrin	  
DISCUSSION	   	  
91	  
overexpressing	   pyramidal	   neurons.	   This	   would	   mean	   that	   the	  downregulation	   of	   genes	   associated	   with	   inhibitory	   synapse	   function	   at	  GABAergic	   synapses	   is	   caused	  by	  TM-­‐agrin	  overexpression	   in	   the	   same	  cell	  (cis-­‐effect,	   Figure	   20,	   synapses	   1	   and	   2),	   and	   that	   the	   changes	   in	   mRNA	  expression	  levels	  result	  exclusively	  from	  the	  pyramidal	  neuron	  population.	  	  	   This	   would	   predict	   that	   TM-­‐agrin	   is	   directly	   present	   at	   GABAergic	  postsynapses	  and	  has	  a	  downscaling	  effect	  on	  the	  expression	  levels	  of	  genes	  associated	  with	  GABAergic	  synapse	  function.	  Alternatively,	  the	  glutamatergic	  postsynapses	  negatively	  influence	  neighbouring	  GABAergic	  postsynapses	  via	  a	  secondary	  mechanism.	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Figure	   20:	   Four	   different	   synapse	   types	   that	   TM-­‐overexpression	   can	   affect.	   A)	  
Interaction	  modes	  between	  excitatory	  pyramidal	  neurons	  and	  inhibitory	  interneurons	  
in	   the	   cerebral	   cortex.	   Excitatory	   synapses	   are	  highlighted	  by	   green	  dots,	   inhibitory	  
synapses	  by	  red	  dots.	  TM-­‐agrin	  is	  assumed	  to	  be	  able	  to	  distribute	  in	  the	  pre-­‐	  and/or	  
the	  postsynaptic	  partner	  of	  a	  synapse.	  This	  creates	   four	  different	  scenarios	  how	  TM-­‐
agrin	  overexpression	  can	  affect	  synapses	  (B).	  1)	  A	  glutamatergic	  synapse	  between	  two	  
pyramidal	   neurons,	   overexpressing	   TM-­‐agrin	   on	   both	   synaptic	   membranes.	   2)	   A	  
GABAergic	   synapse	   on	   a	   pyramidal	   neuron,	   overexpressing	   TM-­‐agrin	   only	   on	   the	  
postsynaptic	   membrane.	   3)	   A	   glutamatergic	   synapse	   on	   an	   inhibitory	   interneuron,	  
overexpressing	  TM-­‐agrin	  only	  on	  the	  presynaptic	  membrane.	  4)	  A	  GABAergic	  synapse	  
between	   two	   inhibitory	   interneurons,	   of	   which	   neither	   partner	   overexpresses	   TM-­‐
agrin.	  This	  type	  of	  synapse	  could	  only	  be	  affected	  by	  secondary	  circuit-­‐ramifications.	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4.6.	  Working	  model	  
We	   observed	   that	   the	   PSDs	   of	   glutamatergic	   synapses	   and	   dendritic	   spine	  heads	  are	  larger	  and	  incorporate	  more	  PSD95	  scaffolding	  protein	  in	  response	  to	  TM-­‐agrin	  overexpression	  in	  the	  adult	  mice.	  Additionally,	  gene	  expression	  levels	   of	   proteins	   at	   glutamatergic	   synapses	   were	   upregulated,	   while	   gene	  expression	   relating	   to	   GABAergic	   synapses	   was	   downregulated.	   It	   appears	  that	   TM-­‐agrin	   affects	   excitatory	   and	   inhibitory	   synapses	   in	   a	   directly	  opposite	   way.	   Three	   different	   scenarios	   might	   explain	   these	   results	   by	  making	  use	  of	  the	  model	  of	  the	  four	  synapse	  types	  described	  in	  Figure	  20.	  	   Scenario	   one:	   the	   synapses	   are	   strengthened	   by	   TM-­‐agrin	  overexpression,	   resulting	   in	   more	   intensely	   stained	   PSD95	   clusters	   and	  upregulation	   of	   NMDA	   receptor	   expression,	   if	   TM-­‐agrin	   is	   present	   in	   high	  levels	   at	   both	   sides	   of	   the	   synaptic	   cleft	   (Figure	   20,	   synapse	   type	   1).	   Any	  other	  combination	  (Figure	  20,	  synapse	  types	  2,	  3	  and	  4)	  results	  in	  a	  synapse-­‐weakening	   effect	   accompanied	   by	   downregulation	   of	   receptor	   genes.	  GABAergic	   inhibitory	   synapses	   in	   this	  model	  never	  have	  high	   levels	   of	  TM-­‐agrin	  on	  both	  sides,	  while	  there	  are	  glutamatergic	  synapses	  with	  and	  without	  high	   levels	   of	   TM-­‐agrin	   on	   both	   sides	   (Figure	   20,	   synapse	   1	   and	   3	  respectively).	   If	   we	   assume	   that	   agrin	   only	   strengthens	   the	   synapse	   if	   it	   is	  present	  at	  a	  stoichiometric	  ratio	  on	  both	  sides,	  this	  would	  explain	  why	  only	  glutamatergic	  synapses	  are	  strengthened.	  On	  the	  molecular	   level,	  one	  could	  interpret	  the	  downregulation	  of	  GABAergic	  synapse	  associated	  genes	  by	  the	  adhesion	   molecule	   disturbing	   the	   pre-­‐	   or	   postsynaptic	   membrane	  organization	   when	   left	   without	   sufficient	   amounts	   of	   a	   binding	   partner.	   I	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favour	  this	  scenario	  because	  it	  explains	  why	  only	  glutamatergic	  synapses	  are	  strengthened	  by	  TM-­‐agrin	  overexpression.	  	  	   Scenario	  two:	  the	  TM-­‐agrin	  I	  cloned	  (y4/z0)	  affects	  GABAergic	  synapses	  only	   on	   the	   postsynaptic	   side,	   and	   only	   in	   a	   manner	   which	   results	   in	  downregulation	   of	   postsynapse-­‐associated	   genes	   (such	   as	   genes	   coding	   for	  the	  GABAA	  α1	  subunit,	  Neuroligin-­‐2	  and	  gephyrin).	  Considering	  the	  intricate	  organization	  of	  the	  cerebral	  cortex,	   it	   is	  plausible	  that	  a	  lack	  of	  inhibition	  in	  the	   circuit	  would	   result	   in	   a	   shift	   in	   the	  excitation	   to	   inhibition	  balance	   (as	  shown	  in	  neuronal	  cultures	  for	  example	  in:	  Marchenkova	  et	  al.,	  2016).	  On	  the	  molecular	  level,	  one	  interpretation	  could	  be	  that	  TM-­‐agrin	  overexpression	  on	  one	   side	   of	   the	   synaptic	   cleft	   blocks	   other	   synaptogenic	   proteins	   from	  strengthening	   the	   GABAergic	   synapse.	   One	   candidate	   protein	   would	   be	  pleiotrophin.	  Pleiotrophin	  strengthens	  GABAergic	  synapses	  as	  shown	  by	  the	  appearance	   of	   higher	   frequency	   of	   spontaneous	   postsynaptic	   inhibitory	  currents	   in	   pleiotrophin	   overexpressing	   mice	   (Pavlov	   et	   al.,	   2006).	   Since	  agrin	   binds	  pleiotrophin	   at	   the	  NMJ	   (Daggett	   et	   al.,	   1996),	   it	   is	   conceivable	  that	   TM-­‐agrin	   counteracts	   this	   inhibitory	   synapse	   strengthening	   effect.	  Alternatively,	   TM-­‐agrin	   could	   be	   scavenging	   soluble	   synapse-­‐strengthening	  factors.	  	  	   A	   third,	   entirely	   different	   scenario	   to	   explain	   why	   TM-­‐agrin	  overexpression	  does	  not	  lead	  to	  an	  increase	  in	  synapse	  numbers	  but	  instead	  to	  larger,	  denser	  PSDs	  in	  response	  to	  adult	  onset	  of	  overexpression,	  would	  be	  the	  reduced	  plasticity	   in	  adult	  networks.	  Agrin	  overexpression	  was	   induced	  in	  postnatal	  week	  five,	  which	  is	  two	  weeks	  after	  the	  developmental	  phase	  of	  synaptogenesis	   is	   finished	   (Li	   et	   al.,	   1997;	   O'Connor	   et	   al.,	   1994).	   If	   the	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neurons	   cannot	   accommodate	   more	   synapses,	   the	   overexpression	   of	   a	  synaptogenic	   protein	   might	   be	   expected	   to	   act	   as	   a	   synapse-­‐strengthener.	  Precedence	   for	   synapse	   inducers	   having	   different	   effects	   on	   synapses	  depending	   on	   the	   maturity	   of	   the	   neurons	   is	   the	   overexpression	   of	  neuroligin-­‐1	   in	   immature	   hippocampus	   dentate	   gyrus	   granule	   neurons	  (Schnell	   et	   al.,	   2012).	   In	   contrast	   to	   the	   overexpression	   in	   adult	   neurons,	  which	  mainly	  leads	  to	  an	  increase	  in	  average	  spine	  head	  size	  and	  stabilization	  of	   existing	   synapses,	   new-­‐born	   neurons	   infected	   with	   neuroligin-­‐1	  overexpressing	   retrovirus	   form	   a	   larger	   amount	   of	   filopodia	   and	   exhibit	   a	  higher	  density	  of	  dendritic	  spines	  on	  growing	  dendrites	  than	  their	  wildtype	  neighbours	  (Dahlhaus	  et	  al.,	  2010).	  Since	  new-­‐born	  granule	  neurons	  need	  to	  integrate	   and	   form	   new	   connections	   in	   the	   existing	   hippocampal	   network,	  this	   study	   suggests	   that	   the	   effect	   of	   Neuroligin-­‐1	   is	   dependent	   on	   the	  plasticity	   of	   the	   network.	   TM-­‐agrin	   could	   act	   in	   a	   similar	  manner,	   inducing	  new	   filopodia	   in	   an	   immature	   network	   but	   stabilizing	   existing	   mature	  synapses	  in	  the	  adult	  network.	  However,	  this	  scenario	  does	  not	  explain	  why	  glutamatergic	   and	  GABAergic	   synapses	   are	   affected	   in	   an	  opposing	  manner	  by	  TM-­‐agrin	  overexpression.	  	  
4.7.	  Future	  experiments	  
How	  do	  we	  distinguish	   the	   three	  different	  scenarios	  mentioned	  above	   from	  each	  other?	  Additional	  experiments	  are	  needed	  to	  accurately	  dissect	  whether	  TM-­‐agrin	   acts	   as	   a	   synapse-­‐strengthener	   when	   present	   on	   both	   synaptic	  partners,	   whether	   it	   only	   negatively	   regulates	   GABAergic	   synapses,	   or	  whether	  its	  endogenous	  function	  during	  development	  is	  in	  fact	  synaptogenic.	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   First	   and	   most	   obvious,	   the	   functional	   analyses	   of	   GABAergic	   versus	  glutamatergic	   synapses	   needs	   to	   be	   completed	   by	  Western	   blotting	   to	   test	  whether	  the	  candidate	  proteins	  show	  regulation	  on	  the	  protein	  level,	  as	  well	  as	  by	  analysing	   the	  distribution	  of	  GABAA	  receptor	  and	  gephyrin	   in	  cortical	  sections	  and	  determining	  if	  their	  distribution	  changes	  in	  response	  to	  higher	  levels	  of	  TM-­‐agrin.	  	  	   To	   test	  whether	   the	   effects	  of	   increased	   size	  of	  dendritic	   spine	  heads,	  larger	   and	  more	   intensely	   stained	   postsynaptic	   densities	   in	   the	   cortex	   and	  hippocampus,	   and	   the	   regulation	   of	   excitatory	   and	   inhibitory	   synapse	  associated	   genes	   truly	   translate	   into	   functional	   plasticity,	   we	   need	   to	  electrophysiologically	  characterize	  neurons	  which	  overexpress	  TM	  agrin	  and	  their	   pre-­‐	   and	   postsynaptic	   partners.	   By	   comparing	   the	   frequency	   of	  spontaneous	   postsynaptic	   activity,	   or	   the	   threshold	   to	   induce	   epileptic	  seizures,	   one	   could	   test	   whether	   the	   basal	   activity	   is	   indeed	   higher	   in	  pyramidal	   neurons	   overexpressing	   TM-­‐agrin.	   One	   way	   to	   conclusively	  determine	   whether	   GABAergic	   interneurons	   are	   affected	   in	   trans	   by	  neighbouring	   TM-­‐agrin	   overexpressing	   pyramidal	   cells	   would	   be	   by	  selectively	  patch-­‐clamping	   inhibitory	   interneurons	   in	   the	  cortex	   in	  order	   to	  test	  whether	  they	  show	  decreased	  inhibition	  in	  the	  TM-­‐agrin	  overexpressing	  mice.	  	  	   Additionally,	  testing	  for	  behavioural	  effects,	  such	  as	  shorter	  translation	  of	   newly	   acquired	   abilities	   into	   long-­‐term-­‐memories,	   using	   for	   example	   a	  water	  maze	  test	  (D'Hooge	  and	  De	  Deyn,	  2001)	  is	  a	  prerequisite	  to	  analyse	  the	  relationship	   between	   functional	   plasticity	   and	   facilitation	   of	   long-­‐term-­‐memory	  formation	  after	  TM-­‐agrin	  overexpression.	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   The	   Golgi	   impregnation	   method	   has	   one	   obvious	   disadvantage:	   One	  cannot	  co-­‐stain	  for	  cell-­‐specific	  markers.	  Since	  the	  Cre-­‐induction	  rate	  can	  be	  estimated	  to	  be	  around	  70%,	  it	  would	  be	  interesting	  to	  confirm	  the	  results	  of	  dendritic	  spine	  morphology	  and	  extend	  the	  analysis	  to	  neuronal	  morphology	  by	  analysing	  Thy1-­‐YFP-­‐H	  mice	  (Feng	  et	  al.,	  2000).	  These	  mice	  express	  YFP	  in	  only	   a	   small	   subset	   of	   neurons.	  This	  would	  make	   it	   possible	   to	   analyse	   the	  dendritic	  spines	  in	  detail	  using	  confocal	  microscopy	  and	  restrict	  the	  analysis	  to	  confirmed	  Cre-­‐positive,	  TM-­‐agrin	  overexpressing	  cells.	  	   In	  addition,	  a	  more	  detailed	  analysis	  of	  single	  cells	  would	  be	  possible	  in	  cultures	   of	   embryonic	   neurons.	   Primary	   neuronal	   cultures	   are	   very	   useful	  tools	   to	   study	   neuronal	   circuits	   because	   individual	   synapses	   can	   be	   traced	  back	  via	  the	  dendrites	  to	  their	  neuron.	  In	  contrast,	  the	  3-­‐dimensional	  in	  vivo	  system	   makes	   tracing	   of	   individual	   synapses	   difficult.	   By	   visualizing	   the	  different	   neuronal	   populations	   with	   specific	   markers	   and	   staining	   their	  dendrites	   in	   vitro,	   one	   could	   analyse	   the	   individual	   effects	   on	   synapses	   of	  glutamatergic	   and	   GABAergic	   cells.	   This	   would	   be	   another	   approach	   to	  determine	   whether	   the	   GABAergic	   synapse-­‐associated	   gene	   expression	  profile	  should	  be	  interpreted	  as	  a	  cis-­‐effect	  or	  a	  trans-­‐effect.	  	  	   There	   is	   a	   possibility	   that	   the	   different	   TM-­‐agrin	   isoforms	   expressed	  during	  the	  synaptogenic	  period	  (Li	  et	  al.,	  1997)	  in	  the	  mouse	  exert	  different	  functions.	  Therefore,	  another	  interesting	  set	  of	  in	  vitro	  experiments	  would	  be	  to	  clone	  and	  express	  the	  different	  isoforms	  in	  culture	  and	  test	  if	  the	  effects	  on	  PSD95	  and	  gephyrin	  clustering	  differ	  between	  them.	  	   The	  third	  scenario	  implies	  that	  agrin	  is	  in	  fact	  acting	  synaptogenic,	  but	  the	   system	   we	   are	   using	   is	   not	   plastic	   enough	   to	   accommodate	   more	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synapses.	   One	   way	   to	   test	   this	   alternative	  model	   would	   be	   to	   overexpress	  TM-­‐agrin	  in	  a	  more	  plastic	  system,	  i.e.	  to	  perform	  early	  postnatal	  induction	  of	  expression.	  Neurogenesis	  in	  the	  mouse	  starts	  around	  embryonic	  day	  10	  to	  12	  (Molyneaux	   et	   al.,	   2007),	   but	   the	   CamKIIα	   promoter	   only	   drives	   gene	  expression	  from	  around	  postnatal	  day	  3	  (Casanova	  et	  al.,	  2001).	  However,	  it	  would	  be	  interesting	  to	  determine	  whether	  the	  overexpression	  effect	  differs	  from	  the	  adult	  and	  if	  we	  could	  observe	  an	  increase	  in	  synapse	  numbers.	  	   Taken	  together,	   in	  addition	  to	  raising	  new	  questions	  opening	  the	  door	  to	   further	   experiments,	   the	   new	   evidence	   provided	   here	   of	   TM-­‐agrin	  overexpression	  resulting	  in	  an	  increased	  size	  of	  dendritic	  spine	  heads,	  larger	  and	   more	   intensely	   stained	   postsynaptic	   densities	   in	   the	   cortex	   and	  hippocampus,	   together	   with	   the	   regulation	   of	   excitatory	   and	   inhibitory	  synapse	   associated	   genes	   in	   response	   to	   TM-­‐agrin	   overexpression,	   added	  significantly	  to	  the	  understanding	  of	  TM-­‐agrin	  function	  in	  the	  CNS.	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  reading	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  wildtype	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